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ABSTRACT
Rat· !:!erum phO~phorylch.oJ.ine binding prote.in, (peBP) · ....8:s
~reviously shown to inhibit hepa~fl)-lipaprotein...preci~·i'ta't~?n
reactian~ "Compa~ison of.·the effect of Pr.;BP ~.I). hepa'rin-
.""iof' PCap to m.uitilaflleil.a~ ii.pos.omes· ~l7pare,d.Th~' b'indirg'\-. .
with -eg9 phosphat.idylchoHh·e (PC) and lysophosphatidyHholine
U.PC)' was !k~died and \he 'b~n~~'ng .....as found ~o 'be.ca2~.'
'd~pendQnt and r~q:u'tred" the in~o;pora~ion of 2~'" LPC' ~ntQr; tlT~
., --_.._--
,li:posome~: 'The bind;g w:~ .inh,ibited by PhosPh.or.y~Chol.ine
. nl-chC?line). s'ubst;ituti.on of phospho'rylcholine head groupS
b¥ ph~sphOrYlethanolamineand phosphox;ylrt..,rine on the PC 'of'
the Hposomes reduced 'the blnding considerably .indicating·
inVO'iven:'~nt;,of _the PhOS.Ph~;~lch~i.ine he~d gr~uPl} :in t.he·
. . . r
,b,i~<\ing of PCBP to liposomes. .
Studies on; t}:l.e ·b,tnd.if!.g of human pta.ama,2:!P0ltrotei08 to
'oJ PCBP ,illlll"!ObH'iz~d on sePha~ose,aho~~d 'that v~y 10.... · den~ity
·lip.oprotei~s "-(VLOL) were 'part'lally" b-ound . and the: bound
. :--,' .,......
fractfon, -contai.~e:d higher amou~ta of apoprotein <,apo >.
, . . .
lipoprote.;i..n PJ"e.c.ipitation rlj!action' with similar, pro~eins
" fr~m. ~ther. species reve",led a 'strikillg 'di~ferent;:e ·b.~twee~
the glycasylated rat .peBP. an~ fem~le hamster fP ~_n4-the n?"n-'
. glycosyla ted vat:iet.ies . (human ~nd ra.bbit t~P-' s). ,WberE1~~ FP:
shared the ihhil;litary effect wi,'th rat. PeBP,. h"uma~ anp-_ rabb"it
. CRP, failed to inh~b.i.t· l;.he· prec",iJ;lita,ti"on re,ac'tion aU~9;8'tin~,~
.a, r,~~~ ,_<;If _#the' ~i~~t~ aci,.d reSid~e~, an P9~p .apd ,~~._~~.:~th:~.·. .', ....
....n. ~echanisni Of -inhib,it-i0!1 r;f h,:!parin-lipopr,ote~.n''p~.ecipi~aH.on_<....._,





of . PeSP _~o. the L~L receptor--..-!.i te.
, . ' , I •
The effectiveness of ,Sepharose,:,PCS·::.I:O.lumns to' ~~n~
\
Inve.st;lg",tions 'to·"exam'ine the 'effec:;t of PCBP' on the
.,' ,'- ,
-'c -D.hl'f.?"'?:'.jiP"'9f-~ma.n----t.DL--t.~Cept:orsCd. li ..:err--mem'''''r.larn.;I'''e".-s----'~-
from estradiol tr~eated ra,ts showe.d' .•.that, i;'CBP --tnh1.b:.ytei:1ClHi--·-.-,~"~:
bind-ing of LDL to receptors. p~~incuba~'ion of l'iver'membran~s
r with .PC~~ .di,d n,ot ',a~~ct the b"ir:idin.9 of~.121I:-LDL to. the
· m~mb~~ne~. ,Gel filtratl<?n ~n~lysis of, the in9ubation p~odUCt.s
fro~ ~he,LDL-receptor ass·aya'. Bh~w~ci·.a' ~onc:entration dep'e~dent
biri4in~ :~~'" <2S'I~-'PCBP .to:. ·~D~..· '~ese' r'es~lts~99~S~ .t~a~ thl;!
,inhibitory effect of. pesp is ·p~ObablY·· due to .flhi.d. ph.as'e
" '(. . '':'
interactions between LD~' and PC,8P. <;lnd rio~ .due, to the bin~int;l
'E. All' the :.19W 'density lipop~oteinB_(LPL) w~l:'e bOU.;:d to the
column. Incase of h~gh d~n·~i.ty l:ip.oprot~ins '(HUL) only;a sltla.l:l
, fraction was r.eta~ned· on the column but that b~~nd fracti~n·.
contilin.ed all' the' apo E an.d·Lp(a) al-tplied. The binding 0,£'
l1pop'rotein1J" was ca 2+ dep~ndeht ~nd'the bound~~pop~otei~s ~ere
eluted by ,a P-choline gradient..' ',Prior ',I;!quilibratlon ,"af
· sePha~ose-p.CBP co~umn ....it~. P-~oline, 'preve~ted the binding'
of' LDL ,but' the removal of 'siadc 'a.cid from PCBP liad"no
eff:ect',cm th'e bindi"g of lioL tc; immobili~ed desialylated,
.......~BP. ·Chemical m6diiica~ion o~' argi.nyi': ~esid'ties on ~pd a.' in
LDL r~suited 'in"ttiarked ~~duct.i6n'~f.bin.~~n~·~her,e·as~pdi~ica,~io~
·df, "lYSiri~'-:'i'esi'due" had'~~" effe~t..' The. resul t-~ 'sugge~t a




LDL from cpntrol and hypercholest.rolel~ic
rabbits' ......he"ri ~sed ~ in' 'r1!""xtr,acorporeai plasm~phereticr system .
....all tested, Results sho.... ed that oSepharose-pC.BP colUinris
bound some. circulating plasm., Hpoprot.eins· an~ most (>90\)
of tli.e· /bound liP·oprol;.eil1-.','fraction cont,atn?n VLOL + .LD~.·
The results ':obt,ained' in this _stu~y' support the possibility
..........Of ~ role of rat P~BP '~nd similar cit'culati.ng. PhoSPh6rYlchOiin~'
·binding proteins'(of oth~r species in .liPo p rp t"e\n. ;Eh.abOl.i. 9m'~ .:
. . -,': ',- ~ \
.. '. -.. ,
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CHAPTER I
INTRODUCTioN - A REVIEW
Lipids when transported.. in ~rasma exist as soluble
complaxes 'with' speci'£ic protei!l~ ter~ed aApOlipoproteins "
or a~proteins (apo). The lipid-protein complexes in p;asma,i
are te..r!fled as rrp~protei'ns. The function, of lipop·rotEdns· i~
i,
t~ 1;raneP.'or~' hydrophobic Ii-pide in. the aqueous. erolirOhmrnt
of pla,sma from the tissu~s, that synthesize lipids to /the
tissues that utilize them. The t;ansport function and
. m~ta:bolic £'ate ,of lipopro't.eins, ~epend pril'!\ari lyon the
structure of· li'poproteins ~and the interactions ,th~Y undergo
in t~; Ph.Yei010gi,~~l'.mUoieu ;{~th',p~~ety ce~,7'ul.a~ ~rid e-l.:a.. "
cel~.ular macrolfl~le~ul,es.· In ,tnis thesis! ,st~dies' a~presen,t,~_
on the iz:1teractlon of lipoprote';'n$ with a phosphorylcholihe
'. bi~ding protein (P:CBP) trom rat serum. T.he'refore; the ,aim 'of ...
this' reviC!w-i~ to' briefly 'introduce ,the reader to the .f~el!i~
ofplall:ma lii!gprotei':!so In addition, studies on the'interact~on
of ~ lipoproteins w~th glycos4llltnoglycans have ~een included
which are relevant "to the work reported in th.is thesis .
...·Fi~al~y., major, POird:; of in~ormation 'on the ,structure .and'
oproperties, ,of C":re'acti~e prQt~ins - a family of., 'prote~ns
liIith'ligand ,:!pecificity ,toward~ phosphoryl~holine. have been
presented.
1 . .1. .OVervie.... on Plasma Lipoprcn.eins
A. General phys'icochemi.cal propertiea
. ,"
Lipoproteins represent the third lllOst abundant group of
extra~~lar~cronaolecules in the circulation of huraa.ns, only
albUrni~'gamma 9lob~lins b~in9 present in great:r amounts.
Amongst the plasma proteins, npoproteins have a uniquely
1010' de,ns~t.¥. Depending. on' ;~t~'.re ~oportions o£ lipid and.
protein~ {n the liipoprotein, the size llnd hydrated density of
- .1/.
lipoproteins 'vary, ,c~D8~derabl.y. Plasma lipoprote~ns were
first separat.E;d ant! classified According ,t.o their differential
. . . . '"
, elec.trophoretic mi,sration on ,SOlid' sup~,rt meula in.to'thoa,e
remaining at the origin: beta:- ' pre beta- ~n_d alpha m"igrat.in9
species (TabJ,e.l) U I .
,.' Lipoproteir:s are .now IllOst co~only isol~te~ on a large
scal~py ...s~uential ultr~ntrifu9al fro~t~t~on at. i'tcrea~ing
den$it.y solutions of SOdi~ chloride or sodium bromide (2)'.
. Thel'"f·. are' four major classes of lipoproteins.~ isoia~ed at
different dd'hSit-ies viz.... the chylomici'ons.• very low 'density
C lipoprota.ns (VLDLo.), low density "lipOprote~n8 (LOW.' and the
nigh densi ty lipopro~eins (HOL), ,111ese are consid~red to
'repr'ese~t tit,. major iipoprotein species in humans, (3).
Within- each cLass, subpopulations of particles have beEtn
recognize'd ....he~ the. more comn:only used floatation tec~~iqueS
.... ere comPl,ement.,ed· './ith densi.ty gradierit' fractionation.
affinity and col'umn chromatogral:lh'y, and elect:ropho:etic ~
':..:






Classi'fication of )?lasmei: l'ip~pr~teins.
...-:-
Lipoprotein ,- . Density'" Diameter· Mo!"ecular "-e=>- _





Chylomicrons <0.94 750-1000() origin
VLOL 0.94-1. 90.6 550 5.27 ,..,..,..
IDL . 1. 006:..1. 019 . 250 4.75 beta
LOL 1. 019-1. 063 . 200 3.95 beta·
" 1.063"-1.125</HDL? 110· .0.22 alpila
HDL3 1.125-1. 21 B8 0.16 alpha
,-,









of VLDL have been identified. ''The Lor.. class has bep.n ,1fvidect'
...
fnto .two main' subclasses, intermediate density Hpopr-oteins
.(IOL) of d 1.006-1.019 g/(111 and LOt. prop~r of d 1.019-1.063
g/ml. Of the HDL' s. ~he best' defined sUbclasse~b"y flotationa 1
criteria are HOL2'\d \.06h~.120) and \1~L) (d.l.i.20-1.2\O 9
Iml).. The average chemical camp9sition of the va;-ious
lipop.rotein species is' shown in 'I'abl~ 2 •.Movi~9 across th~
Table 2 from.chylomicrons to HDL) •.the 7on~ent5 of.-~rote.in•
. / chol.~steryl ester and PhOSPh?li~idS inct"e3S~. \ whereas the.'
"trig'lyceri<:le content deCreaGes: 'rhus tlie chylomic\-ons' and ,the
V.L~L, are rel~tivelY triglyceride rich wherea;J. approximat~ly
half of the'l.ipid (0 HOI., p~cies' is .phosphr:llipid,. The
major" constitue:lt, .of the ~~hO~iPi,J1 in the _li.~qproteins
i~ pnosphatidylchol.inf'l (pcl, .to acloitio" to thO! ahove! rnentionen.
~ajor "1ipoprotei~ spec+es, in humans, B.erg (5) has uescri.b~n
\
,another minor lipopcotein', Lp(a) lipoorotein, .....hich is
t) P"s.:'. in ,.,yio,.amo"t' to mo",' oo·,ma.' i"li'iouais.·
Lp(a) lipoprotein is choles"t.E!rol-rich and contains the
, si.alic acid rich LPJ.!~.r antigen,
Apol~poprotein5 ,
Studies conducted during the last several ye"l.:g· have
.~ sho.....n that in addition to the solubilization of 'hydcophQbi'c
, , . ,
lipids in the aqu~ous environment of the" pta'sma, the apoprot~tn5
have' .'important' m~tabolic functions. The maj~r biOSY~the~Lc








CJ.ernieal cOllpOaltioo of plasma lipoproteins












.... '. '-'. .:·:'7;"'::1
of the !tIajor apoproteins are present.ed in The
nomen:lat.ure of apoprot.eins -introduced by Alaupovic
(6)\ is most ..... idely used and ha; be,en' follo\<,6d' in this thesill.
At least five major apclptot.eins namely A, B, C, 'U and ~ huv-e
been charact.erized. The' A apoprot.eina, apo A-I. A-II a'nd A-
IV are th~ee distinct proteins predomina"ntly found in the IlDL
dem.;i ty range ~n pla"sma and ~re ~lSO aseociated ..... i til <;:hylond.crone
('Table 3). Apoprotein-"B (apo 8) is the'II',ajor apoprotein ,of
LDL and is ~lso present in VLDL 'and chylomicrona. Apo B is
extremely insoluble in aqueous b~J=fers after the lipid!" have
,bee:n removed from the lipoprotein. It ia sensitive to
oxidatLon. and pf'oteases .• Handicapped by theB~ difff<;u'lotiea',
e .....en the estim.tted n>'olecular~.~ight: of this -'apoprotc'in is
unce.tain. Rece~t~y,- Kane!.!:.!!. (7) "hav;; shown that ap,o a
'i.s, hetero9~neal,1S and .exist;s primarily as ~:¥o'~ forms: apo B-
'-..). 100 a high~r molecular w'eigh..t form and. a'p0 8-48 the lower
moleculO:r weight form. Apo 1:S-100 ia synthesiznd exclusively
by the liver whereas apo .B-4tl is synthesized by int.estine
The C iilPoprotein~ (apo C) are represented by three
low moiec:ul~r weight 'proteins designated" as' apo' C-1, C-Il.
and C-I1I. Th-ese ~poprotein's are component,s of. c.~YIOmicro~8:·
VLDL' and HOL. Apo O. aLso tel:med as ap,o A--Il1 by Kastner.
\/j), is assoc:iatecl with HDL. Apo E is a, constitu"ent. of
cJ;ly10microns, VLD~'and HOrA The amino acid s~qu6nc:eB of. ,apo
A-I, A-~~~ C-:-1, C-,t1,' C-III and E are also k.no,;"n (9), Apo"
-A-II, B. C-III, .0 and E are 91y:o·prot.ein~ (4).
Table 3,










AI 29.331 Inteiltine. liver HOL2' AOL) Activation of LCAT
A-II a,707(x2) Inte.tine, ·liver HD!-2. HDL). Activation of hepatic
lymp'h chylomicron lipase




5-100 Liver VLDL. LOI. SecretiOn of VLDL.
Chylomicrons
receptor binding
8-48 • 264.Uoo Intestine Chylomicron secretion.
C-I 6,500 liver ChylOrllicron.a • .....ctivat.ion of LeAT.
. VLDL, HOI. LPL lIetivator7
C-II 8,837 Liver . Chylomicrons, Activation of LPL
8.240
VLDL. HOI.
Liver Chy lamicrons. Inhibition of LPL
VLDI:., ,HOI.
D (A-III) 32,5,00 , HOLi. HOL)" d) 1. 21 ,
E 34,145 Liver Chylomicron, Receptor b.indiny,








•-c. Structure of plasma lipoproteins
Based on experim,;ntal and theoretical considerations
sever~l models of lipopro'tein structure have been proposed,
A commo.nly held concept, supported by 'physical and chemi~al
data, is that plasma lipoproteins are, sPhe~icalor quas ispharica \
'particles having a core of t.dglycerides ,and/o'C cholesteryl
e!iters stabilised by a monolayer composed of ~hO~PhOllplrt';,
choiesterol and spec~fic apoproteins (3). ~ 1",r98 body of
experimental evidence, favou'ts the concept that a[)oprotains
pla~an essential role as determill';;;ta of lipo[.lrotein Btructur~.
.,' '..'
An important ~tep in the" definition of spe<:ific. mechanisms
);ly .....hic;:h apciprote~.ns perfor~' their' stl-octurai'fun.ction: has
.::-_.~ . been the ~stablishlpent of th~ primary .structure of ~G.t of
. .~.. the apoproteins.
Segerest ~ ~ (10). and Jack'so~ ~ '!..!.. (11) have pt'oposert
a model for HDL based ~n a lipid-prQtein interaction hypothesis,
kno.....n all the arophipathic-helix theory. This model is cons~~~ent
with X-ray. 9catt"ering data. An increase in the 'Cl -helical·
content of the apoprotein .occurs, .....her apoproteins bind with
pllospholipids (3). ~n an attempt. to exp~ain this association
of apoproteins with phOSPhOlipidS," Segerest .~ ~ (10)
proposed thai the apoproteins form a unique structure wh-idh·
J llOWS their inter'action with phospholipids. The outstanding. eature' of the 0. -helical segments of. the ap6proteins 4..9 _.that
they are amphipathi:c. One face of .the hel ix is extremely
hydr"OPhObic. and interacts with the' carbons Ci-C4 of the
,'<I".
:.-,
PhOS!'hOliPid fatty acyl chains. The opposite face of'the
~x is hYdrO~hilic and' contains acidic amino ac~ds neax: th~
centre which' are frequently paired with basic amino acid
redid-uee at ·the .edge of the helix, The authors PQstulate
that there mqy be ionic interactions between the pairings of
acidic and b(l,sic residues and the zwitter-ioni'c polar head
gro~ps of phospholipids, With' this unique arrangement, the
apdproteins 'can pressnt a polar sU~face' to the aqueous
environment of. the polar ~ead groups ,?f the phosphOlipids
afld the plasma, and a ··n~n-polar s~rface. to the hr~!OPh2..~iC .
f~tty·a:.yl cha;ins of phospholipids ..
Assman and Brewer. (i2) .have. proposed a moele! for .;!.OL
" , ' )' "
Which. places.part.ic~laremphasls·o.n the hydrophobic interac~ions
betw~en ;~lypeptides and' the fatty acyl ch~ins of- phQ~;phoiipidS
\ "
and V.1ews the. apoprote.j.ns as icebergs inunersed in a sea of
·lipids, This- mod~l attribute~ only a minor role to the
ionic interactions between apoproteiri and phospholipids.
\;'.~ .
The- importance of hydrophobi.c' interacti">ns betwe~n.
ph08,PhOlis..td!s and appprotein in HDL i5 also emphasized in
the moqel proposed by St9ffel ~~, (13) wh~ch rules out the
... ", '
occurre~ce of stJjong el';1trostatic interactions__invol.viny
.the· ?olar h~ad groups of phosph~l.ipid8 an,d the polar i3urface
of the apoproE.eins.
T.he first model that atteJUJ;Sts_ .to consider all the~
, lipoproteins Wi-th a 'fmrnon ..structure has been· proposed :by
Shen ~ !i.' (14,) ~,' .They ~~~~.th~·structur~ f~om co~o8iti~nal .. ~
, '.' ." ..
"...J 10
analysis of the lipopr~tein~ and founJ good corrl:!latlon
between ,ize and. ~hemical c6~position of the 1).p<?proteins.
According to' this > 'hydrophobic lipid core hypothesis I. both
•the apoprot~il\S.and' the hydrophilic head groups of.p!lOspholip'ids .:::
ar~ closely packed at the outer sur"face of the lipoprptein. -{.
chole,6t:;ol interacts di:!sctly with the. protein but is not '-..
exposed to the aqueous environment. The hY1-rophobic core
consists of triglycerides and cholesteryl esters'which is
• .# •
. surrounded. by the.. monol~yer of protein, phospholipid and
cholest"erol. PhO~h~'1iPidS,,and pro~ein compete for~space ~n
"the surface of, the li"poprotelns. A ;'odel for the general.
s.tructure of i~poproteins proposed 'b: Shen ~.!!.. (14) 1s "
sh~wn in Fig 1.'
D,' Mechanisms of formation, secretion and 'degradation of
lipoproteins
T'wo o,rgans have been shown synthesize .pl~sma .
lipoproteins, J:.he liver and the intestine. .~hYlo!"i.crons
origi?ate from the intestine as a consequence of ~he ~i.etary
in,take o£ 'fat and e,nter the---circula'tion throagh the lympha.tic
., . .
system. In the circul"'tion, there is a ;-ap.id transfer of
apo C-II, ~-liI and E from HDL to CbYl~microns. ' These
ap.ro~ei~ addi~;~~ "are accomp~?ied bY{ a 1058 of a~o A~I,
A-IV ~n~. ~hOS'PhOli~id8 hiC~ _ appear ~o be transferred' t·o
plasma HDL fraction tiS,l ). The acquisi"tion of apo, C-Il.· a







... , .... '.
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permits ~PL to hydro'lyse 20-30\ of, the core t1;iglyceridee.
During the course of ch~lomicron.~riglyceride hydrolysis ..
apo C-II and C-III are lost. from the chy\omicron. surfa,ce and
transferred back to t,he HDL ~ractiori (15). The fatty acida
releaSE!9 on tri.glyceride hydrolysis are tak·en up by tissues
(mu~cle and. adiPC?se'\(fbr oxidative metabo;ism or s,torago,
The chtomicrons_/. with their core trigly~erides, depl~ted,
form saller particles ,}tfth have been termed as chylomicro:n
'remn.1")t8' (16): The pr~'senCE! of apo E on'these remnant
particlest mediates their clear:ance by li_ver cells via a·
') _. r~cePtor' .ter~ed- ~B :po 'E o~ chyiomicron r.emnant r1ceptor .
(-17,18), •
. . .
,VLOL is· f.armed 1"n the.'liver and the me'tabolic
tran~fo~ationsof' VLOL' upon entry into the plapma compart~ent
are. _similar to those of ChYlO!'1ic"'rons" A~ <J-II· and C-I~I
·are acquired from plasma HDL•. In addition, ape E _content of,
.
VLOL .'is supple,mented b:Jt transfer from I:fDL (15). The core
. . . '. .,
triglyceri;des ot: VLOL are hydrolysed by LPL resulting in j.he
for~ation ~f a ~ma.lle.r lO~ particle ~). OUrin~ '~hiB!6
proces.s ape C-II and C-l.IL are lo~om VLDL to HDL fr.action,
. J. 'Excess aurfa<:e PhoSPhOl~pid'and. cholesterol are transferred
mainly "to HDL. fra~tion and small a~ounts of phospholipId and
Ch~lestero~ m~y form bilamj..nate· vesi9ular structures (19(20)'•
.The' IDL p!1rticles thus g~merated a~e co;~~erted .to LOL, a
process mediated by .LPL"as well as 'another I$nzyme called
~.' . ..:





ape C and IlllI.jor1ty of apo E from" IDL are lost to/.HPti fraction.•
I reBulting 1n for:mation' of LDt, whose major apoprotein is apo
8-100. SOme of th~}~QJ.o-is relllOved hom t~e plasma by t~e ape
E receptgr antrth~ LDL receptor. The tDL receptor' is discussed
below, • <. '
) , ,',.. .
.A major discovery has been t.he recoqnition of t.he 80-
~l:led L~-r'eceptor pathway., w'tliclf accoun~s for the uptake
and degr~dation of LOL by the pe~ipheral cells and liver.
A'rcording to. the studies pioneered by Goldstein and Brown.
(21)-, -the 'crittical c~mpon~nt of this ptechanism is a high
, . . ~affini~y-receptor. i. e ,. ~he LOt receptor or apa at' E receptor,
, . ,
. loca;'i~~H:l: on the" plasma llIe...I!!b~~n.e~ of ~ells. -"A~~ - B-I00 .~nd'
. ape; E have b~en shown to media,:e. the interaction of,-lipoproteins
with, this LOL teceptor', Th~ binding oi LOL~sets.. in motion ~
series of events 'p.y Whic~ LOL 1s taken up by"l:be c.~lls
~hrough ab8orpt~~. endocytosis, tran,sfarred to the lysoaomea,
a~d h}!drolyzed by acid hyaroly'sis, This pr~cllss of LDL
uPt~ke •and lYSO.~l degradaiion lead~ to ~he 'suppre~sion of
. cholesterol synthesIs th"rough mod·u~ation of the activity of
::~:::::h::::ii:~:;::::::n~:!.:~~l:~n:::'~:de:::::·::~~V":,' ,
,.J, ' , !:>
.number of LOL receptors exVrl!8.sed on th~ cell surface, Tn 8 .. -,
upt.ake of LDL. by' the receptor-med~ated pr:oce'ss permits cells
'to acquire '.chO'l~'erol from. the lipoprotein and 'this in turn
not- ol)~y.providell at.erol ~or I!!embr~ne synthesis. but al~o for





celLular ,regl;llatory actions that prevent over-accl:lmulation
of cholesterol in the cells.
LDL carry the butlt; of plasma cholesterol in man and elevated
teveJ!s of plasma LDL are correlated with increased ~isk af
atherosclero~i5 (21,22). The importance of LDL receptors. in
regulating plasma LDL le:,els has been confirmed by the
qbse~vation th~.t genetic absence '(or defective f~cti.oning)
of L~L receptor rfsults in prema~\Jre onset of ,atherosClerosis
(23,24)." I • •
. \ As mentioned above, ap,0 E-containin9 lipoproteins are
also\apable Of' lo.tera.ctlng wi th .t~e LDL r~cePt~r and re'i!Uld7-ing
cholesterol metabolism (2.5), This has bee~ :fhown w.!t·h
several subclasses ,of HOI. that do not contain apa 9 but do
contain apo 'E. "these sUbclas~os are HD'~l and HDLe • Selective-
q,. ch~miC~l,. modif1lcation 'of arginine or lysine re~idue8 ~~olish
the ability of LOL and HOLe t~ interact wit" LDL _receptors"
on c\llt\lred.fibr~b~s.ts ~26.:n)". 'I'hese,studie~ demons'e<ated
the imp:ortan~e of a limited number of arginine and lysine
residues of apo Band apo.F. i'o me.diating the recept.or- ~ipoprotein
interactions ..
The ~iosynthesis.of~?L a~90 o'ccurs incboth the inteBtine
and '~he i.iver (2B). There is strong evidene~ indicating
that ·HDL is secreted as a.' nascent' precursor from these'
organs' which is d~scoidal ~n 8tru~ture and con~ts of.
phospholipids, unesterified cholesterol-and apoproteins (.II,PO
A-lor. apo E) but is d~ficient i~ '~les'terYL e~ters" The
·::..".,
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~·ig. 2. General scheme of plasma lipoprotein metabolism'.
Dietary "trig,lyceride and cholesterol enter the circulation
. .;
,in- the form of chy~om!'crons formed in the il'\testine. .In the
capillar-,ies ·ofi,. adipose and muscle tissue, the triglyceride
core is markedly reduced, through the action .of enzym,e LPL
an~ the fatty acids are" removed. The cholesterol-enriched
'- ..."\ .
remnants are' removed by liver through ·.the hepatic rernanant
F~eptor8 (apo E rece~tC?r8). : Thei~o~est'erol i's' either
secreted as bile acids .i~to_ intestine .o.r pac~aged with
triga.;ce~ide to form VLDL. VLDL is secret~d·tnto the circ~lation'
and the triglyceride is hydrolysed by-the enzyme LPC in adipose
or muscle tissue :leadin~ to. the fo-rma,tion \IDL. Some .IDL
ie, cleared by the liver through the LOL receptors (apo B. E
receptors) and the 'remainder is tr~nsformed into LilL. Nost
of the LOL' is 'ta~en up 'by liv~r or other tissues tn:rough _tlte
LOL receptors and thus cle'a.red f,rom th'it circulation. H'OL
acquires cellular cholesterol from peripheral cells whi~h. is
., 10. , .
rapidly esterlfied".by the 'enzyme LeAT. A por~,.ion of the
peripheral ce:ll' derived chp;Lesterol est~r~ may be:1-ran.sferred
to VLOL or lOL a~d ul~imately.... taken l!P by various. cells
(adapted from "Brown and· Goldstein (22).










I maturation of dia,e0idal HDL requi~es ChOlesterOl"esterificaJion
",hleh is mediated by the lecithin-chol:esterql acyl transferase
(LCAT) enzyme reaction "(28). LCAT acts specifil=ally 'on
. plasma HOI.' by converting the lecithin ..::.nd unesterified
cholesterol .of t1DL to chole"st'eryl esters and lysoleci'l;.hin"
("29,jp). Once esterifie:d. the £oree cholestli!r<:l 1eo..,e8 the
surface C'oat and IllOves ..into the non-polar lipid core ~n the
cent~r of the particle, leading to the tra~8formation of
dls~. shaped 'nascent' :H,oL. into sphllrical 'mature' Hl~~. A~O
. In addition to 'their 'dirli!ct biosynthe.8i~. in the I"lyer'
. .
and intestine, Hie dist:oi~al structures haY~ been postulated
to form as P1;oducts pinched off from chylomicron ,md"' VLOL
.
surface as the .hydrolysis of core triglyceride takes place
(19~20).· In'~ddition 'to the function of HDL to serve as a
rl7'servoir for apopro~eins.. it is now be,lieved that the HOL·':
LCAT system is involved in the reverse transport of Cholesterol
, . . . . .
as cholesteryl ester from periphe~al tissues to the liver for
ut;~izaJion .~nd ultimate excre~ion ~f cholester~l' in the
bile tJ-?). According to ·this concept. BOL and in part.ij:ular
the nascent: phospholipid-apoprotein. discoidal structure can
.acqui~e unesterified cholesterol from pe,ripheral tissues and
esterification of this cholesteroi by LCAT leads to the
formation of ~ature HDL;' The .newl~ formed ,choles.tarol






trans'ferred.tQ' LOL and VLDL "and finally cleared bY t.h~ ayer
(4)'. HDL that cont,llin apo E may t:fe directly removed, by the
hepatic ape £ receptor and ~DL that colltain predomin~ntly
ape. A-I can interact. \oIit_h cells via the hepatic ape A-I I
receptor (4,32). In "keeping ....ith the rOle'of HDL-in'cellular
I .
cholesterol e9re88, an extensive literature has accumulated
Sl!.ppor~tin9 a 'negative cor:elation betwee',1 'Plasma- IlDL levels' ~
and incide~ce of cardi6yascular d.isease· (j j. 34) .
. . .
In addition to the enzyme-mediated processes mentioned
~boYe. 'SP~C~fic protein-mediated trll.n8~er of lip'ids b~ween
lipopro'tein s~ecies has also been shown. In"th,e lipoprotain-..
-'free fraction (d) 1.21 g/ml).o"f human 'plasma, a protein.
termed ~s cholesteryl ester ~t.ransfer p~otei_n ,hat· been'
d~lIlOnstr~'ted that 'lneSiates the ,xchange Of, core cholesteryl
esters.·of each lipopro'tein, especial.ly fro.m ItDL to VLDli. It
has also b'een pos:ulated ~hat such a process .is accOlllpanied
by ba~k t~ns£e.r ~ t.riglycerides from VLDL .to HDL (35,3.6).
In addition a protein t.hat may facilitate t.he tra,nsfer of
"'phospholipids betlo'een llpoproteins' has~ been ·r~90r;.ed t~7 l .
ThiS. ph?SPh?lipid:tr~nsfer p[-otein fr~m hum!"n ~8ma' 'h~
been shown ~o mediate the transfer of .p)lJDs~iiP.1d8 frQrn
vesicles of eljig" iecttJ:lin to HO.L.. The purified {Jrotein has a
molecular weight of 41,000. (37).
From the abov~ discussion, it. ,i.: apPIlr~nt that a ~et. of
\~eChanism~ is
1 ipop~t.ein8,·
operative ~n con~rollin9 the _synthesis of




sUbsequent cl~rance. 1'he net consequence of these processes
is. the delivery ,Of lipids to tissues ....hile the lipoproteins
acqui.re the a~propriate surface structure to inte.ract ....ith
cells and mediate contro·l of· their c:hole~rol production
.. .
'and Is~~rC~ion. I~ th~re~ore beco~es ~evatit to, study the
int~ractions of lipoproteins with" various plasma con.atituents
and cells in order to gain insigh"t into the hoemostatic
controls of circula~ing .It"poproteins.
During the past few ye~rs considerable advances have
been made in the stud~ .of ~la5ma lfpoprotein in various
animal :spec"ies. Selective aspects of lipoprotein struc'ture
and metabolism' in .rats will be discussed here, pince it has
r~levanc'e to' the· work desc~ibed in this.thesis,
. -
In most studies, rat. 'plasma l~poprote,ins have ,been
lso1a!ji!d by ultra.entri,~ugation and designated UE!ing the
den'sity r~ng~s establisl:ted for human lipoproteins. 1'he ,rat
has lipoproteins E:quivalent to all the ,major lipoprotein
liIp.e·cies· in' hU1l\a," plasma., , 'l'he major plasma. lipoprotein
species of the r~~ are HoL which carry, approximately 75% o.E
the pla~ma c:hole~terol 68), In addition to the HDL2. the
rat has anot-her HDL.:.like lipoprotein called HOLI (39)'•. Both
. .'
,HDL2 arid HDLI, in rats contain apo E in substantial amounts
and it- is~-the major a~~Pt'oteinfconstlt.uentof HoLl.
In t;1escribing the rat Pl'~:ma 'apopr~teiris, investigators
._" • • '1\
have applied the nomenclature developed for human apoproteins.
'0 '




human apo E (40). I~ addition ra.tr apo C-I and C-II also
a~pear t.o be homologous to their human counterpart's'-based on
similarities in ami'no acid composition (4i). 1'he l-'dmary
structure of rat apo A-I is very s'imila-r 'to that of human
apo A-I (42). Rat apo A-IV has also been described (43).
Unlike the human organs. both the rat. intestine and liver
sy'nthesize apo 8-48 (44).
There are two major, differences in the metabol!sml1of If.
lipoproteins between rat and human. The rat possesaea an
efficient me.chanism for clsarance of VL.oL from the circu'lation
due 'to interaction with t.he hepatic apo E) receptor. - Th,is
rapid clearance i~ att~ibuted the pr:~Beli.ce of b~th apo 8-100
and' 0-48 in rat. VLDL. The ape 8-48 component.; which is the-
major proportion of the VLDL -apo 8 is rapidly cleared from t~e
plasma and only' a portion. of a-laO forms LDL." (45.46). This
ca?ses low' Levels of LDL in rat 'plasma, 'Wh.l:.ch may account
for the resistance of the rat to the development of
atherosclerosis compared to humans.
The second major difference is the absence of cholestaryl
ester exchange protein in rat plasma as a result of whlch
there is ,accumulation of choles~eryl esters in HO~ and a
\ .





The 9lycOs~minoglycans a,:e charaot.eristic .components of
20
ve;tebrate' connective tis9ues.(48). They are long. unbranched
C4:bohydrates which contain .'!'any aeidic.{sulfate or, carboxyl)
groups. They do no~ normally cccu-r as free polysaccharide
chains ~ vi~, but a~ proteoglycans in whlch many chal,ns
are linked at the terminal reducing sugar residue to a
protein mdl,ecule. Glycosaminoglycans are primar:ily molecule~
I
of extracellular space and ~he1 thus occur in greatest
'abundance in those tiss.ues in which the extracellular space
is laege. These are often tissues with' a structural function
such as cartilage,' cornea, skin and blood vessel walls. -In
other' sofk.t.issues sueR as liver, kidn'~y ~nd 'Drain glycosamino-
glycane are a'lso. present, but ~n' smaller amou,?,ts .
.Th~re are 's'even' p,ifferent types of '9lyc_oflaminoglrc~ns,.
(namely, hyaluroni~ acid, chon"droiti~ '4-sulfate. chondroitin':'
6-sulfa.te, dermatan sulfate, keratan sulfate, heparin. sulfate
and heparin) tha"t. are c~only found in vertebrat.e t.is·sue
( "(48). They are ,all long unbranched poly.sac<7harides in which
the chain is made up of disacchaFide repeating,unit.s consisting
of a hexosamine and a hexuronic acid. The amino grou~s of"
the hexo8~mine .residues at" --gene!"ally substituted with N-
acetyl, gr,?ups, 'but can also cor-tain N-sl.flfate .groups in
heparin and hep&:rin sulfate. The presence of sulfate and/or'
carboxyl groups, on each disac~~aride ~n·it: makes'li;' chain
strong. poiyania'ns and t~i9 domin~tes. to a large extent their.
interaction wi th other maJ,.ecuies. In th\ection information
on th? int.rac:iO~of ~l:co••min09lyc:n~wi h pl••rna lipoprotein.
. ,




In 1955, fJlt"t'stein and Samaille (4.9) showed that hepar!l\
forlll9 insoluble comple~e6wi t.h serum lipoproteins in the presencel
. .
of divalent cations. Bven in the absence of divalent cations,
heparin increased the electrophoretic mobility of~-llpovrotein
(LOLl. thus sho'wing the formation of a soluble complex with
"in increased "negative/ cna~~e L50,. llOL and other ser"um
proteins did not form any- complex in\the presence of 0.01%
,
.
heparin. - Subsequently -aurstein ,and Scholnick (51) sho.....ed
that by a jUdicious use of different divalent cations an'd by
suitable adjustment of ,the concentr~tion of heparin •
cations has bee~ used 'foi quantitative estimation of pa.rticular
lipoprotein classes i"n plasma (51). The in!l'eractionsl between
( ,
various glycosaminoglycans and, lipoprotein;i !:.!! Yit~o'have.
chylomicrons,. V!:.I)L and LDL can ,be sequent.ia~~y precip~tate~.




been st.udied. by a number of techn~qu'es. ll'he early stUdies
by Bernfeld utqis'ed n~phlo~etery a~d free bou'mla~y
electrophoresis (SU,'S2). Iverius (53') has studied ~hf]
bindin<j of lipoproteins' !to g,i·~cosaminOgl~ca.n'ilnnlobili;ed on
agar9se, ,In a.ddition these interactr"o'ns.•h~ve al~o. b~en
stud~ed by gel 'f~l~ration ch'romatograph~ \5~) and by
pre~ipitation techniques (SSJ:'" C~lcium indu,:,ep. 'precipitatton "
~as bee~ widely us~ in measurin~.the interactlo~~'il.iPop.rp~eine
. with, hepar:i;n by turb~etric "ssays (55'. T\"rese assays are.







B. Nature of lipoprotein-91Ycosami~o91ycaninteractions
The' nature "of interactions bet ....een lipoprotei!ls and
glycosaminoglycans has been investigated in various s~udies.
The: fel'lowing discl.1ssfon has been limited to s,lected studies
that outl-ine trye current understanding of glycosafljinoglycan-
~P9pr~tein inter~ct.ion5l-,ithparticula"r'ernphasis on studie~ .
that ut~sed fe~rin. . . ,
I~erius (53) investigated the interaction of lipoproteins
.,,;ith hepari~.im~o'bilised on Sf!:~~arise.\ Il'he}po B con.taini~g
lipbp"rpteins VLDL and LOL bound to heparin-SephaJ;"ose in t.he
'., . '.
absence ~f divalent cations, whe;eas HOL did not b.ind .• The
binding of VLDL 'or LOL to"heparion-sepharose could be abolished
--, .by N-acetylatian af tho lysino residues af the ~paprateins,
l:i.uggesting·.an. important. role fOr the lysi~e residu~s: Sinee
bot~ VLO,~ and LO~ but n0't: HOL were' boun,d to heparin-Sepharos.e,
it was pr\?P?sed th).\t 'apo B in part was responsible for
binding of VLOL and LOL to he~arin. > , ~
. \. How~X)r '0 HOL SUbf~aet.ions \hat contain apo E as the
exc~usive or predo"mina~.t apop~ot:ein_,namelY·e~~ine HOLe
(56), a fraction of rat HOL (57) and a fraction of human HOL
(5S) hav~ \leen shown to bind to heparin-seph~~ose. rn thet"r
.,' . - ',..
~tudiee '.with ca~ine HOLc '. Mahely !! !l. ("56 ~ reported -that
. acety'~ati0f! ,and c;arbamylation,of ape E prev,,:n-ted'the .bindil)'g
of HOLe t~ 'h~parin":sepharose ,j:.hus demonst.ratin~ an imP.Cft~nt








role for apo E in the binding.
The studies of Shel.bo~rne and Quact.fort. (59) have also
shown the importance ,of &1'0 E in t~~nding of VLDJ... ~o
hegarin. VLOL 'subfractions containing no apo E were shown
nut t;o bind to hep~in-s.ePha~ose at l-'hysiological, ionic
str~ngth and in the absence' of diva;ent cat,ions. Apo' E.
isolated irJ.o wh~le Jipop;rotein was treated......ith· phenylglyoKal
to rnodi,fy th'e argini~e residu,es arid this modified apo j: was
not able to bin,d to hep'afin-sepharo~e.
• Pan ~ ~. (54) have studied the formation 0'£ a soluble .
complex in .the absence' Qf divalent catio!l~ betwe.en hJ;tpar.).p
" an~ L~L by gel fii~ratior:.Chromat.?~;aPhY,.__ No billding of H~~
or VLDL to ~eparin could be demonstrated •. It. 'was f,utther
. . ) . .
demonstrated that. mOdifi~at.ion of histig.ine, ly~ine or' "1
arginine residues on t.he apoprote'ln resulted .i,n a 10S8 in
heparin bind·ing. q
On the bas is df the, st!-1dies mentioned above, it would
a'ppear likely 'that the interaction of lipoproteins' 'wit.h
heparin 'involves the basic amino acid groups in the apopr~teins'
{apo B ~nd E}. lve"rius {SJ} postulated that the lipopr~te(n7
glycosaminoglycan ~o.mp.Lex fqrmation is' primarily .caused through
ionic int.eractions between basic amino groups of the apopro,tein
. . ~, .
.and the:nio.niC sU!fa~.· g,!ups of .91YCOBami.nOg~Y_cans"{~?Y"'. '..
Several studies, (60,61,62) have al,o examine.d the:
involvement·, of ehe pho~pholipi4 mo~etY ~f liPor/r.ote,in in. .'
the inte.r,action wi th heparin and.,,other'Bulfated polyaAcch.A,rides.
"24
Treatment of LD~ with .PhO~phO·lipaSe 'c was to interfere
with its' precipitation with heparin in t.he presence. of Ca2+:
The- formation of,insolu'ble complexes decreased as the degree
t
. o'f hYdr01Y~h of Ph~SPhOliPi~S' increased (60l,:. Girard and
Canal (61) extfacted phOspholipids from human serum ,a'nd
$lowed .j.nteraction of the phospholipid~ with ;heparin in ~he
. p-res,,:n~\ an'd absence of· .ca~+.. 1n the presence ?f Ca 2 +, tlie
soluble phOioPholipid-heparin co'mplexes were conLerted into
insolu!>le" pr,ec:ipitate.
~ and.' Nishid~. ('62) fta:ve Sh~n that in.';he· presence o'f
~ ,;w2 +, ',~i9h ,ml?le~ular' wei9.ht.'dextral'\' sulfate (m.Olecul~r :..:.. ...
weight', 150,000)- prec"ipita:tes- lec~~hin' dispersions' and
lysole;.ithin micelles.prepared f~om egg york. 'I'lle prec1pitatio"n
. .
was p~oposed to,arise fr~m two mutual'ly enha,pcing interactions
involving both'positive and negative charges of the zWitterionic
phospholipidS" w.ith abe resulting from the inte-raction between
the pos.Hive charc~e of. the l').itrogen base in lecitryin and the
.' . . .
/
:. ' sUlfa~e· ne,gative charge of dextran sulfate,_ afd the. other.
,.:...•... '" . from -.ca 2,+' cross linKing. o~ 'phosphata g,ro~p§. of neig.hbouri~.g·
. " phospholipids. The above'mentioned studies suggest that·
phosphd-u,pids are involve~. in the interao;:tion' of heparin
with .lip~proteins in the pr~s~nce of Ca2+.
On .the basis of the observations' discussed in preceeding.
,. .
pat"agraphs and .other evidence, it is generally agreed that ;.
" '.. ,---.., ~
the interactions' between. lipoprot.eins and glycosaminoglycans




the sulfated groupi!J'. of glycosaminoglycans interact .primar.ily
with the basic 'amino groups 'of apaproteina (apo ~and E) to
form soluble co\~exe5: b) Indepf:ndent cit this, t,he add~tion
of divalent cations can bridge the 8~lfated groups of
glycosaminoglycans a"nd lipoprotein phos!>holipid, thereby
promoting the' a9gregc:'~ion and insolubility of the compl£:Xes .
. s.
c. Functional .significance of lipoprot.ei~-91yco,aamin09~YCan9
. in.teraction. L ..
The functional possibilities of the interactions between.
li~pro~ei.ns apd .g·t"YC08~min091YCan:'inJude'~ role ~~ the
development. of ,atherosclerosis (63,64). The most: likely
mechanillm by which plasma iipoproteins' can be selectively
v -
retained !.f1. arteries is, by ionic' binp.ing. The, fact that
91ycoaamin09\YCan.a can fqrrn ;ornplexes !E~ ..';~,th 'the
aJ:.he.rogenic LOL an~ VLOL but not HOL (exce,?t apo E containing
HOL) mak'e'k 'such. putative interactions very important :or the
sequestration of plasma llpopro'teins ~ithin the artery,
Recently,. attention has been focussea "'<m t~e au,rface
charge of ,LOt; in term~ of atherogenesis (65,66). In the
arterial wall, an electrostatj.c interaction of LOL with"
glycosaminoglycans may make the lipoprotein particles m~re
electr<?negative. Unlike arteria,l smooth muscle ce l+s, macrophagea
bind,and ihte;nalize only electronegative L~L by. a:,high






Schematic ill.ustration of the mechanism of interaction
•between 91ycosamino91ycans and plaslIla lipoproteins in the
preaence of Ca 2+. (
p proposed by various authors (53.63 1 64). electfo8t~tic
In.terll.ctlons govarh tho. formation of insoluble 11poprotein-
91Y;'Ol!la~~no:!ycan ~omplexos. The sulfated groups of
glycosaml'noglycans interact with the basic amino groups 'of
lysine an4 arginine residues present in apo Band E. The
positive c'harge of the PhosP~~1iPidcholine hitrogerJ. interac.ts
with the SUlfate, negatlve charge of the gl.ycosaminoglycan.
;... ~ The formation of insoluble liPoprotein-91!cosamin091YCan
complex is -enhanced by ca 2 + cross-llnl<lng of the phosphol.lpid




process ,has been proposed t.o result. in the formation of fat-
filled foam cells present in atherosclerotic lesions. It 18
0'£ parti~ul.ar interest that 'exogenous sulphated
glycosaminoglycans adl'l'linistered to anim0......have &.l;.,le"ged
.ant'i-atheroscle.r:;o~i6effects (63.67). This behaviour'haa been
~btributed to their controlling the interaction of a"therQ<Jenic
lipoprot.eins. with arterial. 91yco8a~inoglycan8.
• More recently. interest has been" focusesd on the interaC~ion
0.£ apo B a~d apo E contai~in9 lipoproteins with hepar"in .
because of pa,rallels ~tween~parinbinding and the interaction
....ith cell: surface Lot. receptors (5'6,68). Heparin has. been
shown to compete with LDL receptors for binding with LDL and'
,has been usea to displace LDL bour.d to" LDL rec-eptors (69).
Furthermore, there appears to be a _corre{ation between
PreciJitability of L~L and ~DLc with 'h:~arin and the binding
o'I!'LDL and- HOLe to' rec~~tors (70). The interaction of
:J.ipoprotei~s .wit\l both thf LDL receptors and heparin appear~
to involve similar basic am,ino acide present on apo S arnll
'apo E' (56).
1.3. C-reactive protein and its homoloss
Introduction
The acute phase rcsp~n6e consists of the in.creased \
produ7tion of a number of Pl'as~a p:oteins w~iCh occur fO~lo.... in9 •
- moat - forms .of tissue injury', 'inflaltllllation, infection and
malignant neoplasia.. The c-reac~ive pro~'ein (CRP) 'was
'8
of th"e' first Acute phase proteins to be identified. OUI.'ing
the acute phase response, the serum concentra~ion of CRP may.
l.ncrea~·e 1000 fold or more" (71). oCR? was discovered in
humans by TiUet and Francis (72foin 19'30 a& a material that
preo;::lpi'ta.ted with pneumococcal C-polysac~haride (CPS).
AJ>ernethy and Avery (73) then characterized human eRP' as a
protel.n and irief'!tiJied the requirement: 'fqr calci:um i[\. its
inte~a~tion..with. CPS. CPS is a heteropolymer consisting ~
N-a"cety l'-g~lactosamine. 0-9 lucas e, N-al::etyl-d iami no;~i­
deo~hexose, ribitol and phosphorylcholine t'74) (Fig~ 4). The
binding of human CRP with CPS has been shown t9 be me.~iated




discovery, i';l the sera of patients with various infecti,ons
~nd .inf-lammatory diseases, eRP and its homologs ,have been
identified' in' various mammalian spec.ies, in certain fish:a:nd
dven invertebrates (Table' 4), T'h: k~o'Hn specific~ty of
hu.an CR" ;0' phospho,ylcholine in the .~,e.ence ~' Ca'·ha. ..
been utiliz-ed (0, puri,'fy the variou5 protein~ homologous to
human CRp\.using either an invnobilized CPS, p.hospho~ylchonne
or phosphorylcholilil'e derivative affinity adsorbents .. A.nother
protei~ in man', called serum amyloid P compon~nt (SAl?) ha,.s
b'een shown t·o be rela"ted to CRP'(77). It is nO'H believed
that 'c~~ and ·SA.P belong t~ un;que family of proteins knoW
as ':pe'ntra~inl'l" (77) .. Humpn CRP is composed of five subunits'
and' SA.P cont~.ins .ten '~~rd:t.s. I('~.e latter d~ffers from CRP'
, -in that it is not an acute phase protein and L,t is glycosylated.
29
.....,\
Fig. 4. Structure of Pneumococcus c polysaccharide,
Brundish and Baddiley (74) reported' that pneumococc~l C
polysaccharide is composed of N-acetyl-D-ga'lactosamine,' 0.-
glucose. N-ac:tyl-di,aminotri-deoxyhexose •. ribitol and
PhOSPhor'y,}chOline, The dashed lines 'indicate the.
phosphoryl.choline. unit. which is the prl,mary binding site for-




Molecular Properties of C-rea.ctive proteins
'F
] ..1'
H_n aabbi:t Plaice Dog£i-sh "Limulus
CRP (~t7s) CRP CRP CRp·(71,77)* (B5) (B6) (B7)
Molecular .....eight ' 110,OQ(J 115,000 300, QUO 2S0;OOCl 'SOO,080
(daltons)' . :;:r
Subun.its
.Association of noo- , 000- nonL covalent noo-
sUbuni"ts covalent covalent covalent (disulphidel. coY.alent
Glyc.?sylation :- +
~ - -- -------.
Level in normal Trace Trace 0.05-0.06 0.' 5 I
se:runr-tmg!ml: )
Induction due to 1000 1000 small
a/Tute .phase. (£0.1<1)




The definition of a protein as a member ';f the pe£ltraxln.
family depends on the structure df subunits by electron
lnicroscopy. Tll'e name pentraxin is lerive"d from the observation
that "the subunits of both CRP alld .•SAP ar.e arra'nyed ~n annul.ar
discs ....ith cyWc pen~ame:ic symmetry (77): The determination
of.a CRP or' SAP homology is currently' u~t.ermined b; 'the
ligand bi~di[lg capacity of the' prot.-ein. A pent~alCin is
termed as 'CRP' if it posse~~~a2+ depehden~phosphorylcholi~e
"'. binding specificity' a,nd is termed- liS '..sAP' if it binds to
agarase, in ~ ~aicium-dependent manne~ (7~).
Q
Besides the p.entameric· ·symmetry of its subun1k.s, human·
SAP also shareSosubstant:ial (Slb) a~il\o.acid s.equence homology
with h~man CIfP (71,1). CRP and SAP are beiiev~.d to be products
9f g~ne dup.licab.ion (78). The structural genes for both
ha..ve been ~apped to chroma's~rft1j 1 (80). SAP is a 'precursor of
amy19id P component whi~h is found in' basem~~t membranes and
a6sociated w.i.th amyloid deposit UH).· In this sectio'n some t
p'e;-tinent iiterature o~,- 'the structure, ligand bindiny an<J
·biological·properties of -buma~, CRP and its homo logs )0'111 be
revie'fled. ~
'8. Structure and ligand binding
Table 4 shows s6rne of the properties of human CRP and
hOmOl~g'Ou.S proteins describe~ in' various v,ertebrat"es
invertebrates.
glycosylated
',Human and Rabbit C.RP~ coneist of five'non-





associated, with evidence for the existence of an lntrachain
disu,lphide b~id'J!'! within ea:ch subunit. '(&'<:.83,b41. Plaice
(Pleuronectea platessa·'L.) CRP is except.io:onat in that it
co_ntai~8 non-covalently associated 'subunits of two different
molecular· ....eightlf of which only one type is glycosylated
(8S). uogfish .(Mus,telus~~) eRP hal::l been isolat.ed and
purified (86) and its mOlecular properties are prcsel1t.ed in
Table 4. The "invertebrate homolog of eRP ie.~ eRP
has been .lso1atad from.the haemolymph o.f...-ohorseshoe crab
(Limulus polyphemus) using phosphory leholine affinit.y adsorbent
(87)". It consists of two types of "non-identical subunits
with moLileular we.ighta. in the range "of IB, 000 a~d 2·4.000,
Bot.h types' of. SUbunits are ylycosy::"ated. Un~H::e the hU/l\~n
and rabbit CRP, Limulus 'CRP is a '"ajor normal. haelllOly'mph-
c~l!IPonent at a con==io'n ~f' ~pproximate0./l\9/ml (87),
l.'he Ca2+ dependent binaing speci.ficity of human CRp'for
phosytfory~ChO!ine was fi~st demQnstrateq by Vo!anaJds and'
Kaplan (76) from their studies on the .inhibition of CHP-C'PS
precipitat,ion reactlont Gotschlich and Edel·rnan' (tiS) sho....ed
that each of th~ive subunits of:hufi:!an CRP m~lecule probably
,b.inc1s two Ca"Zt ions after ....hich CRP' binds one rnol:e 0·£
Ph!J,;PhOry~cl1opne.pers",bunit, The ligand be~~ bound by
. ;human CRP is p.h~·aPho.~YIChO,line '\76} ~ut. <;Ither phosph.ate
·,.,monoesters are also ~und w~th a stoich~~l)letry of 1 .mo~~ p;r
CRP ~u,bunit olthoU9!' ,with, ./I\UC~ lower affinity· (l:!9). "0~n9
'.")~ and }Ulllams (90)' '!"t.udied the ability of .<1 'number of smal!
3J
molecuLar .... eight. compounds inhibit the human CRP-CPS
J
interaction and ~mph.4si:z.ed the specificity fo[" ehoaphate
monoester yr(,lup. 1-'or i,nstance choline baes'-sulfonll.te or
sulfate were ~ot inhibitory•. ly was also foun'd that i'ncreasill~
the space between the phosphate and t.rimethylammonium group
by one carbon decreased the inhibitory power by t ....ci fold.
,Oliveira ~~. (91) based on their rtudi,es of human CRP with
BSI\. conjugated wi~h phoephorylcholine or phosphoryletrhanolam1.ne -
proposed ,the idea that two loc~ on ell,cn subunit of CkP are
invol"ved in the binding of phosphorYlcholine. Their resMltll
showed t.hat the binding site of CRP .consisto of two locil II.
. primary l:ocus responsible "'fo[" th.e· calcium dependent binding
of' phosphory.lester moiety of phosphoFylc,holine and a secondary
locu~ for binding'the .cationic 'group -<;:>f phosp'horYlcholine.
provided they contained both a free carboxyl an'd a free.e.-:
aminog~oup thus confirming the 'zwitterlonic n.ture' of the
. . .
bind'i,.flg site (92).
The studies. menti~ned above &uggest the speeifici\..y of
t~c .bimHng slte on hum~n CRt> for 'Ph08P1l0ry.lehoiine. However,
studiell cr;>mparing the preeipitatiori of human and. rabbit CRI?
with BSA..-p:hosphorylehol~ne and .BSA-ph08phoryleth,:,nolamin~
suggest a ~ajor difference in the. bindin.g proper;i!,s of
h~man and rabbit CRP (t:l9). For humanCRP, precipi'oati_on.requ~red
bo.th a pho"phat'e group and either a secondary tertiary.
":.
3.
amino ?ro"Up at -appropriate spaci?9. while wit6rabbit CRP
only ca:l+' Il)edi'a,ted binding of phosphate group wa~i9ato'ry
. '
for precipitation. The interactions of hU':!1an and Limulus CRP
.... ith spin labelle~ decivatiyes' ~ Phos!"hOrYIChOli~e have'
been. st.'udled using electron spin resonance spectroscopy
(9J). It was suggested that the ~'hOS~Ylchol!ne"'inding .....
. \ "-
sites' on both human an?~ CRP are qu~te sh~llow". not
,exC'e!ding SAO in depth.
The role," pf Ca:l t in- the bindin~ of phosphorylcholirie
"has been. eXPlor~in a num.oer of 8t~Cl.ies (~8,90,94.95):. Results
- r • . .
indicate that Ca 2+ induces a conformationai change in <human
CRP wh;i~h 1~ neces.sary"'fOr it to e~pres8"1.ts Char~ri5tic
phusphorylchollne binding prop.erty (68,90).. The. exist~nce
of .ca2-induced conformation.al changes i';- buma'n C~P h'ave, bJ'en
confirmed u,Sl~9 monocional mouse'"anti-humanCRP ant.ibodies ~94).
Potempa ~~. (95) haCle repprted th~ in the presence of
ea'i+ human CRP resists denaturat;ion by heating or by high
concentrations of urea. All these result.s indicate that
:~ca;+ in~uc~ conformational changes in hum,an CRP which ~ay
be required far',it to bihd phosphorlflcholine.
The, other major. bin~ing,property of h~mjln CRP appears
to' b~ ·it.a ability 1::0 bind pol,ycatipns such as poly-L;"lyp,i ne .
and pOly-L-arginine pol:yOlers, lysine, ~nd aryinine rich r
hlatones r mY'!lin basic protein and leukocyte cati<:?nl~ protein
(7'}). ,It hae' been sl'!a",n.. that in the absence of ~a2+" ,CR~
an,d polycation form camp'lexes .At .appropriate concentrations-
35
,leading. to aggregation ~nd precipitation (96). These
interactions were inhibited by Ca 2 + but addition of
phosphory'lc:holine in ~the pres~J1eI f c~..2+ promoted the
<J .
interactions (97). ~h~ int~ractiO)lSbe een c~p and-pqlycations
were also mod~l.ated by he~jlrin (9, . It has bee~ suggested
that ca2~' may be· responsible for modulation ~etween the
phosphorylchoU.,ne and polycat~n .bindin·g ~eaction8". The
polycation bin~in9 site on CRP is proPosed to be with!,n
I' cloae to' thl! phosphoFylcholioe blnding aite (77,96).




Impqrtant ~::,ance8 h~ve' oeen made in. determinio: ~ t.he
amino acid .sequence of cnp' s. frot1lsome species. The c6mplete,
amino acid sequepce of ·hUPla~ CRP has been dete,rmined. by
"sequ~ncing 't.he protein and also as der\ved from complementary -
DNA an,d gen?mic DNA nuc;e~tide analysis (19,83,99).
The complete ami~o acid sequence of ra~bft CRP has -been
elucidated (~4) ~d partial ",mino acid sequen~o~~,L~mulus
,(jl7) dnd plaice CRP\is also available (85),
Based on the sequence d·a-ta, eX,tenBi:ve~ homologies are
. .
noted between huma:t'I and rabbit CRP. Ra~it. CRP ,has ,70i
ide{ltity to human' CRP residue .ftJr r'sidu~ .(8f)' Co.mparisolll
of the sequ'ences deri'ved for, human, rabbit and LimuIJa CRP'
with,SAP and:the myeloma protein~ (a group of ~hosphOrYlcholine
binding "immunoglobulins) 'has per~itted the asei'gnment ofarnJ.':"o' q:
, . ,
..
acid residues that may be involved in the bindinq of
'!hosphorYlcholine. ~ince. the sequence Phe i3 - Tyr 34 - Met
35 ~ Gly ·36.present in the first hypervariable region of the
heavy, cl:lain is common to ph~sPhorylcholine, binding myeloma ,
t-'rotei~-;, Young a.nd ~illiarit8 (90) have suggested that in·
CRP, a'" similar sequence', Phe 39, - Tyr 40. - ~r 41 - Glu 42
may be involved in binding phosphorylcholine.· They postulated
th-at the ~hospl\o~oline bi~ding site' ~n CRP may c?nsist
of "oluf ,ami Glu 66 for the positively Charged, quarternary
ammonium ion and Lys 57 and Arg 58 ,for the neqatively charged.
. . .
phosphoryl group respecti:;:.elY; " . _ .
The sequence in the propo,sed 'binding aite f'lr'
'Phos~~~rYlc~"olihe also reveal~d i!!!~r.t~nt variation betw~~!l
hUIJl~ CRP and ':l"abbit CRP,' Glu 42 in human CRP has been
rep~aced.by Asp in' rabb~t CRP,' LY~ .57 in human C'RP ha~ been
'replaced.- by Phe in ~abb~'t and ~im~lUs CRP. Therefore, Wang
.~ ~,(H4) euggey. that. sin..ce Glu 66 'f~ human CRP is not'
~ ~'l '
conserved in other CRr, it is not likely to be involved in
the bi'n~in9 of -positively c:!harged group pf the 'ligand.
It is 'of interest t.o note that,W~)Q ~~, ,(79) in their
search for, hdmo~ogies of CRP with pr'oteins. other than SAP in
the amino acid ,and nucleotide databases···have 'suggested 2b•
. ' -', .'. Il
homol~!JY'betwee~nthe f~rst.25 amino. acids of- human CRP and snake
phospholipase' Az.and ~uman apolipoprotein CII.
/ G~1.l 61, Whic~ i:. ~on$erv~.n:a'll,CRPspec~ee and also




. . .37 . ~\.
proposed to, be involved in bindi~m ion (84). lun "the
other han~ by_analogy ....ith other calcium" binding proteins n ~
.has been SU~gested that tyr /esidues may l;>e involved in the
binding Jf Ca2+ by CRP (90).
,-'"'l D; aiolo9ic~1 properties of CRP
t-lumerous properties of hultJan CRP have been desct:;fbed which
may bear relation,ship with the biological function' of thitl
protein. The elevation of CRP levels in serum in response
~" to i~~:CtiOn/infl."E4t.ion suggests th,at its ,function' may be
reia,ted to' -host de e and repair :;,nd this, suggestion has
provid~C1 the •rationale 0 much of ,the, work.' .' .
.
CRP and the compl~me~t systim
yFOIIOWing ti.ssue d.amage in rabbits. CRP h~8 been eho~"n
to be deposited on necrotic cells but not normal cells
(100,1011. Similarly, CRP deposition in experimental allergic
encephalbmylitis in rabbits has been inve!;lt.igat.ed and CRP
wa"s detect.ed in' some of t.he spi:nal cord lesiqils, the amount
. of CRP corr~latin9 with the propo;rj:.ion of polymorphonuclear
leUkocytes (77)".
There have been reporS.s of CR~ depositi.on in inflammat~ry
,I conditions in man (77). The deposits.w~c.e found in t,h,,; cuta.neous .
lesions c~mtaining mllinly neutr~phils of .certain patients'
with vasculitis and. also in association .....ith synovial· cell
nuclei in· syrfo~ia.l biopsies of pitients w1J.h rheumato~d
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arthritis '.
Kapla~ and Volanakis (102) were the first to report the :,
activation of h~man complement by CRP-CPS complexes. It .....as
ahown tbat addition of CPS to CRP containing acute phase
se"ra re8ult~d in cons~mption-of complemeJot. The activation
'of complement pathway was completely ,inhibited by ph05phoryl-
choline. Volanakis (lOj) has shown that human CRP does not
.bind to the intact'membranes of living cell's but binds to damaged
or al~erf.cellS. ~n addition it has' been shown t~at CRP
can bind to' lipOBomes and this binlHng' ~theh activat.es· the
complement path""ayo. It was d~~on8trated that the binding of
'~;p ~o l,!.I?id emuls"ions c:onsiStin.;),f e+ther p}\OeP.hatidYIChO~ine·
or sphingomyelin with chals"sterol, led' to -complement fixation.
Furthe.q, evidence for the 'involvement. of human CRP in
complement acti~ation comes from the work of Gewurz and
) coworkers as. discussed beloW', whol not only showed the CRP
initiated complemenl:- ~ctivation but also demobstrated that
ligand~ tha"t were able to induce ~omplement ac.tivatl"on
included a ""-'de, va.riety of polycatio'ns and poly!=ation"-polyanion
comple-xes mef.ltioned below.
Complement activation by the classical pathway occurre<;J
when protamine was added to acute phase ~erum or when CRP
and prQ~amine wer'!' added to normal serum (104). Other.
pOlycatio:ns' sholtm to ,rea~t with CRP and c~nsume complement
h~mOPOly~e,rs1 L-~y,sine, and argihine,' 'hl'st~nes"




granule!! (105). CRP was shown to enlulOce c?~plement activation
by!olyanions llke DNA, hyaluronic acid and ~hondrlotln .
sulfate ~l06)., ' . .
Richards ~g. (107.10.8) demonstrated that human CRP could
activate ~uma'n co~plement upon binding to liposomss ,consisting
of dimyristoyl phosphatidylcholine. cholesterol and galactose
ceramide ""hen. appreciab(e amounts of strong positive charge
(s'tearY,lamine) was .also inc~rporated. Increased cholEusterol .
in the liposome and the pres~nce of ceramide liPias..enhanae~
. complement activation (199). The ability of CRP to .initiate
complement dependent !,a,.emolysie
erythrocytes coated .....ith CPS (110) •.
a,hown using sheep
1i. Interaction of CRP with phagocytic cells and ly~mphocytes
Human CRP has been shown '0' bi~d to human monocytes and
mediate p}la.90cytosis (In). Using eryth~?cytes as particl~s
for upt~ke.·by human monocytee, it has been shown that CRP
'mediates ph~gocyt.osis of CPS-coated erythrocytes sensitized
with CRP in the presence of complement. Studies with m.0use
macrophages ,ind1-cated that c~p. may interact wit~ a membfane
. .
receptor, FeR. or. a clos.ely related receptor on monocy,tes
(
112). ':hie c?nC~U·Sionwas re.ached on the ba.sis of obseivpti.on~
that CRP-CPS complexes inhibited the· uptake of .IgG coated
. erythrocytes by monocytes and that a selective inhibit.or· of .
.F~R acti'vity, 2-deoxYg'iucose, blocked the effects of CRP-CPS
complexes on macrophages. These!..!?; vitro ~ffects of CRP.
",:;"
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demonstrable !!!. vivo in a mouse model in which CRP
promoted the sequ.estration of CPS-coated erythrocytes by
spleen, This effect required both the complement and the
presence of CRP (113).
Sin~ CRP binds to CPS of Streptococus pneumoniae. the
ability of CRP to bind to bacteria and activate complement
Iilystem has a~ been t~,~_t:.ed (113). /It was shown that CRP
binds to Streptococus pneumoniae TY~ 27 ~hiCh contains
phosphorylcholine in its capsular polysaccharide and enhances
compleme~t' consumption. Usi~g 'a lTIOuse model, it has' been
shown 'that administra~ion.·of human CRP 'provi~eB protection
agai~st' pneumococcal infection '(11,3). This effect ~as see~
both in mic~ that la'cked circula~ing antibodies to phOSphory~­
choline ,and in normal mice.
St;udies on the interacti~,between humanCRP a,nd peripheral
blood lympocytes show that CRP by "itself does not binr to
the lymphocytes but req:uires the addition -of ~ ligand .kUCh .
as CPS wherefPon CRP binds to' a subs,et;. ~f lymphocytes .bearing')
the FcR recept-ors (114). Prefel'ential binding to FcR bearing
lymphl?cytes was also demonstr"ble when lymphocytes wer-e
re~cted with heat-modified CRP', The effects of binding qf
CRP' complexes on l.ymphopyte functi~:)Os such a~ riatural kiUer
activity were investi'gated' an~ CRP complexes o~ CRP has been l..
shown' to have no effect on thi.~ activity (114). However,
tre,atment' of, 'human lymphocytes with anti.;cRP antibody arid
complement has been shown to abolish some aspects of natural
. . , ,
activity.
41
kille'c funct ion (114).
Interaction of CRP with platelets
Fiedel and Gewur; (itS) initially reported the ability
of .CRP to "'inhibit p~telet responsiveness to a i wide variety
of platelet activators. Subsequently a low molecular .....eight
~ct6r. co-eluting with human CRP isolated from pleural or
ascites fluids using CPS or phosphorylcho~ineaff1nity ad8orben~s
was showr:t to be responsible~ for the inhibition of platelet
aggregation and release reactions (116). In the absence of
{ ~ow mOle.9 Ular W~i91lt ~act:'f' .eRE> d.id not" inhibit platelet
activatipn. The inhibH.or}- .capacity of CRP .... lo..... molecular
factor was substantially reversl!d in the presence .of CPS.
It was further shown that· heat-modified.CRP-acthy,ted platelets
to elicit reaction~ of shape change" aggregation and releaee
of dense- granule constituents. I~ addition•.he~t-lI\Odifia'd
CRP a·lso· activated platele,ts to o;;enerate thromboxane A2'
Intere~tin9lY, complexes of CRP and pcU.ycations caused
sim'ilar activation of plate~ets (117).' More .ret:?ently (ilS)
it has .peen reported that l'e~tid1e fragment.s derived 'froc.n the
degradation of eRP are 'associated ....ith the p14telet inhibitory
'\
There are two reports which sU9geet that human and
) . rapbit CRP can in~'t?i~ platele,t-activating fact~r (PAF) 'ind~ced .
aggregatipn of platelets, ,(119,120,). PAE:. a pote·nt platelet




i-v. !.nt:raction of rabbit CRP with ChrolllatiJ
In a recent s tud.y, rabbi t C RP was ,shown to bi nd to
isolated chromatin in the presence of calcium (122).
Furthermore, CRP ,precipitated nuclecscme core particles from
chicken erythrocytes: In j:l.ddition, it has bilen sho....n that
human CRP mediates'lt.he solubilisation of chromatin by complement
!!! vitro (123). B~sed on these results it has been postulated
that CRP ,may mediate the rem~va"l O!",Chromatin fragments from
the ~d~ after cell death by complement mediated p~agocytosis. ,".;_
V," Sununar"y.
, It appears from a variety of studies Utat human CRP can
mediate complement actillation, enhance phagocytosis', modulat;
platelet activity and ,scavenge chrom'atin particles after
cell. death. All these prcperties are mediated through the liga~d
binding .specific.ity for phosphoryl choline and polycatiGJ:Is.
TheS'e studies po~nt' tb a role of CRP {n host defense during
injury. and inflarrimation, a role in keeping with its effects
upon 90mplement, platelet and phagocytic systems.
E. Syrian hamster fem~ protein
A _novel protein termed as female protein I FP)
isolate)! by Coe (124)· from the serum of Syrian hamsters-. FP .
~a8 ori.ginally no~ed because it was a prominent.. protein only
in female sez:a, bpt
43
in male Subsequent.ly FP
",: ~
shown to be a member of the pentraxin family of proteins
(125). However this protein has cert.ain uniqua Characteristics
in comparison t.o other members of t.he pentraxin family anu
hence deserves'separat.e discussion.
i
i. Struct.ure and ligand binding specificities
FP has been shown t,,). ha'lole similaritles with botn human
CR~ and~ SAP. It is composed of five subunit.s., t'nlOlecular weig~t
3lJ,OOO of each subunit). held togeth!"r by non-cov~lent bonds
and exhibits the p~nta9(:mal structure typical of the pentrAxins
(126). Li)(e ~RP, FP binds to ph.os~horY1Cholin;......e!finlty
adsorbent and requires Ca 2 + for this binding. Not. only d!Jes
FP possess phosphorylcholine binding specificity but it alao
binds to Seflharosc in a Ca 2 + dependent manner like SA".
However, the affinity of FP for phosphorylchollne is <jreater
t.han Seph8orose. Irhe .phosphorylcholine binding site on FP is
be~ieved to be inVOlved in......the int.eraction with Se1Jharose
(126') •
The amino acid compoBition of FP was similar t.o t.hat of
human CRP and sequence analysis of 23 of the first 26 residues
from the amino terminus showed 83\ homology wit.h SAP.
protein"was shown to be glycosyuted (127). Recently a
complementary DNA ~lone corresponding to FP ....as illolat.ed and
~ ,
used to determine the nucleotide sequence and derive the amino
acid ~equence of FP (128). The am!no acid'sequence of FP "':'80,8
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shown to be 69 percent identica 1 to human SAP and SO percent
identical to human CRP.
Although the amino acid sequence of ~p is more "!limilar
t~ human SAP than to human eRP, FP has been shown to bind to
phosphorylchol ine (126). On the ~er hand FP has been
shown to be constituent of hamster amyloid deposita, a
-Rroperty usually associated witn :;;AP (126).
F:r;~m the discussion. p'resen~ed 'above FP appears to be a
homo109; 0'£ ~oth human ,eRP and SAP. However based on the
,current j:'riteria ad~Pted far nomenclature i.e. a pent.raxin
that S'h\;,WB ~a2+-dependent binding to phosphorylchol;l.ne being
classified as homologou$ with CRP, FP would be defined -as' a
CRP homolog. Its :.-amin~ acid sequence however sugg~ts closer
relationship with SAP. Therefore:it appears that determination
of CRP
alone.
SAP homology cannot be based on binding criteria
I'
iii. ·Hormonal regulation'of FP
FP is th~ only penfraXin which has been ShoW"~ to be
under stringent sex hormona,l control (126). The serum level
ofF:P in ac;luit female syrian hamsters is about 1-2 mg/ml
whereas the seru~ of adult male syrian hamsters contains
about. 100 fold less'. The low level in male was s,uggested to
be d~e to supression of .. FP by testosteI:.one. since' it was
inducible.' after: treatment with diet.hyls.tilbesterol. (DES) or
. b~ castr~tion.
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'--R. Rat" serum phosphorylcholine binding protein
In 1973, Mookerj~a, (IZ9) ....hile seeking the functi~n 6f
choline and 'phosphorylcholLne in lipoprotein metabolism
inve6~igated the possible role of phosphorylcholine in the
lnter<,\ctlon between -heparin and lipoprotein in the prese'nce
of Ca2 +. These efforts led to a discovery that pho\lphorylchollne
in minute \!lmounts plays a. role to accelerate the preclpit.,at,ion
of rat serum lipoproteins by heparin and Ca 2+ (l~~). St.udies
conducted to "test the ,specificity o.E the eff~ct 'of
PhosPhO~YIC:hOl.ine on hepaTin-lip0plf0tein pred.pltatlon
reaction showed that 5h01£l"e and a'number of chol11'1e dedvati"-'ea.
inorganic and 'organic phosphatesl amin..:> and neutral sugara
had no effect on' the pt;ecipitation reaction... Th,ese results
suggested th.e importance of phosphorylat~,lq).lat.ernary nitroqen
grou~ i:: promottng t~ heparin-lipopr"t.e~n ~r.~_Cipitation
reaction in rat. ·serum.
. Further investig""tio.ns wer~· <:'arrieq o...ut to. gain insight
into th.e .spe"cifie enhanci.ng· effect of phosphorylcflol1ne on
heparin - rat serum lipoprotein precipitation (130). Attllmr:;ts
to show the effect ~f phosphory.lcholin~on he~arin-lipoprotcln
precipitatio~using pu~rifilld rat chylomicr.on9 ~no ·'Vf,OL .
et"\oved unsuccessful, .....hich suggest.ed that the phosphorylcholine
, effect .....as related to the. use of total serum'. The effect 'of
phosphorylch61ine in promoting the in~eractlon between
, . .
heparin and pure chylomlcrons and VLDL· WIlS regained when a




added to ihe assays, suggesti.ng that rat "serum ·.contains a
,protein factor( e)· ....hich normally inhibitli the heparin-lipoprotein.
precipitation reaction .• A number of fu~ther trials sho....ed
that a protein fraction 'of rat serum prepared by precipitat,1..on
.... ith 30-50\ ammonium sulphate inhibited hepari~-VLDL and
heFarin-chylomicron precipitation reactions in a c~ncentration
dependent 'manner. the ~nhibitory effect of the ,protein
fractiOn, ....as relieved, ....hen PhO~p~OrYIChOli~e was added to
the assays., From these results it became apparent that rat
. serum contai~s a protein-fac;.or ....hich can i'llhibit. heparin-
l~poprotein precipita~ion react.ion and addition'·of
phOsphOrYlchOl-i~ coun~eracts the inh":j.bitory· ef-fect of this
protein factor. '.,
'on t,he .basi,s o0t;e~specific e~fect of,phosphorylcholine, ......
9\ this prot.ein facto.r, a lig~nd bin,d~n.g ~peCifiCity... o~ ~the
f8qtor to....ard? phosp~·orYl·c~oli!\e.....as anticipated. subs~quentlY~' '
Nagpurkar .and ,Mookerjea ,(l~l). purified the protein from rat
serum using a phenyl" phosphorylcholine-Seph8~oseaffinity'
adsorbent. T~e 'protein bou~d to 'e affinity adsorbent was
'" .
...
eluted by phospnorylcholine" but. coul-d not be eluted using
ace\;.ylcho~ine or c~Oline .chlori~e: On the basi~ of its
ligand binding, property for .pho8,phoi'y~choline,. ~he p;rotein
was termed 8S ph08PhorYl~hOline binding, protein (peBP). The
molecular ~eight of purified' peBP was .found. to be 12S,000.byv.
.gel-ch~OIlIat.ographyon Sephaet;yl S"'300. - The mo~ecular weight
of the. protein l't'as also determined by the .sodium'd0c:'lecyl
''-.'
I
.The ant-iserum also ~alled to
SUliate polyacrylamide gel electrophoresis ·(S&s-PII.GE) Ilnd it
separated into two bands of molecular weight. 47,OVU and
.' "-
24.000. attributable to a monomer and dimer of the sallie
unit. Redu<;:tion wit.h 2-inercaPtoetha~olresulted in 'di9S0~Oll
of the dimer, giving rise to i!l single band of molecular weigh't
24.<lOO. From these observations it was conclllded that. ~p
,.
consist.s of five subunits. three of which are held together
noncovalently while the ~ther two Iare covdlently b~nded~
t.hrough a disulfide ·br~dge. Amino abid analysis showed that
.eaCh sUbunit consists of'145 amino acids and the p["()tei~ was
found t.o contai~ Ie'\!. dai'bohydrllte. The' carbohydre.te molt-ty
cons·is..ts of glucosami.ne. galactosamine. hexosamine, nElutral-
hexoses and sialic acid. Peap was found "to' be pr~sent in
normal"rat'serum in substant."ial amOun7s (v.6-0.7 tn'll/m,l).
~uri·1).. e<1 pcap when add~'d to. he'parin-lipot'rotein
precipitation ~ssays us.ing ,purified rat chylomicrons OF VLDL
inhibiteq, the - prec~p·itatiori. reacti~n anq. ~dditiqn 'of
~~ pho'SphorYlcho'~lne reversed -tJie inh;oitor'y effect of l'CBP.
Antibody to PCBP raised,in rabbits produced a single precipitin
line against the pure 'aqtigen thus confirming'the immunochemical
identity' of. t.he, i.50lated --pro..teln 'obtained from rat. serum.
Ho....ever. the .ant~5erum··fai~e~t~ produce a~y pr.ecipitin line
, against r<;'t chylomicron, VLDL, LDL and HDL t~ereby sU99.esting
that Peep .has no illUTlunochelnical identity with the a'poproteins'
of the serum lipo.protein~.
- .




Binding 'studies u!lng th~ equilibrium dialysis technique
showed that. PCBl' binds 3 ·mol of phosphorylchollne per mol of
protein in the presence of Ca 2+ (J.~2)·. The s)nthes'i; and.
\
secretion of PCBP by. the liver was shawn using an isolated
hepatocyte system (133). Tunicamycin,-an antibiotic which
lohi.bits the glycosylation of .the core linkage region Oaf N-
ylycoprateins inhibited its syntheais,
Sutlsequent to the isolation of l'C~p by Nagpurkar and
Mookerjea (ljlJ, Pontet !.!:.~. (134) and De Beer ~ ~.
'(135) isolated an i'dentical-.protein from raE ,S"er:um ana
. '
termed· it as SAP and rat. CRP' r~spectively.. The criteria
utilized fc.c n~ming ~e, protei~ ~.s rat CRP by De Bee~. ~ !.!
(13~.l was :~.tB binding specific! ty towaidS-CP'\ ~ 7~) I Similaritie~
.....ith human CRP' wE!re noted, i .. e., pentagonal structure when.
eX~in;ned by electron lllicl-oscoPY an~ amino acid slequence
. homology with CRP, although only 30% of the amino acids froln
the carboxyl terminal were sequenced anB showed 71 percent
hO:,'Ol09Y with ~an CRP and 54 percent homology with SAP (136)':
While the' amino acid sequence analysis. which b~ itself
is incomplete, supports the relationship of th;s protein to
. human CRP, however, certa·in abbe rant features ha,ve also been
noted. Unlike human ali rabbit CRP, PCBp is glycosylated and
. is present as a p,rominent con~tituent of nor\av<at. serum·
(131). In additi~n, rat serum PCBP/CRP, unl'lee human CRP.,
fails ,to, {lcti'Vate the compl,ment pathW~y'andd~es ot Agglutinate
.' ~.
49
or prec:lpita{e soluble CPS (78). Complete amino acid
'sequence anal"ysis together wit.h the use of 6nlolecular biological
techniques may establish a more m&anin~ful homology ..... ith
huma~RP at the protei; "lnd genetic' level. Balled on ity
pentagonal structure, PCBP has been classified llli a member
of. the pentrax in family (126).
1.4. Purpoale of present research.
On the basis o~the observo.tion that peBP has an inhibitory
effect on heparin-lipoprotein precipitation reaction and hua
a specificity for phosphoryL choline ligan.d. it seemed reaaonable
that understanding the molecular basis of binding properties
of PCBP with phospholipids and Pl~!lma~~teins w~u14
.shed light '" the functionf!s) of thia protein. IHu-cldatlon
(Of, 1~8 function in"'ti:pgprotein .metabolism ,may ald lIdvan..,e
the knowle,dge of other members of the pentraxin f"amily.
, , .
In this thesis' previous st,udles on the role of PeBP in
I· -,
heparin-li'po.protein in~eractions have been extended. A"'
comparison of peBP with e~'bs of other pentraxins.· humall; and
rabbit CRP. hamster FP on heparin-lipoprotein precipitation
. .
reaction has been made. Tl\'e rOle-'of sialic acid residues on
. peBP and FP. in heparin-lipopr~tein precipitation reactions -~
has. been inveetigatpd. 'Theee stud~es may throw light on the
nature a'nd mechan'ism of the effect· of ·PCBP/and other pentraxinll >-
I '~n ~eparin-iiJ?oprotein interactiona.





containing liposomes has been undertaken gain insight
\ ,
into the nature and specificity of PCBP-phosphol-ipid
interactions. \ .
The bi;dlng of human plasma liPotroteln~ 1:.0 i~Obilized
PeBP has been character ized in order to identi fy the bllsic
felltures involved in the interaction of PeBP with plasma
lipoproteins. The characterization of the lipoprotein hound
and unbound 'to immobilize'd peBP .... ith respect to .apoprotein
and lipid composition may help in understanding the nature
and specificity of PeBP-lipoprotein interacti'Ons.
The effect of peBPon interactions between membrane LDL
rece'plers and LDL has been investigated to eXPlo're the_~88ibl.e
~" .'
functional~ effect(,s) of PCBP-l!.povrotein interaction.
Fip'ally t~e ab.llity of Sephar~se-PCBP 90lumns'to bind
lipoproteins' ~heri used in an i!! ~experlmentalplasmaphereeic .'
',.,', ' ."' \
ayet.em uei~g fabbit model has been 't:eeted. to. evaluate the








Male Spt'ollgu-e-Oa ..... ley rats (body weight.. 250-3009)
....ere obtained £rom Cha'rles River Canada Inc., La Praire, PO
<lod were fed purin~. -rat chow ~ libitum (Ralston Purina of
Canada Ltd •• Don Mills, Ontario).
it) Rabbita
Mall! white New Zealand rabbita (body.weight 1.5-2.5 kg)
""'ere purchalied from. Charles River Cana<la Inc., La Praire. PQ
and were fed rabbi.t. chow.' ~ libitum (Robi~pod MuitifOOc]s'
John' a).
B. Reagents aria Chemicals
Unless otherwise apeci.fied, reagents a.nd Chemicals




{ats were" anesthesized lightly' .... ith ether. the
abdomen opened and .blood obtained from the ...."'bdomin"'l a~;)rttl.
The bloOd w",s allowed to Clot for 1 hr at room tempel:'ature
followed by ,another hour at- 40<:. then centrifuged for 15
minutes a~ lOOOX9 on a bench top centrifuge to. obtain ti:le'






ii) Rabbi t s rl1~
Blood ",as obtained by' cardiac puncture from rabbits
u'}der anesthesia induced by intraperitoneal injection of sodium
phenobarbita 1,65 m9/kg body ",e1gbl't, fromM,T.C. Pharmaceuticals.
Hamilton, Ontario. Serum was prepared as described above
for rats.
iii) Human Plasma
Fresh, . re j ect7/' plasma from normal donors prepared
with citrate 'phos'Phate dextrose as an anti-coagulant, was
, ,.
obtained from Canadian Reil Cross Society, St. !ohn's and
used within 24 hrs for isolation of lipoproteins. In some
cases human plasma was prepared from freshly -irawn venous
blood of healthy human subjects.. Blood wl!:s drawn into
h.eparin";'zed tubes and plas1l\a prerared by low ~peed
,
iv) -Hamster sera "\
Sera fr~m male', fe\tale. FP-depleted female,
. . .
diethylstilbestrol (DES)' treated male, and testosterope-
'. . .
treated femal~ sl::rian hamsters were supplied by Dr. J .E.
Cce, NIH, Hamilton, Montana. The sera which ~ad been sent'
by air, packed in cry ice ",ere used immediately on arrival
or stored at :"'200C'.
D-.~
A.ntisarUJ!! .to .pCBP raised in rabbits, was. available from
a p.rev-i'oU"s study (1.31). Antise'rum to rabbit CRP 'raised in
. goats was a 1;lift, from Dr. II O' Cabana. ·Department of Immunology,
Rush Medi.?al <;ollege, chicago. Antiserum to Lp(a) and ap~ C
.........J.
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were made available by Dr. w.e. Breckenridge, Department
of Bioche~istry. Dalhoull ie Univers i ty, Halifax. Nova Scotia.
E. Human CRP and SAP
,
Purified human CRP and SAP ....ere purchasod from DifcQOo
Laboratories and Calbiochem respectively.
2.2. Treatment of animals
A. Induction of inflammat.ion
Inflammation was induced in both rats and rabbits by
the subcutaneous inj~ction of commercial grade turpentine
(rats: 0.5 rnl/lOOg body we.ight; rabbits: 0.5 ml/kg body weight)
in t.~e dQrtolumbar region, equ?-l valum-es being, injected
either 8ide-~f the midline: .. The cont~ol group wall ir1'jected
i~ an identical fashion with 0".9~ ~aline. , Both gr?upa w~re
~ bled, 48 hours after injectipn, and. serum prepared. Th~ seru/I\.
from inflamed rabbits was checked for the presence of CRP by
immunodiffusion analysis using antiserum t? "rabbi't CRP.
B. Administration of'17a-ethinylestrad!ol to rats
17cr-eth'inylestradiol (Sigma) was dissolved in 'prOPYlene
glycol at, a concen6ration o~ 10 mg/ml and admini'etered
sUbcutaneouS,ly'to rats a~ a dose of 3 mg/kg' body weight
every 24 h- for seven da.ys (137).
C.. Induct~on of l!yper'c~o1est'ero1emia in rabbits by
cholesterol diet
A 2" ch~le'Bterol (..../...:>-5', coconut oil (w/w) diet was




oil and mixing it with rabbit-chow. Rabbits were maintained
on this diet for per~ods ranging from 1 to 4 weeks before
~ use in plasma.pheresis expe~iments. Control diet consisted




the' affinity adsorbent for chromatography of phosphoryl-
chol;'ne bind~ng prete"ins was prepared as described by Nagpurkar
and Mookerjea (131l. Typically, 4-nitrophenylphosph<;:lcylchollne
(0.69, 1.1,9 nmol from'Sigma) in methanol wa~ reduceq with H2
at 1 atm using o..2~·Of 5% PalladIum on ch<\,t"coat .as·cat.alyst
for 2 "hbu.rs at room te~~e~ature. The reaction mixfure ....as
filtered, a:~d th~ filtrate- ev:aporated, under reduced pressure;
The. resulting 4--aminoPhenylPhosPhorylchoHne was immediately -
dissolved in O.lM N~HC03 buffer (pH 8.J) containir O.5M NaCl
lit and added to 15g of cyanogen bromide (CNSr) activated Sepharose
4B (Phaqnacia) which had been preViously washed ,with 1 111M
HC!. The mi.xture was qel1:tly m1"xed fOl:" 4 houl:"s' at .l:"oom
temperabure, "filtel:"ed and ~hen ~aShed 'alternately with
buffers a.1M NaHCD3 (pH 8.~) conta-ini'ng ·O.5M N~Cl and O.1M
CH3COOlh (pH 4.2) conta~ninCJ 0;5'1 NaCl. .'rhe Sephjlo.t"ose-
pheny1phosphory1cholin~......as treat~d overnight at 40C ...... i th 1M
e~!,~no1amlne (pH 9.0) and finally l:"esuspended in 5 mo'!. Tris-
m:1.(pH 7.8!. 'rypica11y, the concentration of phosphorylchol1!"e
incorporated ......~s 26 ~mol/m1 of Sephal:"ose.
55
B. Purification of pentraxins
i) PCBP




inflamed rats according to the procedure of Nagpurkar and
/>1ooker jea (1-31). Sepharose':'phenylpho6phorylcholin~affinity
adsorbent. was packed in a column (12xl. 6 em) and -equilibrated
with 200 ml Of'S rrM Tria-Hel buffer (pH 7.S). Normal serum
or serum 'fqll/jm inflamed rats (15 mil was ~rought --to a ~
concentration of 5 rrM with respect to Tria-Hel and applied
on the affinity adsorbent. The cOlumn ....as washed .....ith
equilibration bUf~ers until. absorbance at 2BO nm of "the eluant..
was less ~han 0.02. The serum eJ,.4ted by this washi-ng represents
,
ehe peBP-depleted serum. Thereafter, after ~xhaustiv,:
washing the bound PCBP was eluted _with '50 ml of4- m':" 1'-
choline in the same buffer. The elutea p;otein was exhaustively
dialyzed against "the equi,lib.ration buffer (4 chan~eB J 50
volumes) and stOJ;"ed at -20oC. 'nIe quant; tatiye ~stimatlon
of PCB~ in serum was p. formed as described (131). A known
aliquot of the serum was c matographed o.n the a'ffinity
ad80r~ent. The ~ound PCBP ""as e~ut I by applying a p-cholin: ...
graaient (O-O.IM) ana estimated by he method of Lowry ~
~. (138)". Quantitative derletiqn of PCBP from the s'erum ""as
establishea by immunodif;fusion analysis using the antiserul'll..
~uri~Y of PCBI' pr~p~ations fo~ each batch ""as establi.shed
by polyacrylamide gel elec'trophoresis (PAGI::~ according to the
method 6f Davis (139).
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i1) Rabbit CRP \' S
Rabbit CRP was ,isolated fro\, serum' from inflamed
animals following idllJlticat ~["oce~e used for rat PCBP
using,the aff~nitY .'ldSOrbent (f),V' Rabbit CRP-depl.,eted
,--serum was also obtained in a similar fashion. The complete \
depletion of CR.P from rabbit serum was establisheci. by 1mmuoo-
diEfuEiiC?n analysis usin~ antiserum to rabbit CRP. The CRP
lsotat.ed, was, det'ermin~d to be free crE other rroteins by \.
analysis ,on PAGE (139). Purified CRP was stored at -20o e in
5" mM Tris-I'lCl (pH 7.5) ~t a concentration of less that 1 mg/ml.,
essentially as' described by Coe ~~. (r'25). Female hamster
serum (2 "ml) was' applied to'", column (!),7xSO·cm) pa.eked with .
. 15 ml '?£ 'seph~)o5e-phenylpho8phOrYlC~oline affini~y adsorbertt
. equilibrated. with a.1M ;ris-HCl buffer (pH 7.0) containi!'9 0.5
mM Ca2-\-. The column was washed ext.ensivP"ly with equilibration
buffer and 'FP was e,luted with. a P-choline gradient (0 to 3.3
ll'J'O'in the equilibration buffer. FP eluted was estimateti by
iii)~
FP was isolated from ~normal female hamster )
the m!!t.hod of Lowry et at. (lJ8), diaLyzed extensively against
10' roM sodium ~h~SPh::(pH 7.0) containin'g ,15Q mM "Cb and
stored at -i.ooc. The ,purity of F,P was checked by PAGE' (139).
C. PreparatLon of desialyl'ated pentraxin's ~
i) Desialylated PCBP _,/~
PCBP (lcfmg; 8o,nme:l, basedon'MW 125,0001 was ~~cubated
in 20 mL of Sll'MTris-HCl buffer (pH 7.6) :witl:\2',5U neuraminidase
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/
) (from Cl~stri,jium perfringens type.x ,fram'sigma: EC 3.2.1.18)
at 37Qg.J for 12h. The r'elease of sialic acid was monitored
using the method of Warren {l40). ,l\fter completion of the
reaction, the incubation mixture was applied t'a the Sepharose-
phenylphosphory\choline affinity column (30 mL bed volum(!).
The column was washed extens;.vely wit~ ;ris-llCl buffer and.
the hound desialy1.at..ed peBP was eluted with a <ri-choiine
gradient (0-25 mM) in Tria-HCl buffer. The protein WIIS
dialysed against S mM Tris-HCt (pH 1.8) (4 changes. SO
volumes) and stor:ed aJ;. -20 c c.
H) Deslalylated FP
FP' (J mg; 20 nmol based '~n 150,000 MW) was deBia~y'lated
by neuramin1.dase treatment by ~ncubatn..n9 1.0 10 ml of 5 mM
Tria-Hel buffer (pH 7.6) with 1 unit o"")f neuraminidase (E.C.
3.2.1.18) from Clostridium eerfrinlJens type"X at nOe for
l2h. Release of sialic acid was mOnitored u!ling the method
of Warren·(140}. A.t the end of the incubation, the reaction
mixture was applied to Sep'hafose-phcnylphosl'horylcholine
affinity adsorbent (15 ml bfld volume, O.7x50 em) equilibr.ated
with 0.1"1 Tris-Hel buffer (pH ·7.0) containing 0.-5 .mM ea 2+.
- - .
he column was extensively was.hed with the equ.iLibration
buffer and the bound desialyLated FP was eluted with a P-
choline· gradient Q)-3.3 mM) in the sam·e. buff~r. The protein
was -dialysed extensively against 10 mM sodium phosphate
buffer; (pH 7:0) containing 150 mM !'IaCl and .star.ed at -20o C.
D. 18'Olation of human plasma lipoproteinB
f'_
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l..ipoprotein!l isolated from 250 ml plasma units.
Prior to iaolat1oIJ sodium azide ;"as added to ~~e plasma at- a
final concentration of 0.01% (w/v). Lipoproteins were
iSOlated by sequential flotation in a Beckman L5-S0':l
1l1trac.~ntrifuge o!Icco"rding to the method of Havel ~~.•
..(2). using a aeckman 601i rotor. The plasma was adjusted
to desired dens itias by the addltion of solid NaBi'.
Cent["ifugation was carried out in 36 ml pollyallomer quiCk
seal tubes (Beckman,) ~t 12°(:., At the: end of the centrif~gation
tubes were sliced \<Iit.h a. tube slicer (BeCKman), so as "to
obtain. two fractions, l1he sup~~natant containing the i~olated
lipoprote..in and the infarna'te containing the remaining
lipoproteins. 'The bottom fraction ""a:a th~n adjusted- t;o
desired densit1' to obtain the next lipoprotein fraction. The
. .
top fraction containing t"he isolated lipoprotein w~s washed
by recentrifU9.ation at th~OPriate density, The
lipoproteins were isola.t.ed following the removal of chylomicrons
(17,000 RPM, 30 min at 100c), VL.OL was isolated at d 1.006
g/ml (40,000 RPM, 18 hat lOOC). LOr; was then isolated between
dens.ities 1.030 and 1.063 g/ml (45,000 RPM, 15 h at lOCc).
HOL.was isolated between densiti~s 1.063 and 1.21 g/ml (50,000
RPM, 24 h at 10°C). Purified lipoprot~in fractions were
dialyzed for 24 h at 40C against 3 .changes of 50 volu~es of
O.OlM Tria-HCI buffer (pH, 7.5) cont'aining a'-ISM NaCl and 0.01 %
(w/v) soClium azide. The protein content of the lipoproteins
,war meatured by a modified method of Lowry u5io.g sodium
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dodecyl sulfate (50S) to clear turbidLty (141). The lipoproteins
....ere stored in sterile plastic t.ubes at 40C aJld used within
J weeks. The purity of the lipoproteins wu ascertained by
examining the apoprotein content on SOS-PAGE using 4-]0\
gradient gels (142).
E. Preparation of liver memoranes from 17a-ethinxl
estradiol treated rats
Liver memb"ranes, were prepared essentially as described
b:( KQvane,n ~~. (137). ,Rats ~ere killed by decapitation
and ~he livers ~ere irntjlediately ['emoved an\::laC~d in ice
cold O.15M NaCl. Equal al'iquots from 5 livers '~ere weighed
and pooled for homogenization. All furtner steps wer.e
carried out at 40C. One gram of pooled liver, wAS hOl)lOgeni:1;ed
with two IO-sec pulses 1n a Polytron homogenizer (Brinkman
I,nstruments. Setting No. 10) in 10 mt .~ homogenization
buffer (l50 mM NaCl, 1 mM CaC12 and ..10 ~ Tria-HC!, pH 7.5).
The whole homogenate was centrifu9.ed at 500Kg for 5 mi~.
The res·utti?9 SOOxg supernatant was centrifuged at 80~Oxg
f0r 15 min, and the 8000xg supernatant was centrifuged at
100,OOOxg for 60 min., Each lOO,OOOxg pellet ....as resuspend"ed
in 6 ~.of hOmOger;ization buffer by. f1.ushing 10 times tllrough
a 22 gauge n~ and the l>us.pension was again resed{mented'
at 10a,OO.oxg for 60 min. The final pellet was assayed
imrnediat~lY or rapidly frozen in liquid nitrcyen, st~'re~·at




Multilamel101r liposomes were prepared ~o stu~y the
. i
•
(' F. Preparation of phospholipid containing liposomes ..
"
binding ·Qf peBP'to phospholipid containing liposcxnes.· E9'i
PC. e99 LPC. phosphatidylethanolamine. phosphatidylserlne•.
........;. . .
synthetic: dioleoyl- and dipalmi..toylpho8~hati~ytcholine:BSA,
fatty acid-fr!!s aSA were purc;hasea. from Sigma and synthetic;
i.-oleoyi-2-Pal~1tOYlPh08Pha~.idYIChOii~ewali a 9i~t from Dr,'-
,K.M.W., Ke'ough, Department of Biochemistry, Memorial University
.\ .
of Newfoundland.
MultilameU:e.r l1posomes were prefi,ared by dil:lBPlving t.he
phospholipids a.t ·~he desired conc:entrat.ion in choloroform
and evaporatil19 the, chlorofQrm solution to .dx:yness. under:
nitr0gen., The resulting lipid,' mixture was disper.sed i,n 2 ml
of O.qSM T~1s-HCl buffe~ ~~H 7 •.8), so' all; to giv~ a final
. phospholipid concentt"~tion of 10 mH. The dispersion .... as .
v~rt~xed. for 3 nain be£ci~e using in the 'assay' in order to
p.rodlJce ~n~ uniform 8us'pensi~n. 'Freshly prepll.:t:e"d. liposomea'
....ere a1....ays ·~~ed in, the assays •
. ' . .
G•.preparation of Sepharose-PCBP and Sephar08e-
<leai~lYlated-PCBP'af"UnitY adsorbents •.
pU:1f1.ed pc;a,p was cov.a.1Cif'ltlY linked to Sephar'ose "1n th~
£011.01111ng ·....ayl. Five·'grams., of CN~~ activa~ed sepharos.e;48 /
IPharmacia) were. washed "',ith i~oo ml of.1 tnM:-HCl. S~Pharoee
was .. then..Ultered almoai ·t.o dryne.,a and 18 'mg PCB,P in 2S '~l





NaCl were added. The mixture was gently mixed at 2~OC And
filtered after 2 hra. The resulting Sep.harase-peBP was
treated for 16 h at' 4°C with 1M ethanolamine' (pH- 9.0). The r
protein content of the filtrate was measured (138) to determine
the amount of PeBP not coupled t,o Sepharose. The amount of
peBP coupled. to Sepharose was .determined by Bl.lJ;!t~acting the
'protein present -in filtrate. fro~ .total p·rot~in'added. for'h
- .
coupli'tl9:4 With this procedure, 1 'rng of peBP walil coupled per
ml of Sepharos·e. The t:ol..lpling was tested by the' ability, of
sepharOS;-PCBP to, bind antibod'ies to peBP frol)l :the ant,iB\e~um.
D~sialYlat~d peBP (prepared as described before) was CO"up~:'d
in -an identical fashion to give a concentration £f 1 mg
protein per ml of Sepharose. 8lank Sepharose was also
prepared by treating CNBr activated Sepharose 4B as described
a~ve except that no protein .....as added for coupling,
. 2.4. Radioiodini tation pro.c-edures
A. ~.
Radioi6din~ted ,reBP was prepared enz~!Ilatical1Y with
lactoperoxidase and g~ucose o,xidase us'ing radioi~~ination
;;Y~tem 'from ,Ne.... ·Engl.and Nuclear follo.... ing. "the man~facturere
inst:uctions. A typical labelling J;"eaction mixture included
0.168 rng PeBP in 100 \11 of 5 mM Tr!s-HCl (pit 7.8) and 1 fl)Ci
. ' '" .' . .
6f N~125I. Unbound Na l 2 5X was removed "by gel filtra'tion
~hrOmatog,raph~ on' a S!3'~h'ad9X G-SO' coiumn (20x!. 2 em).! 1251_




affinity chromotography. The l25r-PCBP prepared by this
method ha~ a 6pec~fic activity of 0.43 nmol of 125rl mol of
PCBP.
Human 'plasma LOL
Human plasma LOL was radioiodinated by modification
of the method of McFarlane (l43) as described, by 'Wong aod
RUbi,:stel'n "(144). Na125~·.(lOOlJC·i), Iodine monochlor1:de (80
t. nm~l)', l~ gtycine-~aO:H buffer ~ii 10.00 (0.2 m~). and ,LDL (l
mg ,?rotein in 2, ',ml) w.e,re.- I!d~fld s~quentia t ly. A.ft.er 30-60.
ee~, the radioiodinated LOL was applied to a sephadex-G25
column (1.5x2G\c~) and eluted w'ith 0.05M Tri.s-HCI buffer pH
7.4 to separate, labell~d LOL from 'free iodine.' The 1'25I_LOL
protei.n concentration ranged from 0 .. 25 mg. to 0.32 mg/tnl, the
spl'lcific actiYit~ ranqed frol'll.121-24~ dpm/ng, peotein., An
av~rQge of' 5\ of the 125I-radLoactLYity .....as extractable into
ethanol-ether (3:1) and greater than 95% of thl!'· 125I_radio_
activity ......{s precipitable by incubation with 10%. ('1/'1)
tr~chloroace'tic .acld. Labelled. 1..01.. 'was stored in 'sterile
pla,st!ic tUbe~ at 40C and used ..... ithin 2 we~ of prep.aration,"
Be·fot"e each··e.xpedment l25r';'LOL was dialyzed ovet"night
against O.OLM Trie-HCl buffet" (pH 7,4) containing a.15M Na(;)l
to remove any .residual ft"ee iodine.
2,5,' Analytical Procedures
,A. CLt"cular'Dichroism (CO)
CO' spectra ,'of PCBP. and dpsialylate!3 PSBP wer~
•
63 r
measured on e. Jasco'J-20 spectropolarimeter at 250C. PCBP
and desialylated PCBI? samples were prepared in 5 niM Tria-IIC.l
buffer (pH" 7.6). ,The results' are p,es;nt:~ as mean residue
etlipticit.ies ( e) in degree;.cm2.dmole-1 , using the mea~
. .
residue molecular "';eight of ·PCBI? and desiayL~ted PCBI? as
112.2, b.ased.on amillo acids.
I B. SD~~polyacrYlamidegel electrophoresis, of aeoprOl:.e~ns
I ..Apoprote1n content of lipoproteins was analyzed on ~D$";'
PA.GE", uS,ing 4-301 9ro'l.nien~ g,als prepared ~c~ordin9 to the.
method of O' Farre 1 (14,2). Prior t.o e lectrophorp-s i.s, 1 ipoprotein
fractions w,ere delip~ated for 16h at -20o e i,tl) ~thanot-
ether (3:1 '11'1). The delipidated apoproteins. · ere dissolved
in a.2M .Tris-HCl buffer (pH 6.S) contai.ning 3."6~ 50S and ~.O\
r;e:captoethanot. The gradient gels ""er~ r.un at 30 ~ .per' ~
s'lab for 4 hours at constant. amperage. Fot'l?wing
"
ele:,troPtloresis, g~ls were filted in ethanil-water-acljItic.
aci3 and stained overnight in 0.025\ CO~ll\assie brlll'ia,nt-
:blue. Gels were destained by diffusion 'in lO'6 acet.ic acid.' .-: ~
. .
'l',he apoproteins were identified by their r1e8i~eol molecular
we:gh\S d~eermin'ed from calibration' standarl:' run toqe'ther
with the samplE!s',
D•.Electroimmunoassay ~f aeoprotei~S -'"
"Apoproteins w~re ql.i'antitat~d indivirl~;lY by an
e1ec"~immuno.".y (' Rock.,t' .electrophore~ie) foi lowing th,"
proc..edure ,of Laurell ,04..'\. fhe conditions and val:idation 'of







. . . .
the '~:fs for ape 8, E and A-I have been described previously
-by Dolphin !! !.!.. (146).
, The electrode buffer f-or the assay of apo B contained
O. 06M .odl~m bar~ital tru ff~r p~ 8.!t5 Wi.~h 1.. 5\ POIy~t.hY·leneglycol
'. . . \ -
6000 .(PEG-6000) (Sigma). and O.002Sfol calcium lactate a.nd waB
us.ad aLso liS th'e sample di luent. The ele~trophoresis WIIS
. . .
rereor~e~ i'n 1\ ag"aro,'-e .~seakem L.~ .•. ,Mll.rl.ne-·COllOid8 •
.~ockla~d, ME) containing the eie'ct.rode .bu.ffer and 50 9
rabbi,t a,nt~humlln apo ,.lJ .gamma' 91';bUl',in"'p~r m~ ago1lro,se.
electrophoresis. was pe.rformed at 2.5 v/cm. for 18 hour_so at
12°C us"ing a elc.-Rad Model 1415 electrophoresis cell. A.fte,r
electrophoresis the plates were washed in distilled H20' for
, ·1 h. covered with Wh",tman No,. 1 fillter paper, dried at .60OC
. .
:and 'st~ined with c'oommassie+ brilliant blue" R-250. After
staining ~or 1 hour, the p'lates, were; <.lestai.n~d in :1ll~thano1:
acet.1c acid; wa.~"er (5;5:1).
A standard r"eference human seru~ was used for construction
'". ..
of ·st.,andllrd curve. 'l'he as.ll.ay lsensiti-v:ity was between 0.08,
. :~d:~'~"9":Ilp? 8 •. Rocket area. (;Ocket hei~ht x width at 0lle
.. l1al£" lefgth~ as a. funct:.iqn of ~poprotein oon;centration was
".mellsu,r:;.Qd to p1'Ot :"the standard cur~e. Fig. S shows the typical
!'etationsh1p, 'betwee~' rocket _height." and 'apo 8 content of" the
refer,ence serum••
-'





apo E 9amma91obul~n per ml agarase was used. The operational
range of the assay was between 0.02, to O. 20~g apc E (Fig. 5).
iii) "'po A:-I
The- e.l.ectroimmunoo!lssay of apo A.-I employed 1-.a\
agar0ge. 0.06'1 sodium bar~ital buffer. (pH 8.'6)' with 2.5\
dextran'T-lO (Sigma') replacing.the'PEG. The <:Itl;er electrolmmuno-
',/ .." .
a5~ay con~iti~n9 ....ere ·i·dentical ·to· those· qf ~po B. The
assay was used in the range of 0.02 to O. 2\J9 apa 1\-1 (Fig 5).'
iv) "'po C-Il"
The electroimmunoassay of apa C-II ..... as performed 30
described by Tam and areckenridge (147). Il,. 1.3\ agarose gel
with 2% peG 6000 was preparfld in O.05"i _sodium barbital
buffer (pH 8.8) containing 0.01% Tdton X-IOO, 0.01 mI.
eSA/ml gel and 75\.19 antibody per mt agaro!>\.!. The electrophOl:e~is
wa':l run at 2.5 V p~r cm/iSh at 401::. 1'h~ plates were soakod
successively ... in 0.15M NaCl fqr 1; hour and ,in dl.!iti.lled water
\ for 15 ·m·in;---covered with Whatman No. 1 filter paper; dried
at.6,o0c and stained in c;oommassie brilliant blue R-250.
vf~.
,For the electroimmunoil.ssay of Lp{a) a 2\ agarose
~ gel was pI;'epared i.n ·O.OGM soJi"um barbital buffer (pH 8,6)
containing 0.4% PEG-6~.oO. ,,[,h~ e.lec:trophoresl.s was .run at 2
V per cm for 21 'h at 4oC. fne assay w<\s st~ndi'lrr:llZeti.'Wl.th"
isolatod Lp(a) Which, was' a 'lift from Dr. W'.C. BrecKenridgo,
Department· of .Biochemistry, Dalhou,?ie Unl.ver9;ity •
...,
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Fig. 5. Electro,immunoassay of ~poproteinB'
The typical' rockets' obtained' with 8t.a~dard reference
, .
.serum _.< in case of Lp( a), isolated Lp( a ) was used as ,reference)
are ehowry. The vaiidation and conditi~ns for apo', B, 'E: and~
A-l.have.:)ieen described' previously by Dolphin: !!.~. (J.46).·'
.' ~
The eleptroirnm\1noa.ssay for ape .<:-II was perform~ following
the conditions described by Tam and' Breckenridge (147). All
the assays showed a linear r'elationship between the peak









E: Andlysis of' apoproteins by high performance liguid
chromatography (HPLC)
The separation of,apoproteins of isolated VLOL' and from
the plasma f~act~on8.·bound to Sepharose-PCBPwas perfo:med
on'"a perkln-'E~mer,'se~ies 4, HPLC System. Separa~ion was
• performed· oo'a TSK_250 gel filteration column" (300x7.5 ITM~
B.io-Rad). The samples' (containing about 100/.19 protein) were
delipidated with ethanol:ether (3:1) at -20OC overnight:
T1;te- apoproteins were dlBsOlV~d in lOOvl of 0.2 M Tria-Hel
(pH 6.8) con~ainin9 3.6$ SDS.a~d 10% 2-mercaptoethanol. The
sample so~ution was filtering through O.451'I'\filters. An
50,loLl aliquot containing about 50AJ.g protein was used -for each
chromatographic injection. The column was el~ted with o. SM'
sodium sulfate. 0, 2M sodium phosphate buf'fer (pH 6. B) containing
0.11 5DS,' The eluant was monitored at 2110 nm at absorbance
unit full scale (AUFS) of 0,32. The column was run at a
·flow .rate of 1 ml per min.
F, ,Lipid Analysis
~ ~ipid8 in the lipoprotei,n and plasma samples
quantitated i?y gas chromatographic (Gel total. lipid profiling
method .(148)'.. Total lipids (50-300119) were first extracted
QY 'chloroform/met:haflbl (2; ~/v) f~l,1o~ing th.~ method of
Folch.!1 ~ (149). , An internal standard; tride~oin. was
added' p.rior~ to 'the lipid .extraction. PhOS,Pholipase C wa'a
added (for digestion. by vigorous agitation at 30~ for 2




. (pH 7'0.r;-c-a~'2H20 (10\ w/v) ,and ethyl ether (1 ml). The
reaction was tli n stopped by addition of a.IN He1 (S drops).
. . .
The organi_c phase -was evaporated and the lipid ,residue
treated with 'r;RISIL-BSA {Pierc'e} and stored at -200C until
GC analysis.' The lipid pratiles were analY:r.ed on an automated
Hewlett pa.ckard 5440 Gas Cllromatograph using nickel columns
(1/Bx20 ip) packed with 3% QV-l on Gas ehrom Q. The columns
)
were programmed from 170 to 350°C •• Response fac"tors were
established for each of the lipid components by analysis of
~t·andards. .In some canes serum' triytyceride and toial
cholesterol were e"s,timated enzymatically on a Hitachi 70S
Random axis analyzer using the Boehringer Mannheim automated
analysis system. Total cholesterol was me!,9ure~ by the
cholest"erol. e9ter~ge/chole9terol oxidase technique using
c;~erc~a( kit (CHOD-PAP test. kit. f~om Boehrin~er). The
t"rigiycerides were measured by the glycerol 3-phosphatl!-
oxidase method (Boehringer).
G. Chemicai modification of LDL
The lysin"e residues of LDLwere modified by acetoacetylation
using "fresh Ill" distill.ed diketene (Sigma) as descri~cd by.
__..,I' weisgrab~r ~ ~. (27). Diketene (either (29 or 4.0~mOl)
was added to LDL (l mg protein). and the reaction "ell lowed to
proceed 'f~r S min at 250C. "The rea'ctlon was stopped by
dialyBia a9~inst O. 2M 80di~m c~rbona tel 80~ium bi~arbonate
buffer (pH ~.5). Control LOL was treated in BlmUar fashion






1,,"2-cyclahex.ane,dion~ (Aldrich) was used to modify
selective~y the argini~e residues as described by Mahley ~
!.!. (26), LDL (2-3 mg proteih) wa's m,ixlI'ed with O.;5~· 1,2
cycloh-exanedione and incubated either faf' 2 or 3 h at 35 0 C.
The' sample was di.alyzed for 40. ~ against '0. 15M Nl:l.Cl at 4°C.
For control LOL, 1,2-cyloh,exanediane was excluded from the
incubation mixt!-\re. The extent of lysine and arginine
'rnodific~tionwas determined b;l..amino acid analysis as descr~bed
below.
H. Amino acid analysis
Am,ino acid analysis of the various LDL samples was
performed exactly as. described by (26, '1.:). Hydrolysis of samples
(0.5 mg protein) was performed i,n 1 ml 6N HCl at 1l0oC for'
24h 11.1 sealed tubeo flushed with nitrogen and evacuated.
The analysis ~as pef'f<;>rmed on Beckman' Model 121-MB "amino
acid analyzer. Values reported were averaged' from duplicate
samples.
2.6 .•" Assays'and bin<Ung studies
A) Lipoerotein-heparin-c'a2+ predpita tion as~ays
i) Assay's with serum
The assays were performed essential~y as described
by Moakerjea (i30~. S!'lrum from normal and inflamed rats and
r~bbits, male and female hamsters,. DES-treatel:! m:le hamste'is
and testosterone-treate( f~male hamsters werE! used' for 'th~-
. '4 h~parin-l~poprotein-ca2+, precipitat~on assa~a. ~'Serum from
anima~8 depleted,of ,their ,PCPS, CRP anq. FP, I1S' required, '~a8
70
also used in the assays. The depleted serum' was concentrated
• back. to iea original volume in a .Amicon ultracentrifugation
<;::ell using a UM-.IO me!!,br,~Jc' at 4°C before_ usc:. The standard'
assay mixture contained 5.0 mM Tria-Hel buffer (pH.7.6l, heparin
(50 uni ts) CaC12' 2H20 (~oncentrationas sped tied for indi vid~al'
, .
a.saays) P-choline (added at co'ncentrations indicated for
individual assays) and th~ respec'tive seru~-{lSOLJl) in a
total volume of 2.5 ml. The assay was initiated ~ addition a-
of the serum. 'In experiments where the- effect of a pa,rtlcule;
frotain ....as to be tested, the prote-in ~ a 190 i~cluded in
the incubation mixture. Inc1)bation was carrier! out at 400c
for 1 hour' .... ith shaking. The turbidity developed as a
result of lipoprotein "precipitation was measured at 600 nm
in a ~ye-unicam spectrophotom~ter. Results reported are
representative of_at least three assays. Variations between
the assays was less than 10\.
ii) A.ssays using purified human plasma l1poproteins
The a.ssa.ys were performed exactly as "describerl
a'bove except that purified human. plasma ,lipoproteins were~
used instead of whole serum. The protein concent~atlon of VLoi~
or LDL used were. 2.2 mg/ml and 2.6 mg/ml respect i va ~y. •
B. Binding of l2SI_PCBP 'to lipo8omes
Assay' mixtures to study' the binding Qf 1251_PCB~ to'
liposomes contained 15 mM Tris·IlCl buffer (pH 7.B), 125 1_'
, .
peBP' (0.9 g). specified amounts of peBP, IlSA. (0.1.\ w/vl,
.liposotnes of specified composition (600 nmols phospho-




various concentrations of Ca2 + in a tot"'al volume of 0.5 ml.
Specif~etJ .conc:.entrations of P-choline was included ~n, -the
,incubation mixt.ure to' examine its effect on the binding.
Incubation ....as carried out in eppendorf. aentrifuge tubes at
370e. fOF 1 hour with shaking'. The bound and unbpund"PCBP were'
. . -'
'separated by ce.ntrifug&tion at 12,aOOxg for ·30 mili. The
amount of peBP bound was calculated by counting the 125L_
peBP in the sedimented liposomes using' a Beckman 5500 ga~a
counter. The effic.leney of liposorne sedimentation. was
, ,
monitored by phospholipid phosphate analysis of .the sediments
(150,15-11! Each experiment ....a~ performed ,at least three
times to compensate for variation in liposome preparatiqn and
rep,resentative values were used for the result~: The vari.ation
bet....een· each. assay was less than 10%.
"c. Binding of lipoproteins to Sepharose-PCBP
S'ephar?se-P.CBP columns (0.7Ixl5 em) were used to study
the binding of human plasma and ,..rat serum lipoproteins. The
columns were eql,1il~brated with ~.OlM Tris-HCl b~f~er (pH 7.4)
. , .
containing 0.15M NaCl and 10 rnM Ca2+. Plasma or isolated
lipoproteins were. br"ought to 10 mM' wi.\.h respect to Ca2+
concentration to st':.dy the binding 1-n the pres~nce of Ca 2+.
After the applic~tion of the sample... th.e column was washed.
wit.h the same buffer until absorbance at 280 nm of the eluant
was less than rJ.02. Tlte "c.oiumns were run at a flow rate of
,
20 ml per hpur- at 260C and 2 ml fractions collected. The





lipoprot.e:ins were e~ut'ed using a 0-250 nt<l ~-choline gradient
NaCl did nC!t elute. any additipnal li~oprote.i.n9.. Sepharose-
.PCBP colulnns used for lipoprotein bind~n.Q ,etud~.t.es w.'lre
regenerated aftj!r one use· in t~e foll~wing waYI Th~ c~.lumn9
were washed consecutively with 4 bed. volumes of O.lM Tris-
HCl buffer (pH 8.5) contai~i~g 0.5M Na~ and O.lM .CH3COO Na






Further elution with .1. 4Min the equilibration C!uffer.
the column·,was washed extensively with O.OIM Tris-HCl buffer.
(pH 7.4) containing O.ISM NaCl.'
to rat li.ver membrane receptor.s
i) ai:nding of 125 1 LDL ...to r~t liver :embranes
Studies on th·e effect of PCBP on 'the binding of'LDL
....
The binaing assays were carried out essentialLy
described by ~ovan,n !!! ~' 1137J, On the day of the "pedment, 'L
the membrane (laO, OOOxg pelle~s) preparation' was' thawed and
resu~pended in l'~of ~O mM Tria-HCI buffer (pH 7.5) containinf,j
50 mM N,aCl 'and 1 mM ea2+ by, flushing ten times through ~ 22-
gauge needle. The suspension. was sonicated at oOe for two
10 sec bursts in a. sonifier cell' disrupter (Mode~ Wl8S, Heat
systems 'Ultrasonic rnc), using a microprobe at sstting no.
, ,
6. The. protein concelJtration of each suspension was,adjusted.
wit~ ,'tJ:te sa.'!1e ,buffer to 10 mg/mL The binding, assay :a~
performed by incubating the liver membra.':~8. (100-12U~9
protein), specified a~ount' ~f 125 1 _LDL. buffer A (20 JI'IM" T'ri's
. HCl (pH 7.5) containing 20 mM NaCl and io mg/ml of bov in'e
' .. ','.
·~rum .'~~in~ ,,0 fi~:::2e<~~
cont~dne~' eit;her ~c~2t' _(~ 'mM)-co~ EDTA
'. co~c~~tr~.tiC;!:I~ ',ot: peBP' ~~~e' inc.hld~'in tn~-
: H.s- ef;e~t., on' b~n~din9' I:cu~lii;J::o~ w~;e '~a~~-i~~
' , ~..
." l)e:t~ using Beckman niicrofu9~ t:ubes :{l-l:.5..~ml






. S4~O c~~~~_ ('1. 5; t:: 4S c:~~e. column ,Wag el~fed ~~~h O. DIM
Tris-~Cl bU~fer. (pH~7~~) ~ontainin9 100 mM ·NlI.ci'; 'and C~H. (S
ml"q~a ''flow rat~ of '24 ml/h.-· ..The fra~t1on.. · (~ ..·n11) were,
~o·~~. for rad.Loac;tiYi~y- in.a Be·~k.lllan "SS_QO 'gaftna .C:o~ntBr•.
The elution vOl~me~ for Lb~ ·al).d '12~1_PCBP ~e~e ~eterrnl~ed 1.~
slilP~rate ·.axp~r~tIle~ta. ~ The ,,-oid volume 0'£ tli.e. ~orumit.. WfUI
~ :- det~rmined ";sing 'Blue pe·lCti~.n::::lQQO
. ~~" . ,In aneth.er..,...aet of exper.im~nts. the" 'supernatants" (looU1.). '..
2~'~::5:;i:!?-7~li:!5'~::·~'S::~~·
. :' ..w~re f?l?ta~ned by ·~Jl;~tr..i·~ugat:i~n· of _th~ ~~811y :m'!x,tu%-:; a~ .
: .•12.~OO~q··f?·~·.JOmin"at 40~. '•
• 2~ 1. ,"Plasmapheresis _expe~ime.nt8
1\. ~ In vitro" studies'
~ ..
•. ';-
'.. ~~~CUy .:e:::::;:~P::::~:O:o·:hi~:\ ·::::::~'r.::~:p::~~·r:" ...:';
~~ p'~r ml of sePh'a'ros8. :To ';tUdY\he"binding Of"l'iPoproteina:
'. "... . .... . ..
. from 'piasma, Sepharose-'PeBP colum~s '(2 11I'1 bed volume: O.Sxlu'. ",.:.';""
.'.- :~, ;"-;-~m)~~e_~~~libr.~~~d_W.1:t~o~:Oi.~~ri~~Hc·i: ~U.ffer _·~o~~ai·n~~.~ .:~._~.~
",' .. O~~ ·:'N.a~l, ~P.H", 7:4). .-In' ~xp~ri~eI\tB.w)1e~e the 'e·~f.~ct.~,0£'
" Ca~+ ~c~~cent.rat!on 6n th«: bt~ding' .of Upo.pret.eins, .fro~,
~lasma' was:~'t~ :~~ 8t'udi~d, .the•. e.q~l.~ibr~t.ion'b~ffer corl"tained.
the desired a.mdunt of C~)+. The piaema oample before·apPli;~a.tion
" .' ...'.'.' .. '.,
t,? t:;he co);~n .....u-b'r: ught ·to the duifed: c~2+ c~ncentration:
"'~" " . ,TO ~tudy' th~ !!tf~c' 'of th~. _unt 'of CJ'!Oleater·Ol ·in the ..
~-' .. "
_;... ~pl~8ma' .on: t.b:e ,bi-~di\ii.g 'o( ··plasJ.tla. IJpc:'P·r6te.~ns, .incr,~:~ir'l·g· .
Y~.~l1~~~..?~ ..~hy;perChO'lest~·rOle.~iC· p,l~.ma;.-:"er~- op'plied'. 'tb ':.;'"
sePhar08e,~p,GB_P:...~.:In :a11 Ule. !!!.' v~:~o ,~X]:l:.er.iments .f.~he COl~m.':lS - .
we~e: oper.at.ed .~t. a :lO~ r.at"e -0'£ ~O, mljh at .25.~C·' and,. O. ~ rnl\
.. ··'fr.actlons, ~~re ciOll?qte~:';he~twas":'-cOnti~U51y_mOnl.tEr_~d
,a~ 280... ·nm "a:,~.~' t~\.COl~m'ns. ,we:r.e ~luted·.-.unti.~., no ;~r~~ ;":.~~
m.~.erlar.b.orb\n~ at·2aO ~ wa. eluted: The bound f,:a·ct!~nB ,(
we'~e, 'eiuieJ. "by..:20.'· ~. Eb'TA -s,~luti~ri. -SU]j_~~quent.' to _this; .. ~ ~ , :.'".
·:,ut-hi~'P"~8'':~'·Of·· elther '00 "". 'P'~c;,~li?e 0;.1\ :4. NacldiJ _. ._ >-
-:rot,. el~t~ ~ny: ~ddi.ti~.~a~. :~.7~.o~.r:ot~fi.n~s, ~?i.18 infi,?,atin~, that: :~:
'..tlle elution ti:.-. 'EDTA was .quant.itati,<e~ , ' ''.,'\ ': ,..,' •
.p~aBm:b~e~·::,t,':.-::h:'::::::-lfr:::i::~:~i~e :~~e~~:::::2:c::.;
c;l·~m~~.,.~e~e :,e.~ti~mat~.~.: ~'y, e,~ZY~~ti.;, '~e~hdd'" a~\: ~~'~:~i:ibe'~
.:.~...efOF.e~ ":I:DL":~h...o.,•...e..••.e",.'.' and. VLD.~:~ ...ui~~C.h.".lest,e~~. ,..co..n.ten.t....
'of the plasma samples .anp Ibound ':f~actions was m~~s red .aft1!·r·
th,e p~e~ipit,ition.'of ,V,~o.L· +',·LD.L fra~tion us·.i·~9. a.-
'1~~p'~(~n;~'~~9~ne:e~" prec·iPlt~t.i\n,,·:p,r~ced~;~· ,(t.52 ).~ , By :~~is<
',- T~\.ea6'ri ;';1 'o~ pluma-''6r-,·the bound ·fract.ion,. 40 1J~' ~;f






-'"'voI'eire added, ,followed .b~ th~rdu9h mi~ing .after each ad·~ition•
.- The' samples-~e;e in~Ubat.eEl ~~r l~'min at i~~, tller\~nt;rt~Uged .,"
-,' . . .. . . ,". : .
_. :or: 30· min at· 1500x~at 4~;. The s~perlJ'a:tants we~.~ ..q~~Ck~Y
_:. transfet;ed a.nd-·-st~~~d- at-. 46c undl ,cholesterOl estimation-"
by. the ·enz.ymatic met1l0ci.. descri~ed be~re.· p.rotein 'content
.of, the ,frac<:.itons.' bound. to _SePhar?~~:~llP..'We-re. estimated by 'the- -•...
. -" -, ... \ ,.... , .
~~d and. a; ~rou~~~g ,P_~',ate. were placed underl~he ~abbit:•.
E'ach ~i.rilb was taped. secure:ly. 'to. t~e _cirad~e. to iT!.aiiitaiJ:' t~e
p'top~t .p,o"sition. ,.' . .
.. '-Hal~'thane'''-nitro,us foxide, and'. qxygen were ad~~nist:~~d
. . .\' -" ... ,," ,'" '.' . ~ ~. :, '.'. '.
t.o,the an.illial,in.col1centrations C?f 1\, O.4L an.d .2L-respectively.
:..The. respi"rator' was set at: a ~·~te·."~f 35, breaths' ·per, minu'te
,Z;"'~th:: a'.' tid'a! '~~l~me' b"f· :2~O ml/~9~ ~riO-~' to' -tr~Cheo8·~~my./
' .. ~-;j'~~h:i8' ,~hti~re ··~:8~ini~'i's.ter~)~: ".' ~e~p~r~t6~, ma~k~ - O~~El'
'J.' .
18.
·t_~?". :·r~C7heo~to,:,y.....as ~er~~~.med: :'the:. r~~'pir~t:or-was' hOO~' up .
'.~t:oj"t.n.e tr!lcheal .tlJ~!,!,
. -,' ,I. b) ~ra:Che~s'tomy and'vessei-I~ol~tion'
A"'vent'ral~ -midlin~~ inCi~;~h' ·wa·g 'ma~d~in ',the- neck'
· " .,..
.... i' , '.' ',' ,". ,"' .
, through the skin a'n<;l·subcutaneous,tissue."u§i.ng.eLectrocautery.
'~n~:.b;60d vess~.ls ,tr'~~sec:ed ~~:! 't.he \.n',ciSi~n· w~r~;cauteri...·eQ..
caroti:d aJ;'tery an,d ju'<3U.la;-, V~in.' .....~~t-t;:~--b~
~~. L b,l~t,~:iSgec:ti6n th"rOLlg~;,'th~·fasci.'~ .. "'A pi~c:'o,r 4':0, mersnen~ :.'
,1:.,-;' '. , ',.. ..' 'd d - ' . , d' clam~e'd .... ith "llIQsquito~/ .. -J. -.- was' pas,se ~roun ',:' e~ch. ~~sse,l a".:" '.,,' . I " ,'; . _',
r.;, ..'"," fo:ce~.~~~he:neCJ( incision' ~~s 't1:'ten, c!'lI.ered wfth mols~~ne~.
~ t'di.e ~'idi.i~e. of' .the expos!,!,~ ,m~s;t~! i,~y~r;\'A,S"'f',:)Und .and"; ~lun.t . . ,,..;
;':: ~;. ;q~~~sec;t-~~ 'Us!':Ill, M~hanb~u.m. ~ciSS~,~~·.~ . ->he. ,tra~~he~ \<ias -·.;~·~.s' t ." . ::
:.~. .i--: e'xll?~'e4" -. . . . .. : :'\'
~,.:
:i~ ), A.~ ,i~.~ision ......48 made:': in "t.he; ti~Chea- 'usin:9 a !22... _blade ," / ~-.,.






, " , '. . : ~: ;.
·'·te)· Femoral Artet:"y -Is'olation: An "ob,lique ....e~tr,al
Incialdn ~a~ -lna'de l~,.th·e· ri9'h~' ~fndieg of ~the '-r~~~it. _:~iunt:-'
." . ..... ..-.,>' -',. .'. I
· di.s~ectlon w~s,used to ~Solate the f~mq,t'a.rarter~. Approxim~t.~ly
",3__~~'o':4\m'-6f t~~..-a",.te'r,~·"~as: ~x~os-ed.;' ", : ..:""
Two" pi'e~e'fI: of '4'~-ci ,me~sll.e~~·, i....~~e- .pa·ss~'d· -around' the
c.' v.,ji.'.~'; ~h.'~.' ••' w•• l~\J;.te~d;'t'llY, ~ ~m~ll~i~~"~•
.•," "',', "'-',". " I
.-,,'
": ;.'\ji,h' l' .' ~ ..,J"\ .,'- .-:,'.1t;i~;filf~~;1£;~)1ll,;;ti\itt~-$iIK;0.~~;,'l+,;li)i;it~i~~l!;;'0Jii)ld.;i<;~:;,i,;;{~;~,;'\d~t,\'ilii;{,;;;/;'~
'·9 .
10..···
. p.la.~e .·.·:The,: externa~· ·~~d: ~i the c~th~e~'was'''at~~h'ed:-:t~<a'n·
~'y.se!:. ;"'hi~~·:'yJ,!-"in...:£ti,~n' 'C'O':l~~cted. to ,the ~b~bble -trap "as' ~e;
~ F:hiu;~: 6._' .' ' '.' :".. /.
.the vessel wH.h"Potts Smith ~ardiov~8C·~l'a~.·~~is~'c:r~
,. ", , - ... ~ , ". ., i ;
a~\i~a, PE':'":O' cannula was ihsert~'d? Th.;,.(e.cOt'l.d'· Pi~<!~ ,Of .
. " '.mer~~.lenEl was tied s~curely arou,:.d. t~e .c~nnul~ and vessel·
""such t)a~ ·t~e cannUla.. w~'~~~. not ...s~i" ... :z'1'!e extElt'l}al,. end :ci~~
,..,. the - pannula was· att·llph~d·'.t~. an· llrte~.1al 'preS:.s'ur~· transducer".
_~--!,T!!,he"-,,inc'is~s cover.ad w~ th· mo~s~e~ ). .•
~; ..
. , ~i,~ilar.,lY, .~~e, ..caro,~ld a~~er~ .~~~.l~~~~.~·~· ~ran~a.l.lY' •. \ •
dinall nick was. made .in ,th~ vessel ,and .a PE-1"90 .cannula
:ins~.~ted~. Mers·ilen~,.(~::.~),.wa~, use) t~ s.e·'C:.Ul:e th~ C~'?~..Ulc;. :,~~ .
"':'2J.~~_., :rhe 'exte.:rlHtLlIDsL2t"the catl.l}.u,lq_w~a..8..,...iitach,ed.to ·~I)e=,_._;.
" t:Ub~n9' 'gOi~~ thr6ucj~~ Pi ..a.~ p~; ·'Fig:~re :6:' .~~.e" ~neI·~l~n· a.rea
. in, ~he,. neck w:'s .co~~re.!,'l'wi th·' moi!!tened 9auze. -.
-'5'he' animal 'was ~e'pa~,in:ized w~~~' ~~iO~~~~ht
. heJ?~rin .~nd. ~.ub~,eq~.~ntlY: hepa~).n.i'~,ed eve.p~' ho'u'r. ~i~h. 1'$,0-
~., ·iu/lt9 bodY' we·ight.': Tpe ,temperat~re"of the,-rabbit ,....a!l ~nit.or~d
t~'~OUg~ 1::l;Q·~~~· of~a; re~ta.l' ~'i.~ct.r~~~·~·r~- theElllb.~e~.~~·. B~.ood. _. ;.;
. t~~'~Uqh Pl!ri'B't~lti~ pump (Pl)':,"tb a., Plasma,.. ~eparato~~~ " The
~i••:~ ':-a•. ~~p~r'ted·;':,,",,__~~~,- re~ ~l~~. ~ell•.,IR~C) -ond-wa:
":':::~~:r':::~1~:~:o::7:;:::::::B:i;:::~:~_::::~~';:OfOI;.,mMI
,',~nt:~~e:~, ~h~ ·,~.o\u,mn·: ':A~_ter':'floWi~~",throug,\h,: thfil CO.lumn:~; ;?e'
::, Pl:-a·s'n\i. :w~s r~t.ur·ne<f to mix' ,with the,' RB~' s, w~th the:' heip of"
'-':~,eJ:'i~tait-ic~pu~P ~P2'}·. The ~'ixt~: 'wa"~ pa~~:d th'ioUg~',~
pedl~tr-i~ bubble t~~p '(B.T:'): all~ . the' bl~~d ·r~~urned'. to th~-
. . '.','- .":" .':,' .' ", ' '







. " il) ·pilloBm~pheresis syste~ j \





tUbin~.(OO - 5/16. 10· j/16l wh1.ch ;'~8 run·through.·a.p"r-istaltic
pump (PI)' to a Travenol. p'lasma separator .. (Fig. ~}. ~nood
';'..~.-.,--..----- . I'
·was. drawn from the artery ,at" a rate.,cf ,22 ml tJer' min. TheI .. .., . . . . . I'·
. \ ... pl:asm~'..~as separll~ed iI,"onl .the· !lac's, lln,d. was chan1~lle~ int,o .\
, .':' .'~' s·eph'ar~~'-~Bp·--coluRlIl. cad12.2H20 "is mH '4~tion')"""~s ' f
, ' ':~r!~~ed' .,into :th~ ,~;asm~ befor~, i~', ~n~r:e,~! ·t~~. ·.clb~·~.,!"n'.~t~a'
. \-..-/;~,t~, Of.:',l. 'm~ .par ~l.nute .:i~~O :.tb,~:.Pl~.s~a at s~OP.~O~k ~: .thr~u~h
:. ~~e' leng~,:, ~~ th~' exper~m.e.?~~, ~7te'r'.:f'lO!~.!1g ~hro~~ th,e , ~
.Sepharose-J?-CBP. co-lu~_n.•.. the E.la8~a was. retur.ned, to mix .'oath, .
th~ r~d. ~lood-: 1::.,118, ~\.rith t.h~ ;'".h·~lP of.peris~al~ic ~ump ~2'• .,.
The mixture wae passea through' tl Pediatric s·ubbil;.e Trap and
.\ ..... _. , .
'. the ~I?l:..ood ~a,s :returfled. tq the jugular veill.. $", ~. r~te' of :
,.llp,erltlin. ., ,r -\.-'
. I : pr'i~r tq' e~perimentation•..th·. ~yste~ was p~imed jl'ith ,
'~lC:-~~~'~' Ri"nger lil, 8~I~t:iO_~ (~~O ml) ~o.!1.l::a~~i~g .~'.2' ~e~~rin
2j' \~e~:maco~:~ ·a.nd ~ju~t.ed ~o' a',PH, of '7-. 7. !,rt:~~al. Pl,Ood
.arp:es .w~!e ~ni~~{ed be~~re .p·as-sinq thr~u'g~ the plasma
s'epatator and~ venQue blood samples just prior to reinfusion
, i,~tc '~~e'.animal, ~~~ilnine-.-;~~~,:·~~ poat-Plasma~~~~~~-: .-~~
cbnc~n~r,!.~1~n8· ~~f albul"(lin ~n~ tOJ:.al protei~, .\~ .dete.rmine
I· ,I,' .,' .', ..
:): tre:"a;~~ft; ~f. l!poprote.i.~ bO~~. ~,Q' .~epr~r,~,se·-pcsP~ dUrin~'
~:;:.' ~lilalim~Ph~e8}8( the c~uhm_.WAS. wash~d~..eXlJ.al.\l!~~.Yely with ,.~. f'
~./ ,.:'" ...... ~:Ol~ .Tri~b~ff~r {'~H 7:"0 ccmt.aini~9 O.15~ .. ~aCI and·.~.""S ~,
,- I·\ . .. .
~~ \.~~~:i,,~;)~i\j:t~6'~!j_,~:,~':.:~,.b_ ~;j!~;-";;;·4;.:.;\;0~;;,~~'i:"L~ .";_:,;~,,;:l;?>i
~ ; ,
.2
'c"a 2+ till the -Clbsorbance at 280. nm of the eluant -was t'el~w
O~02. The bound 'lipoprotein- was then elut~d witn 20 mM "!::OTA
an~ the; eluate' fra~tion5' analyzed f~r tofa'i ChO'le~te,ol,
VLDL + LDL chofesteroL HOL cholesterol. triglYCeridee, and
. ..













STl(DIES ON TK.E: EFFEcr OF 'peBP, FP;' RABBIT AND HUMAN Cil.P ON
HEPARIN":LIPOPROTEIN PREfIPL1'-'TION.
3.1. Introduction'·
'P'CBP ..,a8~previously sholoffi to. inhibit heparin-ser~ml
:-- ~~Goprotei~-;reCiP~t~:~~n in th"e pcese,n,ce, of ca2+' (Ill). The
re~u:t.5 ..of9' th.ls, ~tu~y ~':1ggestJ!d ·tha,t" 'peBP. -du~e to its
ihOS:hOry'~<:~~line~bi'!'I&ing ·.p.r.ope~ty.· may 'if1ter~5-t .... i\h· ..~c
t'll!=llecules exposed on, t~e 8ur.~ac~ o~ the L,ip?pr?t:elns an?
{:~: . thet:eby pievent" th.~ pr.e~ipit"atio:l'\.' This le~ds to the hYJ;lot~'esis ..
J tha"!:. oth~O..tPh~.~~r~~~J.~ne· .b.:indi~g pentrai;~~~' "may a'lso
~;~~.~ • de:n~yrate 8~~ila~ .inhib,itionof 'hepadn-lip~pratein
.> pr~cipit~tion.
:he purpose of tlu~ present investigation was 't~ slUdY .
t~e effects. ?f peBP. FP; rabbit ~d' human CRP 'on
he~ari.n-·li~p~ote~npreciPi~a·tioQ,. The effe~t~ ~i'pentra,xins
on h~parin-lipopr'oteiTi.precipita~ion·rea-etion have been
~tu~!!~__Usi.fi.9 se'r.um from animals 1oiith' differen~ treatme~t-"
. i~, r~~:a'~d ra.bblt, ~i~ inf~~~t~ion. I1\ale a?d ;ema1~ ~~ri~n" .~.. :~" ~.~
ham.st.~rs t..~eated.. with \~ex' h~~m:es. A~inia.ls .t~l~~,~ .as
.abQve ate know.n to have in<;:re~s.ed or deer.eased 'levels of'
·pen.traJe:ins in 'their. ~e'rum (78,.'B2,126). S'tu\ies' :"'er.e done
" '
<t"<. ~ f~1~hOU9h the WOI'ds 's~rum ·lip~protei.n': h"aye,\ieen ~;'ea
;} ~~p~;:~:;~::_e:::::r\nt~{n~Ser~~~~~~~;.?~~it:flwe\elxt;ei~9~~:~~i~~~f
;. only, apo B .C'ontainipg lipoproteins (VLOr. arid LOL) 'form~'::": 't~;\,~Ubl" co"';:L.... wHh '.parin in",t~~:,p,•••nc. of ca2+ ,









. ~he ,r,ole af s~allc acid re'dljiles present. ~~ PeBP 'ani"PP'
. . .. \ '
in_ t.he~r e.Hects b~heparin-lipoprot7rn precipit~t'iO!\ has,
been examined.
'rhese studiu ma'r. prOVide addE!d i~:;i9ht9~'~nt.O~.th~".t.
n~ture r~d 'me~hani~m of the e.ff~c,t.~f PCBP .a,nd oth-er pen~'~a,ltin8
on hepar.ln-l1.pOprote~n.prectpltatlon' r~action, ......
al's~ by' addition of purified...~:~ntraxins:. to th!!'
hep~·dn:-li.lx,prot~iri pcecipitation ~saYS,Ugin9 doiEfer.e'0t(
'kin~~ 'of ~e~~.. 4~ddition•. studies .4re ~·e-·~~i'n9·PUdf~ier\(
VLDL and Lb'i. ioste'ad Of' ~h~te. s,arum as ~ sour~~'Of: l"iPOp~~te:in~.
!=-o monit.or' the effect of pe.ntraxlns heparin-tlpop.rbtein • ":-::~
. precip.itation· rald:i.on uncOmplicat\d. py the ef fects .of other· ._.• ~.; :.~:
~rotei·ns. ;r~sen.~. in ~~o,l'e s~.ra·, r .".. .. :'. ~.,
Since' the" hepa~in":'~iPoprot:e\,pt:ecipitat ion ·reac~ion19 .
.... d~rectlY':'rel'ated ~:-the 'cdnc~ntr:at:on':Of li~ia-s _in '\he 'sera ,::' .: :
. . .....
. ('55)._ U~e: leve_~~ of tdgiyceride a~d·.tc;l'taL ·ch01.e8te~o~.:il\.-
.....
3.2.~lfsl.llts
.. A: COJhparison of heparin-lipoprotein p.reclpitat[o~using' ~rlJm
, , . , ,"
;) from <jontrol and tteated,·<l.nlmals.
(i) ~
''Phe··reSUlt9' "1""'b1'e '5) Sh~ 'no 's'lgnLfic!lnt 'cHff~reh~~ 1n
". . ... '. -, . .' ~ .'.
~ri91YCedde.ans' tota.! cholest17ro1 'leve~9 in:' inflam~d .8etLi~






































A,tlliDaI Tn.glycen.de. , Total ...... #; . PeBP
. . , . . "'-,' chol.est~r~l







. Harns~er~;~' ' ....
·~:;:le-.'~·~·:. _i~~~i~~' :ig~'~i~:' ') ~._-: _ '~:~:~;i,~igl
DES .treate,d Marl": '247+76.30 216+13.37 1;072+0.13'
Testosteron~ -:-. . . ..-.; _" . -
treated. fe,male 267+28 ..04 (151+9.17 _.". • 0.058+0.01.1
t' - (P<O.00'2S,·" ,. •. ',(P<O.Oool)*
~o't." ,.'11 '~.;:e:;='r"~ expresse,"" as 'tOe.';'••n ;c s..;o~. ihe'mes,n except 't;"'~r"s~lts of'"
·.-,·control male"and female JJ,am!!tet=~ wh).cb·r~pr.eijentthe se.rwl\'\{alues fran two an1lllals. Serum'
from.. fi~.e an~mals was eJ'f.amined in· eac:h' 'group ',f,or .:qats;· :DES tr~~ted ma!~ f1ji'mst;ers ond
te,stost.erone treated fern,\le' 'hamst~tso :serum}frpt!l !.eight :a'hima:1s "'!as eXo!l(lIined ,in eAch
.£:~:;t·of<?r .t;abbits.. ,~~a~~s~c~~::si.~rii,f.j;f.an,::.~:w:; :ca1c~lated .. ~ith stU'd~n~s l:lnpai7e~ i
*indic.ate~ ·statistically .~f9~i.fi~.ant .di,.fifeie~ce.•t~.oll\..DES·. tr;eC:ted ma~e"'·h~s.ter;·.~erum.
Totail.· c1?-e:1esf.er0;l. an~,: tr,ig1yceri<fe .were· estJ,-U!atect;'oy enzymatic' me.thod i;!f!;}.ng .t~e
8Qehringer Mal}heim .~qtomated ·ana1y.sis sys.t·em .on:· a; .H±t.at,h.j. '·705·' Ra,rJ;dO"in .Ax.l·x·Jrt~lyser.·
The .c(;mc.entr;~HonG o~. PeSP" CR~ .and·:F~ were.dete:i'mi~ed as ~,:scri~' in·'Cl'!-a~~e.r. ~o"
";~.i\~~~::).;c":~""'" -in~.~~~te.~_nQ.\;~.r~Sl[!nt /"~ ,.•..,., > ':,-._'-~,':~,~~>::. :'.: ".:' '. r·.:~ ,. ,.;,.... >-'
.~ \ o.
\ as' a function.-o! Ca 2 + 'W4S lower .... ith tr-om ~1.nf lamed',
. rats compared't;.o control serum (Fig. 74 and br. -Addition of ,
. ,-.. .
16u M P,:,choUne resu;lt~d in. increased prechritation in the" "
re.glon ~f";O-3.~ !tIM Ca2+ in C~J1tr_<;>~ ··Beru~.~··....hile .a~di t~on', of










The 'serum tr·.f.glyc·~dd~ and total cholesterol "levels
~r~ not 8';grfifica,ntly .di~·f;rent-between ~h'~ndf'~~~~:ha~~er~:
", ~".. - ..
(Tab.le. 5),' bu~, as. e'xpect~d "f1=om.,t)1e work ..-of c~e (126)·; ~h"e
leval of FP ....as markedly h~9her in the female hamster (Table
5).~ .t\. COJllPa\ison of - hepj'l.rin-l!poprotein pr,c\pitat~~'as a
function 0,£ Ca2+ conpentration Sr:lWed lower precip£t\tion
_ reaction in assays ~1.th £emai'e. serum than male s.• lFiq, 9).









'~..•.'-":~.tk2'.' a.. • .~.~.~.)~...'.@~.'M.·
. .0.1 , ·.~'o.1._ '. '. ,n
. ~···:O ;~26:."30~MCa"O lQ2~ mMj{)ea
4:'
-'.!it
Fi~.· 7. cO",!lParis~~- ~f hep~t::in-se'rum iipoprot~fn'prec{piJ:~ion
reaction in control and" serum prom lnflamed,rats &s a function'
.of ca2+ conce~trati~?. " _AS9~YS- ifle~e' c~rri~d':O~~ ~,:in9 150'" 1J 1 . ~ '.
Ber~ from, .(a) c~nt~ol r.at9 --(b). inflamed rats ei~her ~'n-ihe
ab8~nce or ~r~8ence 'of 16' 1J M P-'~hoUne ·£:or i (a) and"· '6.thel'
concentudons ~8' i~·!i.icated f.9r (b~ ",_ He~arin (SOU-) and,"
-:~ri8~.~C~· {50.·"mM,;~_ ~,~ .7:6'). wer~: present in La~l, ~88a.ya· in a·
final volum.e of·~. 5 'ml. The 'tubes, 'were inc,uba'tec.. with
.sha,king. ~'t'40oC f;'r ·60 min. and' the.n m!.xed,.·using a -v~rtex
:mi.x~i' Defore reading'. t~e. ab8.C?r~i!lnce ai.' ~OQ. ..~.
·:····czz··b'" '1''. A~~~ ,:...._. ;;" -
':, ...." .. " . - : ..: .
,1 " .' ,.. .' ~ ,















Fig: 8. COlflparlsOn"Of h-eparin-8e~Ulllipopro~·ein,pre_~ipitation· ... ';' ;. .;
r'ea~~ion ~~co'ntr~l :;~bb-it Is'~ru'm-and ~erum from inflamed
rats as 'a ,.function of ~c'a2+ ·con~entr.atlon·.. ~s·s.ay. ~ere
\>e'rf?,:med' .using,ISO· lJI.9·£ (a) 'i~flamed rabbit '88r~m 0504· (b)·
control.' rabbit ler~m, ( .... ). Other" exper~mel1to5l deto5He' ar,tt -
d~sci-i~ed '"in the" legend to ~ig. 7. '
.'.'-. :---








hamsters sho.....ed .that the total -cholesterol leve1s' were lower
;. ..-




.. . . ". .
in th~ testosterone treated .f~male .ha,;\ster serum compared" to . ~
.DES treated. rna,ie ha~tei serum, whi l~; t,he triglrCerid~ ~
levels were higher 1n the fot'1'I'ler~ Sin'ce FP". is re9ll'lated by
, " - 1·- ,
sex h?'r~nes (126), DES treatment in male h,msters' in~uced F~
PCBP ~aB .p~vioual!a'" :shown to, ha,',!e ~n inhihitl'?ry
on 'heparin;-i~pO~rote.in ~re~ipitation ':'re~'\=t,t'on
.depleted rat' serum On), .-In tl1e pJiesent study
- effect·,was ..a'll!!o dE;mo~tra~;~" when. P~BP w~". add"d I'to
. "\. -,.' '. ','
';lung ,~RP depleted se.rum from inflamed
rab!,it:, seru.m. ~,A.8 s~own 1.-,'1
amounts ,of PeBP
.either .s.e.rum..
. . . -, . ,
~co~par~ with' c;intral male·,hamster.; Table S) and "te.Si'tosterone:
.. treiltmelnt in' fema'ie 'h~m~t.e:s xe9uced..FP _1e'.'e19 (c~mpare ~i th,
. control female )1amsters '1'~bl~ S1:' ,When.he!?adn-lfP.~p[;9t~,in
p.ri!ci.~·ita_~/on wa·s.st::\J~'~ed a's '~'l~-n'ctiO:~ ~,f-,. ca2~" :t~e
precipitation c~action .....as lOyler' ·in 'OES treated, /nale. serum
~o~pa,~dto:e'to,,~ron.tfe:at"'d;f~mal"jr"m<fig. in l:'\ .;








~~action- i~' DES tr~a~ed.'. n:ala:h~~s~e"r~~d testo6t~fo'n~ ··~ieated.
f~~alB Wa:m8~~r B~~Um as' a function ~'f ~a2+ 'co-~cent:ril~ion~'
. Th~ ,~~~~y.8 .w~f.e '~erf~~med>wlth 'l~~ :."lJ 1:0£ D~~ \~'ea~ed
".; .maie ··.$er~· :(: ~.; '> '.~~. te~t'08t~;one, ·t-re~te~'\.~e':al:e~ 8erwn~'~
( .. )'. Oetans' of .the.·,aS8~Y8 'are as' described i,.ri.:i.he
legend "t.o. f 19'.. · 7. Res"ul tB are. pre!lented 'as' ran~e .of :,:_~lues
. (bJl,u} ~~d. roell~ .0£ 'values '(~·Y:rrib.~l.~~,)_ when 'nUR)b.er: ot
·_el(~min~d·" "3.
_. \
Fig. ll~ ~'£fect or'addition of incre~~ing am~~nt8, t.f POBP' on'
..h~pari~-s~~um 'lipOprotein 'precipi;Qt~on re~~t.ion. ,
, ASsays. c?nhll?-~d eith:erlSO' 1J1',.~~.CRP~dep~ete'd rab,bit'
_ ~ serum <'0 l gr .cpntrol. ra~bit' serum:i '0 ) and \II~re _Elefformed .
i~'.·pres.ence of .1~',ri'M ·Ca2.+", Oth~'r ·.det;a~lB·qf the"a88a~'are




_. ~RP ~.Olated. from ir;amed .serUlll was adde<\ i.n inc:reas1ng
·"alllounta to assays .using CRpi-C1epleted rab"it 15erU'lll and
.. pCBP-leplet~d .rat serum :(pig • 12).· Add'! tion o~ up 'la. ]00 1J 9 .
at. c.1& ~~'o:,8d n~ 1nh.;bltOty _e{~~ci"t 'PO ~~e ser~m liPoprof~n".
p'r.eci!,~1ta~ion ;~.aet~cm. ~s.~in? elthe:r se~um.·
~;r: .'(UiIT"~ L~.~;>.o.o.itiO:~' FP on i'ipoprot~in~-\~~ preQ~pi'taHon' .reaction us,ing'male hamster or .F.~:-~ePl.ete~~.:.t.~·,:.·., - ,:'.mal~ h.;~t":••'U'i;:~h""n inF~', l~, ~do.ition ofincre'Bin~.
amOunts .of'.... FP to ",as,say,s ....ith· bo.~h. sera et=.~UIJ:.ed~ in inhi.bi1;-ion.
~T ,~i .lipoprQte'n p~.dpH.tion· ,e.~t10n. 'l'"
.:. .c:-.-CompaTiaO-n 0-£ the effects-' of.- pentraxins on hep~rin-lipo-t~:: ,.' _, p_r~te::'n~::;::~~v~r~n :::::'F;~::b:~::n:n:U;:'CRP ~~n .o.d~d "
U"o ", ," 1.ndividuaU; in- ,incrella:ing amdunts t~ assays· usirtg ~urified .~!E.~>~,r,..:... ·.:".;.;'" ),~~.n:v~·Di. ,~r LDL (F,i'. 14•.. ~o. ,b~ ,The, :.o.o.itiO,n ;'-'PCBP ~r.
~ . ~,pp _re:"ul.ted.. in· inhibi:tiOn. of the ptecipitatiori· reaction~ il1'
~ . - . .. .
.• ' usays "';it~ both .li~oprotei.!'l.9: I.~. contrast .rab~i.~ and"'huma't~:. CRp· shOwed :n~ ,'i~hibitory ~ffect -6~ the precipitatitin '1l8UY"S'









F';g. 1,2"0 Effect'·of'addLt.ion.of.!ncreasing amounts' of rabbit
CRP' on hep~rin-s~r~ ii~oProtein prec~·pi.t.at·ion re'ac:tion." ,The ~
, - ' '" I'" "
&.ss.ay mixture 'contained either 150- 1-1'1 of CRP-depletet;1 sequl\
"': .-,: ", ,' .. - (
:tom' i'n.fl.ame~ rabb'itliJ . ( ,0' ) .or pc~p-depleted control rat,
serum ( A ) and were peifiormed in: the presence. of 15 mH.
o '" ,"'. '... ".












)... fl. . .
Effect'of--ad~ition of increasing 'amounts of pr.Of!
heparin;,sfJrUn;.:'l.ipoprotein. precipitati"On reaction. ,!'snys.
contained 150 ]./ 1 of either male hamster serum" ( • ) or
. ip-deplete~ h'mde" hamster-.·seru~ i ~.' ) an,; ·wer.e'· PlJ1'~''fOrm~d
·~at 10 ~ c~2+.. Ot~er ~etails.. .of ,the 'ass~y,s "are as.~escri~~
i~ legend to 1":1.9" 7 •.










Fi,",::-14, comp"dson of the .ffect~~dd;tiO'~f'inc,~,sl';'
amcunt-;' of pe'ntraxins fn -'heparin-lipoprot~ein preci.t:iitation
'.. . ,
react.ion.' .Assays contained. increasing amoun'ts of.. eitMr
on-e of 'the followin9 pel)traxins _ PCBP (0 l" FP, { .~. l,'
, r·abbit. CRP ( ~ ). or human CRP (' ,0 ) and, we~~ cat{ied out·
with eithell" a) human VLDL (-loa IJ.}:' 220·1J 9 protein) or b~
hum~' LDL (l00 vl: 260 IJg'protein). ,All' 48say~ were performed
at 10 'rnM ca2+~ Otl"~~r de..t~~le :~e as described in le900,u to;
{'I Fig. 7. , .
'.. ~'
'J
," ~ / ... ,'
.'.' ',.~1
~ :' :. i~"~~;;:;":~~~- ~~),i{~~i;,:;~J:~~
'.~" '" '.: .
97
( .. '
showed\ no inhibitory effect on the ,hepa~in-V,\LDLprecip~tation
reaction (Fig ..15).
o. comparison of the effect of desi.alylai:ed -'pentraxins wit:n...'
. (i:) .OC BP.
Tleat:ment of' PC BP\,\f(ith neuraminidase enz:me led to 9-3%
depleti.i,n,of s·ialj.c aciCl (TabJ.e 6) •. ThE\, des-ialylate~ PCBP showed
" .:' '.' I ...", ,,, ,,'
.' reduced•.~.~ilit.y o~ ~AG~.. (lJ.~) ..~h~h ,c;P~.~~d .'&!th :C~P ,<~i9'
, ~ ~6). ' .. D~slaly,l~ted -jCBP' boun.~,~to ·,s.ePhar:ose-p~e~YIP~~SPho·r.(l---:
~-Cha'~in&. ai,f,inity adsorbent. could 'be, e'luted at an, ident~cal'
conce~trati~n <'7.Z5 'mMr' Of"PhPSPhOrYlChOlin~ req~ired' for
the slu'tion of PeBP {pig. ,.17) •., ~e de;si~lylated PCB? cro.as'
r'e~~ted against antis~m ~o PeBP ,and ma~.ntai.~ed....-a-"c..~ntinuous
line of i.mmUn?Ch·~m~cal ident~ty.with roBP (Fi9;... ~8)., .Thk CD
spe:~tra ;0£ deBialyl~ted PCBP in the ~romatic ·and.lUv f'egion
of the spectrum wa~. es,s-e~ti.~{ly. the ~ame as that of (Fig.
19a anl b). Thes'e ··'results suggested that no detectable
den,p.turat::ion had '.QCI;mr;red on·.des~alYlad6n. Howe~r"wft1:,n
d~ialy~at,ed ~BP W~~ ci'dded '(Up ,to' SOO1l9) t~ hepaI:1n l"popf~tei~
" . ~". • 0
~reci~itation ,:,-s·says witl' human VL.DL; it showed, no inhibi-t.ory
effect on :the,precipitation reaction (F;ig; 20). Free,siAlic
.aci'd in th~ presenc~~.or abs'~nce of de,6ial~l.ate.d PC~P. had '~o..
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PROTEIN (ug)
Fig. 15. Effect 0.£ addition 6£ increasing amounts of' human ';,.
, ',.. ..
SAP a"od fatuin on heparin-V('OL precieitat.,ion reaction.
. ..
Assays were carrie'd out using VLOL (5011.~; 'llOllg p.roteln) in
the' presen~e of 'increasing amounts of either ,h.uman SA~ ( ~ )
qr .f~~uin -' 0 ) 'ci.nd,were.-perf~rmed u8'ln~ 'UlmM ca 2+, otji:er
~etahs( of ~ile "assay ,are.as !=les,?ribed in lege~d to Fig. 1.
" '"
1'., acid was' follow&d ~Srn.9 Warr~n's meth~d' (140,) for sialic"acid ~sHmat£on. 'Other
'~". '.',,', ' '. . : .. ;'.. ' . '.
,details ~f ··the' incubation .aTe d~ri.Ded in ~~.aPter· 2.
. . . .~ . .
"De~r-~Ylation :.?~ ~tli ~e:tr~~ina ....aa.:.per~opu~d~ e~2iYmati'c~l.lY by neu.~amina8e tre~tment•.
. ~Cl!,P '(fO ~cj) ~r.FP (3 mg) ~erf) .l.nc~~·~el1,.(n, 5 ~..ariS,-HCl buffer (p.". 7.. 6) w!th .2.5














Deaialylation of PCBP and FP. l:)y. Q~!lira~ini"dase treatmerrf.'".·
1.. " . .' '.
...~
.........





I~,.:,J'{<'~ ..~'.: ...}',;',1. ,~~~~<':. t : AmOunt of' 'Siali!:= acid . Amount'.of ala.lie aciq " Remb'!al ,ib.i: "present. released by rneur,a!I'inida!'e oC sia:Uc IlFi~'
r":'~·'.· .~CBp· .. "









Fig. 16,. PAGE of purifilid PCB I? , desialylated-PCBP and a mixt.ure
,
of peBP and desialYlated-PCBP.
PAGE '"was ,performed on 1'lpolyacrylamide
to ,the method o·~ Oav~s. (l3~) •.
Gel A: '-d~s1aiylated-PC~P (10 j.I'.g).
Gel 8:' mi.xt~·re 'of peBP and des\alylated-PCBP (l(~lJ~ .each') •
. "'. " . ': . - ,'" ....



















Fig 0, lV: -Gradient· ~-lu~ion of PeBP and des1alylated PCBP
bound to Seeharose-phenYlPhosP1'tprylch'C:S.line affinity adsorbent
by f.-choline 0 ' • .. • ,
~CBP ant de:B'i'~Yl'ated PCBP were applied 8epara~ely Co,
J'. ePharose':'Phe~YlPhOSP~9rYlchO~~ne C01U~8.( 3.0 m~' bed V01~e)0.' h, bOl,lnd proteins wllre,. a,luted at ,7_025 mtt, P-cholloe"upoQ,
'. apPl~ca~ian af·a P:"t:hoii~e gra,aient (0-25, mM) 0 The ·r~cov.l"Y








Fig. 18. Ouchterlony double diffusion analysis of the
desialylated PeBP using antiserum to peep.
Center well has antiserum to PeBP raised in rabbits.
Wells '2,4 and 5 contain purified PeBP.
Wells #1 and 3 contain purified desialylated-PCBP.
Fig, '19. C.l.rcUlar. dichroism spectral "nalrais in the far-UV
and aroma:ia'. sYstem ~.f peBP and .de~~al"ylated ~B~•.
.
'{a) Circular dichI'oism spectr~l analysis .il!. the far-UV
reg~on '~f tcSp. :n~' des.~alY~~~ed ~C~P. ' PCBP" .~ -1:"., )\~" ~ ni9(nil'
in 5 mM. Tris-HCl bu~~e~' .(PH 7. 6f. and.d~sialyiat"ed.~B~,'..., :
.' ?---) ,(0. 48' mg/~i in 5"niH Tr.i"s-HCl bU~f~r, ·(pK';. 6). w~re.used·
:0 p~~for~ th~ sp~~t'r~l analyai~ ".' ,g~periment.s we~e ,p~,~~erm'ed
a'~ 250C~ rcell, ltength .. 'O~l' Ctli"j. '(b') ,·Ci,rc,Ula.r dichroism
: " ' " " ' ,'J
',spe,ctral analysis .of pc;:e'p, a';1.d desl~lylate.d 'PC~P in,:th'e
·aro~at:ic· region. EX{le.~imeni:.s w!",~e pe~formed'"uqder exa·c~,!:·""·:·
siniil~r c'o~dit.ions as· mentioned 'in'(a) except that·thti cel!'
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" <Fig; 20. Cdm arison of 'the effect of de ial lated PCB~ wit
.' PC\"; "on h~parin~v~;~ P~~Sipita~~h rl!a.c·ti~ri-•
• ,." ~ "I .~ ..
AssayS" were Fa~rl..ed,out Ua!~g.VLDL q.OO~i\220A19 protein).
either .~n:.t~~ pr~8ence ·ofincrea8ing'~u.nt8of PCB.P',( O',)'or'
'desia,lylat'ed ,peBE' ( e'i an'd were performed u.sing: 10 ~M_
~a2t. ' : :dther d~tails ~f the as'say au: as .de~ciJ,i~ed 'in: 1-e~~nd -:.
I • '-. ,






























~'i9' -21. Effect.,'b£ addit-ion a'£ .increasing ~arnotil1ts af sialic
a~d. o~' hepa~'in-VLDL:f're~ipi·t·atian.reaction. I'· t.',
... ,'Assays' -\of!th ,increa~~ng 'amounts" ~ti·.sialic _'aci~ in he' .
a'bsence -<.6;· or. p;e~~.nce .<fj9t"d~Si~lYl~'te~ .P~a.P w~re-'ca~ ied' . '.~
out :using VLDL" (.5O-~1: ·.:LiO~'9 prat.e·in): a.ot~- assays were.




r ._ \Tr~~tment of FP wiili neuraminidase res.ul~ed in a partia't'
desialYl:tiO~ ~Table 6) •. The ~e81alyl~ted FP.t~~ PAGE 113?J.
appeared as a 81o:-'~ moving band: distinct from FP (.\i~ .. 22) .
. Desialy~ated PI? retained its .abilitl:' ~o liind to sepharose-phenyl-_:
~ho.sph.orylchoUne afjinity -adaotbe~t and couLt;i 'be: elut.ed
.... ,i.~l"! a Phos~horYlcholfne- g.fadient (Fig.. 23).' But. t~~
':'.~~SialYl.ated FP ~hen added to precitl~at"ion. .1l.811:4YS :~i~.h ,_
hU~ VLDL Sh,owea reduced inhibitory.effect compared to'
nat ve FP (Fiy. 2ll), , I
- ,
.PAGE~13~} p;ofiles.af ~pC8P frOID cont·r~l serum .. and
~'erulll ,fr~lII inflalged rats !i~d-. CRP i8~lated from inf\amed'
r.abbit ser.~m are. sJ:1own. 1.n F~9' 25. ~e( mol'iUt~ of -'PCB~.
isolateJ;l-from inflamed ral serum is identical to PeBP isolated
,>"'.
. E. PAGE and 'immuriodtffusi~n·ana.h'sis of PeBp· isolated fr~~
.\
. .
... -·__ from ..control ra't, seru~ .'but is d(stinctly differen-t' from
rabbit CRP .• ~~~n~che~ical'reactiv1~y o~ seljum f~om i~lame~
rats .against. antiserum _to PeBP "and 'antiseru;;' to .rabbit CRP
....as:;;nClly~ed in' e.garose gels fFig: 2~). Inflame"~ rat. ;erum'
- ': . I.. . '. .' ,'. .
_):,rodlfce'd a single .precipiti~ line:.!!", ident'i~r with '!=ontrol
serum and puriifed~ilCBP fro~ contr?l rat serum. Ho.... evers,~~m from i~fl.:artieCt rats fat led to' ~r'o88-;r,e~~t\9~!n.tant~8"rum to rabbit CRP. -:: I
~-~" ','1





'Fig. -"22'. PAGE of' purified. Pi' an"d desialylatec1\FP PAGE was
p'evforrned(;~ :7t' pOly~crYla'mide"gel~' ~c~ord';;:;:to the m'~tho~
of -Davis (139).' G'ell A:.·.pUI;Iified FP '(~5 ~~"PrOt.ein). G~
tl'm{~~~r;e Of-purifi'e.d E'P·and des'ialylated PP (15.\.19 of each




























elution oJ desialylated FE' from23 _
D*;lsialYlated FP (2" 90. rng pr0:tein) 'was applied on.•the
.~ffi'nity ~olumn and-:"luted. ~Y it ,'P-choline gradient. (O-3,~ 3.
mM). The desialylated. FP was
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Fig. 24. Comparison of the effects 'of addition of increasing
--amounts of FP and desia1y'lated FP tHl heparin-VLDL p'recipitatiol1
. '.
Assays with !ncr'easing of either ~'p '.'( O· ... -~r
desialylated .fIP <". ~.l were ca.r.ri~d out usin~ ,VLDL (lOOlrl.,r
220 ~ ~ pr~tein), Both assays were .!?erformed a~ 10 roM <':012+.










F_i9.' 25 •.· PA.GE· of· pUrifted.PC5p a'nd' rabbit CRP.' P~G~'was
'p~rfC:~~ed o~ 7~' fo1.~~~rY~o:mid? gei~' acco~,t1i~~ to' t,he me~hod' ..:
of Davi~ (139.)..·. Gel·A.t r,.pbit C~P IlSP9); ~~ B: mix~ure Of'
ftrat"PCBP fr.o',n.norniai,,~e,rurn,.(i'S \lJI)',and ~a~it C~P (is \19):







Fig. 26. Ouchterlony double-diffusion analysis of serum from
control rats and inflamed rats and rabbits against antiserum
to peBP and rabbit CRP. Centre well, antiserum to peBP:
....ell 1 normal rat serum; well 2, purified PeBP from control
rat serum; well 3, serum. from inflamed rat; well 4, antiserum
to rabbit CRP; well 5, serum from inflamed rabbit.
"112
)
.:~:~r::':;:::::ot:~: :~:O::~:.t:O: "~n :::"p:...no,1 :;lCb.~:
(131). The res~}ts presel}t~d, in the earlier study show.ed .~
s toi~_h iom~tr ic re l~ t ionship between the concentrations' of..
'1 VL~L and peep in the pr:Cipit~tion.reaSHon.,It ....as suggett~d
that . PCB~ . may interact .... Lth PC ,olecules exposed on the
surface of Vt.OL 'and thereby interfere with "the put'icipatfoh _ .
.~ . . . ~. . ':.
9£ the 'phospholipi~s in -t't1e prec,tpit.at".ion .reactio~ re!l\.ilti.~g: "'j-,
in ~he- . .inhib1.t~<?n l?f lipoprot,~~n preci,pitation. (ilL),:' ~t~er,
pho~phor-Ylcholin"e bind"lng" pentraxi~s viz. ~e, ~a.b~it/hu~an.
·.·~RP were exp~tei to'deJ!lOn'lotrate a 8imii~r..inhib~t~ry _effec~'::'
on lipoprotei~-P7ec:ipita.tion'. H.owever tl,e,pr:sent stl!'~Y reveals
an i~portant difference bet'!'leen. 9lyc98Ylated 'pentr-a.Xins
. ,< ..• j,
(·PCBP a~ FP') and non-glycosyl.ated pentraxlns (ra.bbit and h~man
, " :'
CRP) with., re,8p.ect to their eHect;.s on.h'eparin~li~oprotein.··
preciplt:ati,:,n r'~actid~. FP, like '(lCBP inhibited the
"precipita,tion reaction~
The inhibition. o~' p'r!'l'~i~itatibn re~cHon by' peBP was
demonstrateq. by its addition to. assays' with CRP-dep'leted
. '. . .' ,.', . ~ "
r~bbit serum,' 'r;\?rmal ~rilbbit gel:um';a~d ,human yLDL: and LDL
. . . .... '\, .
(Fl,?, 11 and 14 r.- ."Furthe.rmo:~~ aS9ay~ ....itli ser~rn from in~~a~d
rats. wlii.ch ha~ about ~wo' fold increa8'~ in PCBP level's ovc'r'
. ., .. '. '. ' .. .. :'
•control. serum Showrecreased, precip~·ta~io~,react.ions com1?,areQ
'to. normal rat' serum aJ;ld required...~h~.·~ddHi9n of·a?out 32~M
p:--c~oline, t~. cJ?unter t~ j.nhibit~ry effect 'or." P<:B~ (Fi.g •• 7).
I- ~ . . .
I:'rec,ip~t·at.toh 'reaction.
113
I n: ~on.traet ~O PCBI' and FP. rabbit' and ,·h!Jnu:i."n C'~ll;;did
.". ", ". ,"' ; , "." --,I '
n"cit. ~nhibit, ,~he, precipita,tion rea-c.t.ion. s:rullr from ,infla,me~
rabbit._ ,cont.~ined' si9nifle~ntl-Y~ increased 'CRP leve1:!l, ,'"in
- compa~ia~~'~O control 8er~Jl\!. y~t'- it'shOW~d m~,.edlY ~r.~'se,d.
:l.iP"oprot:e~n "p:eCiPi,tllt.ion·"(Fi~. B~ comp,red wi"l:.h 'a,~a~Ys •.
'" "·.'c··.~ •.....
,
Th~lIe results obtained from '" varie~y. of e,xperiments inde:ed,
eonfir~the a~ll-ity of PCBP to inhi'bit lip?protein precipitation
reaction .
. In'the case of FP, s"n inverse relationship between FP
levels and:P"Ce~ipit~tion"raaction....as observed; The Rresence
of FP--in fC!-m-"le "hams'ter s.erunl·r~d~ced·the 'lipoprotei~_
- pr-ec1pitation re"acti:on ,since its- depletion fro~. thi."s eerum-
l;'d t~~n.. .i.t\c".z?)ase, in (he, pteciplta1:i';m .r.eaction (Fig. 9).
The, ~a~kcd dif~erence i~ lip.0iro;.ei,':l- ~r~,~~i.tat;i~n.,rea~ti~ri
betwee.n'IM:~_e and female' sert.lm~may be.it-ttribut~ laa:-9E!-ly to th~
p\:-uenc'e_~( FP i.h' th'e'. 'fem~le' . serum; 1!1rice ."the ,triglyceride
. . . .
nearl~ identical (Tab·U,,'.5 ) .... iDE.S treated male ham~ter serum
~. " "h.ad· incre~aed. levela~"of ::P' ~Clm~~reci't~ t:e~toste~o'~e t,:eatli!d,
,femaLe li"ama ter .serum· an~ 'conseque.nt-ly: Sh'owe.d: decreased
l1!'ClP..:ci.tein p~eci~ita,tion.compa;req t"o' tes.t.os,terone ~~~4t~d
female' h;",ms'ter serum' (Fig. 10). F,inally'. t.he d!,~ect addi\:lon
.,' '. '. \. ,-''-: .
of FP to pr_eC\lPit.ation .assars wi~h. male' ha~st.er".B"er~m.
fl\."'de!1.e~d .fem~ hamster' serum, ~uman 'VLOL' and, LOL Sh~eO:




using control. serum. FurtQermore, t)le additicm ~'f 'rabbit CRP
,to' assays with PCBP-depl.e~e.d sex:, CRP-depletell rabbit
serum· and Of! ?uman or rabbit CRp'to ll.slI;ays with huml:ln VLDL
· ~na LDL showed n~nhibitory eff:,c~ (Fig. 12 e.nd. 1:4~. In h:c,t
tJ;i.e ,.;;t.ddit-1on.of rabbit .CRI' to asa'ay&. with oither <:'RP-deplet:ed
rabbit; se~um. (F"!g':" 12 and'14) human VL~L '!:Ir LDL and human','
. '. -
CRP:"O VLDL'~lnd DOL showe~ a small. increase ~n the prec~pit.ation
','reaction.
, ' ,
dea~~lilated 'an<1, n~t.i,,:~ .l'cY:P 'es.eentiallY ~he
SU9ge'itirig. that no. det;ecte.b1e
~e~.i~la:ib~within t~~ limits of an~I~8i8 ••• '~"""">"',"'"'
the de~ia1~~1~ted,PCBI? ·cross-'r.acted'1a9airi~t
. . . .
· PCBl' .contip~ed to bind t~ S~Pharoae-Ph~nYIPho8phory\~~o~i~e.·
aff1~it"y ~dSorbElnt.a!"ld was ~lutedb~ p-chol1ne' a,t a conce~tt'ation
identic'a'1~o that require:d. for! elutior:af ~~tive pCB~ (t;i9',· 17):
- " .' '. '". ' . ..
This indi.cates that' d~8ia1Yla'"tiondOI'!.& not:: ~;re;;X ~he Phosphoryl.:""
\ ~hO,.line,bindin9· property'. ~f. pCBp. Second. the CD of.
"I. ",
. A rat:ionale-,,~r the lac~ of inh~bition'by hu~..:an or -rab~it
· CRP, became' apparent when the role 0; aialic;: ~c:id reB Idues 6f
PCBI' and .F,P i!l 'lipOprot~i~ri8 prec~pitation ~as in ....e8t.~;ated ..
. , .-, . " ....
·oijeBialy~ati\on.,.c~ PCBP.:resulted .in comp-Iet!'!. los~ of its "
inhi~itofY ey~ct. (Fig. 2~ ~ .. ·..;...~.ile the; ~n~i~~.tor~ ~'aec:'t of
. de8ialyl~t'e~. Ji.'p was .markedly J;ed.uced (Fig -:. 2.4) o. Deeialyl:ati0l'\.
cHd~ cau.eeq\nY appr-eciable .... change;. in rcap·,. Th~8t,,,,,,,aa.
indicate~ three lines of evidence ° First. aes.ialy.lated
i.denttty with peBy {.Fi 9 . ,1"8': Simili)rly t.he ~partiallY,
de-sialylated ,FP .~~intained its ,ability, to bind to-
, :~
•.';
Sepharose-ph~hylphoBphorylcholineaffinity adsorbent (Fig. 2V.
Th"er'efore . it. may be conci'uded that the obtl'erved 10S.S 'of'
>.. . -",,' .• " ',;,-.
intlibitory effect of d~Bi~lyLat~d PCBP.¥d FP was not Aue to
any. denilturatton of, ~heB~ proteins. bY' ~eurarninid~se\red.tment.
The dlBa snowing the l~·BS-O£.inhib1tor.;·~feC<tl1po~desi~l;'lation ", -';"'1
(Fi~ .• 20 and ~4) - is: ·the':efore. int~'r~~e'te~ t:h ~U99~~t th~~/ "'~";
thesta{tc'~~idreoi<lues Oop~-;;P .and FP 'Play .o~~ro;'::o· .' /!
e.xp~s th~H.r .J.nhibitorr:effecl- .In addi.\iOn,.....th7, failur~'
'~f h~mari 'a~d' r~~~RP to··'if'lhi~it.th~ .~r~ci~.itatJ..~~ -rea<:=tio.n
~'~learl:( i~cU,ca,t'e'8 th,at· the. in~i,biti;;'.. effeh i~ n~t' due" ~o
ph"osph'orylchoUne biridJg . pro~~rty alone, )
, " .' . "' ...,,",
A critical.role,_.for negatively .Charged ~ialic ~cid re~idue8
. is consi.st.....enf ~it,h the ·postulat.~d iO'nic n.at:ure of 4.'
- 9iicio~_amiri~-~yca.n-liPoprotein.int'e~actiona (53, 6), ~4,>, ~udfe8'
fro~··.other ,laborat'ories ,.have· shown' an inverse .relations~ip
.' '.'.~ ,:"-" '. ':' , , "\' .
between 'th, 'sla11c acid ,co"Ot.ent, ,?f apo B fin ~D~ and ,the
exie(lt'of intez:a.cti'on wTth ~IYC~,f!~miri.091'yCa'h.S,an~ proteoglycana
(15.3, 1!?4, 155), . The negatively char~.ed sialic' acid ,~residues
'tm,LD~avet:i~en a;cribed to.preven't 'c{~ser intiracti"oris b·et.wee~
sUlpiuited he~arfn and LOt 'w:~th co'iise~uent,r,edU~tiOn" .in 'LDL ,;'.
; . ,'" t
precipitaUon (1'54),' It is therefore not 8~rprisin9 ttJat t~
~, . '. .
.alalic ,i;6id ,t-esidu~s on. peBP, and'F~ play. a ·~r.iti.cal ,~ole -in
t~,e i_n1i.ibit'ion' of hepariri-l~popioteinprecipitation reac~i0l'l:;
Although i1i~iic.acid 'residues, are c'ritical to oblle~~~ theJ . . .' ...
""in-hibit'ory eff.ect',- it. appears that, the
. ',. :'. '.
· t~o :e_ie,ctrosht~c-:.~epUlsi~n b·etween ne~ative,l~_c~arge~)~~alic
acid:, 'an~, SUlPh~te groul?s 0:£ ~'!'~a.5in:' ,.,T:~i.~.41n •. tu,r"n ,may
decrease the electr·ost·at:'ic aU.racti:-ons between ·su'lfat:e
... .
ph?SP.hOrYlc~Ol~e-e bindi~'g :~b'ility .. and ·~ialic acid residues)
· in t.he process "af" in)'\ibltion of li~dl?rotein.'pr~1ip·itat~~Y
pentr'axins may be proposed," It is con¢eivable tha't ·phosphorYl-
choli":e biriding ~l'yc.oSYlat~,oi·~entra)S.ins, ~ay'. ~ind. ~o'~he.
p~s..Ph9lip~dS. on th.e, s.urface cf th"e lipoproteins. The
bi'nding pf 's'ialYl~~ed 'pentraxins t'o, the liPopro~etn_'may lead
·siali.~ acid~ r~i\dues on the p~ry.traxin .is no} ~Ufficient
inhibition. 'Evidehce to support this possihility com!!s fl'-Offi
the"Observ.ati.Oh that ~urified human" SAP, ,a sialic a-c-ld
contain.lng pentraxin t~a~ dpes not 'bi'n.d PhOSflh~rYIChOline,
had no ,effect on the VLOL he'parin<precipitat'ion. ie'action
tFig.- 15). '. Simi.l~~·l;; 'f~'~U'il'l' a ·g,lycoprot.ein which do'es~ot
~i~~ PhO~phorYlC~Ollne h~d ~C? :'~ft;ect on th~'~pr~'ciP"~a~ii~
.... reac1;.i:on·, (F-!:g·:--iS). - 'Addition 'of- f:ee ,sialic ,
preseric~ ~or absenc,e of "desial'y~ate'd PC~P 'to. a'ElsaYE! with VLDL
· .sh~w~1j no effect" "~n th~' ~~eC;:iPit~t~~ .re'a"~~i;~ .(Pi;. ",it 'J:.'.
C,on.sider"ed,"togethe'r·. '!::hese res·ult·s ·i~n·d~·cate·.-·that
Ph~Sp;OrYIC~oi'ine bindi~g. property and the :·.~alic "~id
'", " ~ .~ .
residUEls are· 't?oth required on the ,proteins i"h the molecular
process of' inh~bition,.. "PCBP and, FP,.but not rabbit .a~d·hutpan
CRP or .hu~n SAP, ,fui:fill' both ·thesef"req~ireme~ts. '




posit.ive,ly charg.ed ~ites ~n ape B and--apo"E. SU~ an ~ter·action.
~ay i:nter~~re with' th'~' '!n-teraction -of lip'oproteins ~ith
~e~arin..· I~. ~~y ge·,,;~ca·1.1,e~· that posittve1.y c~arge~ ar'~~~ine
&:nd ly'S'ine ~~8~d.ues _~n ap~O--B' and apo ,E cont.ain1l1:g ii~oprot'eins
are·l;:J..eli~.v~d to. ?t' .'in~Olved in. tq,e in~e.racti~lli. o~:·hepa.,:in
W.;\h iiPo.p,r.o£eins _~ r~~iewe.d,· in .ChaP:~r 1)., wi th ::h~. ~!.esent ... ,
data i:t .is". not poss~ble' to distil}9"ui.sh whether one or' botry
the abov~ ci:t~d'~echa'~i8m8 are opera'tive. .:.
. .',(. /
It may. be pe~tinent -t;;o add JIIere that the inter~ct~pn of
Ifppp;:,oteins wfth sulfated polysaccharides in the presence
... , !"
0.£ '·~iv.a.l~nt.,:catiol)B is 'kl:'ow~' to ,prpduce '60th. s,01.ubl.e -.and.
insOluble·.~ompleXe9' (63 )'•. / In the..·p~eBen:t st\:ldies "the conipiex
~o7mation.-:is ~nitor~d by' ,a turbi¥metriC assay which 'gives
;pil e8timatl~!1 0'£ ,only in8~;Ubie complex f6rmation. Therefore
groups of heparin and the lipopro\:.elns with cons,!"'quent
. reduction in tl!~oprotein preci.;Pitation. f'
. An 'Alternat~ eXPlanation,-consistenf. wi,th the present
data, 'is t.hat the bindi,ng Qf pentraxins. t.o lipoprotein may
inV?lve.'the· in~e'ract~on ·of sialic acid ·residues: ....ith'C \".
"
.,
. '. ". .
t~;e':Sff.e-C~S of pe":tra~in9.~n ·th.~ fo~ma:tion of SOlUbl~.·hepa~in:"
lip!'protsln" compl.eXes. ca:~not ,be deterl!'lined in thes~ ,s-tudlles.
Th~:.re.ason·fol! t.he inC:Fease_in"lipop~~teinprec~Pit,ation
a.~di~.i~n' ,of.' ra~b.~t I~~p_ .t? a..~ea~9.' ''''ith CR,P-d~Pl,ettl4.




. hepa~in and calcium. Cabana"!:!.~. (l56) have reported the
binding o~ ,hurnan an.d raobit. C~P to heparin immobilized on
lI.garose in the:p~esence of Ca 2 +· (1-50 mM) at ~V~niC
st,rength 10.01 lot T.ris. pH .. 7,4). Furthermo:e, under these
conditions, VLOL and LDL were al.so bound to heparin-agaros'e.
The interaction of CRP "';ith lipop~oteins in the p.ressnc'e of
hep"arin. ~nd' Ca 2:t lQay.- e~~lai.n the increll.~e in. preci~~tat.ion· .
. ", '.' .' - \', ".
reac.tion':obseryed in the,pr~8'en~ st'!dy, .It:-ts concetvabls_that' •.-
. '. , . . . - - . .
\ such interactiane between CRr. 'lipopr~teins and heparin may . :';'
. ',".. L-' .
promote .t~e format~onof 'i.nsolubtiE! compl.exes. 'However. f!-irt-her
work'is requ'ired to support t.he poss~~ility. It -may be
pertinent to add tha.t previou~ studies "(131) have failed"to b::
, '~ ", '. -.
show.Ule 'binding of eCBB- to heparin .immobil1.sed on Sepharose.
. . - \
The prese.n't ,study also st\ow~ that addition of human SAP
to alilsays with VLDL 'produc~d an increase in t~e a~90rbance
(Fig. l~). This increase may be attribut!!d to the well
re~9gnized"aggregation" of SAP in the 'pre.gence of Ca2~ (ISO):
, '
. In addit-i.on 'SAP ~as iHso -be~n shown to 'l~,teract ~ith ,heparin
in a Ca 2 +-deP.limdent (O~5-1'''O RIM). "reaction QS8).: .liow~ver;
f~rther w,prk is 'heceuary to s·uppoz.:t these I:'o9"si!Jl1it.:1es:
__~,e pr'~~~nt '~t~die~':,Sho~ed 't;wo o~her diffefen.ces, betwee~
peBP aQd .r~a·bbit. CRP w'~th, rega,rd,s to the normal aeru~
conc~ntr~tions of, these' two pentraxi'ns and: the.ir behaviour
.as acut~ phase reactants .. , FrOJ!l ,~iI:tu~llY. undetect~ble (:or"
trace) levels In' control 'serWll, rabbi t CRr- levels ,increased
",' "." 1, \ •
dramati~al1Y' ,in" 8er,~~ from:; i~'fiame4 rabbits ITab~e. ~). ,In
"
-';.> ~ , ..
:., '
co~tra8t, PCBP is pre8en~ in sAgn:tficant amounts in control
-. - -{ - , -8"ru~ and 1~~ concentration upon inflammation increases by
~~ly_ tlofO fold (T~ble 5), The:prese~ce-.of PCBP,: in inflamed
rat ser\lm warconfirmed t?Y PAGE and lmllllu~odiffusion analysis
(Fig: 25.and 26). I
During - the course of thi.s study changes in serum lipid
, . ' . ,. - "-
levels have been ollserved in r:abbits tha t acc9mp!Sny inflammation'.
On i~·fill:mmat.~o'n ~ dra~tic i~CU<lS~ in serum trlg1ycE7ride
and ~llOlest;ero( levels is SB~:tn" in'" rabb;t a~-rl,lm (Tab~e ~ i.
This .iner~age /IIay largely .expla.i;n t.il8 increase in -lipoprotein
. " ,"
pr;:ecipitation ob.ser.ved when. inflamed r~bbit se·rum _is' u~ed
(Fig. Sa) •. As stated before, the intera~tions ~tween CRP
. iUld l ..ipoproteins in the pre~ence of heparin and Ca2+ may' '
also contribute' to the increase in pt"eeipitation reaetio,n •
. \ t nflamma~~on-induc'ed ch~ngeS in p-lasmll lipid levels. in
rabbit: have also be.~.n o~ser'ved qy C.ab.ana ~ '!.!. (159).
• These studies. show that dur1ng inflammatlC~n, in rabbito PLasma,.' the YLO~ and LDL levels increase. wh.1Ie the HDL
" ..lev.elS decre~Be: 'In contrast to' rabbit.s. infl~mmat;lo.n .dJ...~
. not :ind~ce. any' inc'rease in ~l)~ lip'id leve~s. in rat serum_
......
(T~'tile'5):
.In t~.e pre·aen..t study increa,es' in.1erum ..l.ipid levels\.
- . -
.',,'. hav.a also ~een Observed in the male .&!ld ~ema'le hamste'r se.rum
': .',.,'., - I _ .'.,'
1,"._ ,~n' .~r~.atm.e~.t. .... ith: DES ll.nd tes~~~:r::one re::l'peetivl;!~y (Ta~I.f! _- ~'"
~'-i" 5). 'The influence(lof a.ex' ster'o!ds on p~a8ma. lipopro~ei[1 ' ..:~
!~ . lev~l; is .....ell d'ocumented (160, 'i61) . .~{~~.; . - . , .' ~~ I.. _ I'£i~~:liJ!i:.f;£i\';~i,+.\~,;~~{;~.i.:~';,;.~;L~,~.~!;;1:~.;:;,;~~:,;:~:".·~(:::;;f.",j)~
':" .
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In' conclusion, the pr,esent studies have r~vea1.ed ll.
, atriking ~ifference in the effects of glycoaylatild pe'ntca~ins
(PCBP .and t'P) "and non~glycosylaterl pentraxins (rabbit and
human CRP) towards hepar.J.n:"lipOprotoin prec "t"n5"n reaction.
,purt...hermorel~his dike;ence may be attrie t d to the presence
of. sialic acid residues on PCBP and tOp.
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Chapter 4




A., _Binding of radf.oio'hnated peBP to Se har"ose- hen l as hor 1 .
choline finit. adsorbent ant'! PAGE anal ~is' of ur;l.fie
. 125I_PCBP.. ~
Radioia~in~~ed .P~BP was applied /:;0 a s.ePhar()~e.-.phenY'l
.< ph.osphorylch.oline 'column (5, ml -bed vOlume!. '1'.he pouo ,I
12.5r_PCBP (!:in of," the, C01..111t;.'S a~pl.ie~) ';"a,~ e_~u.t~n_ w~.~h· 4, mM."-t
/-Ch~lineJ ap~. ~!?R~~red as. a single p~'ak fr?ffi Y.le' cotum~.
(rasuItg· not. -shown). This ind'icated that radioiodlnation of
, :., -'0 •
~CBP had not a.ffe~t~~l'~tsbinding p.rop~rty..f-O~PhOS~hOrYICh~\i,!lJ!
liga.nd. The purity of radioiodioa;tell P'CBP was establishe,q,
by electr~Ph~~e.Sing 125I~PCBp·'(O'.9 Vgl di'iute-l with r6 y.~ of ":.
PCBP qn ,pOlyacrylamide .get. according ,to the 11let,hod of" Oa ... is
U;9j ... ~le gd aft~r,st'~i~ing .and de~t:3ining was '~1iced'into
5 mIn sectiol'ls and each see,tion assayed for·radioa.cti ... ity .
. ·O....er 80% Of' 'Ute counts.a.ppii~d ,appeared as a Sin91~, pea~
. _~orr.esponfdin9 to' unlab~lled,.PC~; (Fig, 27). On the ba~is of. a
..these observations it may be assumed that radioior:linated
PC8P is. similar to ·'PCBP.
B. Requirement of BSA to prevent non-'sPcc,ifiC hlocHn? of
125:t;_PCBP to the assay tube in the p["esence of Ca 2+,
Prel iminary eltperi~erits to esta~li~h the assay COJ1ditiona'- .
foro the binding of 1:5I":PCBP to, li po50mes sho~s'ioerable'













i,lito 5~ ~~ .s-ec,done and 90Une.ed f~'r :r:Adio~cti.vf~y:.
"T, t.op of 98.lo.
2'3 I.' 5 6 7 &,9 10
,.' StICE: NO.,'
""F1S]-:--.. 21.· Criteria. of' purity of 125i_ECBP by polyacrylalllide
. ,-
~ gel electrophoresis. 125I_PC8~ 10.91.19) wa;-dilut~~with PeBP
• '. . '. - J' .' ~._.
(16 \l 9~: a~d 'an~;y.~ed 0.n \ :~:lY~CrYJ.amide.·.9.~~' .a~c.ordi.n9.....~~
the met~od d ~avis. (13!J'). \The gel'~as 'at"a.~ne.d with CoomalJ~i~ "',
'~1?lue for 12h,: 'd~s'ta.inedtele~~~oPh~~e\i·~lI:11Y,.and the~ sl~ced










presence of C.'+ (Fig. 2~). ',"i~din9~ccu~red in control
. assays in absence of liposomes. ,[,h~ non speci fic binding
of 12SI_PCBP to the assay tubes was aboiished by the inclusion
. .
of 0.1,\ BSA (w/v) in· the assay mixt\.\re (Fig. 28). The use
of either fatty acid free aSA or eSA. did not affect the ;.~
bindi~g' of PCBP to liposomes, nence 0.01\ BSA was routinely'
used in all assays.
C. .Effect 'of Ca 2 -+: on the binding .ot;. PCBP to liposomes
. .
compos~d of 7St,PC and 25t ~PC:
Fi-g. ~:2-9a shows' the binding. of 125I_PCBP ,to H:pci80me~,as .
a. fun'~~iori of 'ca2+ i:Qnce'~~ras.ion. In the absence of· Ca 2+
,a~out.,20', .of PG:~P add.ed v,~s ~o.u.nd· to ll.posomes,·. and -th,~'
_ ~·bi~d.in9 inc:eased' with: inc~easi':lg am~u'P1ts ~f ca2+.:· A study,
on_ th~ b,inding of PCBP to lipos~me's ~as a function of PCBP
c_cncent'ratio." either, i~ the absen.ce o~ presenc'e o'f 11? roM '~a2~
,showed' that the -binding to tlle- lipos.->me.9 "as three to five,
fold 9-r~M:er in pre'sence, ;fca2'; compared,. to the"' hinding i~ .
the. abs,en~~ of, Ca2+. In the pre'sence' of Ca 2+, the binding
increased.·progressively ansi, app'eared to satur'3.te ·1.n the
range. cif, 3QO:"'400 \lg PCBP •. 'ti?",€wer, in '"eh~,.absenc~ of Ca 2i;.,
the 'binding 'incre';~ed ~p ~~. ~dditio':l.of,lOO ~g P'CBP, bu~
The affinity .of_ t~e binding ai tes' ~~~:,t!:'~_'::"~~.'~~-:.c--:;1
in t~e ,~reeenc:e '.-0'£' c'~2+ ;'las: estimated usin-g












; . Fig. 28. Re uiremen of eSA to revent 00-8 eclfic bindin
of 12~I-PC~~ ".t.o: the ·.,;'al·lS ;;f the a~Bay' tUb~. Assay\ mixture
(0.5 mll 'contained:15 rrM Tris-Hel, (pH- 7.9). O.91J9 12SI'-PCBP,
.. i~Cre~8~ng:an~un'b of ca2 +- ~i, th.er· ih the pr~sence·(.).'~~ ab8~~~~'
( 0 ) ",0£:'0.1.% "f/v as'A,. After' inC;Uba;lcII1.with. shakl0g.'at
,37.~ fbr lh,", t~~. tubes,"were centri~u.ged•.~upernata~ remeV;d
and th~ tube'a 'were 'coun!:ed .for" 125I"':".act.iYi~Y,




lfig. 29. Effect of ca2• on the'binding of US-ReD? to lipoBomes •.
, ,. ,.
a) Assay mixture contained .Vposaraes composed of 7S\' .:-
-PC, 25\ LPC (600 nmol' of phasphd""Upid), 0.9 \..lg-oe 12h-PCBP,
96 \..19 peBP, 0,.1% (",Iv,> ~SA ;and~ted am~uht8 of_ca2~11 .. " ;;
Other cc;mdlt-ions for' Ute assa~'w~e as deSc~\bed in legend-
to Fig. 2B•.The amou'n~ of PCBP bound ":,,a8,C\lcu~ated frOm ..
. 1.2S r-activity a9~ociated Wit~tl~JP:~;~t after cent-ri;ugation~
The recovery. of the phospho'lipid in pellets 'was quanti'tativ~.
The ~xi~um am~unt '~f' PCBP b~lind (42 ~ 9 J has be~~~~sl9ri.l!"d
. '. , ,_., , . ,'. - - "
as ~oo" ~n.d thef.. PCBP
60
bO.~~d aer,di;fferen.t-: ~a2t, .conc~nt~ati.~n8·
).S, e~pr~ss~ as ~h9 -~~rcen~age, ~~ ,maxim~m bound. ... ". 1\
b) . Assays· wd~, cartied"ol,lt ei.ther. in the. preeenp; ~
(.', ) ~:enge ( _ )?J l?·,~ca~+· ~nd'~i\tai~ed.~l}pqeo·~e'a
.... composid of 75% PC and 25% LPC -(600 ri~l<)l phospholipid)., 0:1%
"." .., " ... , .. .... ,."
(w/v) ·~,~A, 1.25~:-PCIBP (0 •.9 \.I g) with .10cre·"8:1.og .amouh"ts of" ,. ~
PCBP. Other detai'ls of· °t:he 'assAy" we.r; as described in
legend to f'ig. 29a'. ,The amo~nt of PeBP'hound ~as calcLllat~d·
,/
c) ~h0\'ls ~~atchard an·alys.i,s of. b:n'~ bf.' PCBl? to ."
",',"';o,om,s,. The 'runts of,' bo~nd .ndfr,,~ poap 'we,', ".tim.te"
from a sa~uration,,~urve (data .not show,:,-)'.al\d. the data pl?tte.d.







"'k2~. ,..tw, _ ,'"~ ,~ 20 • •.
, ,








127 ~ ,) '"
... a~d·. the as,8ociation constant' (Kat calculAted fr~ ~h~ slop~
of t.he .s,ca~Chard plot gave _~ value of 1.8d06M-l (Fig. 29c),
The total numb.'r of Qj.nding aites on the lip090111es' were
;' -
c,alculated fz:;om the intersection of tl)e line with :he~abacislHl.
'\ ~ and .. gave a value of 0',96 nrnol( lImol, of phospholipid., This
value compares favourably with. the total ~iriding capac1ty of





D. Effect 'of L on the bindin o£ PeBP to 11 osomes.
. . ' .
The 'bindin~ PCBP' to ~~po.SO~etI,~on~ainlng. vario~.·
ratios ·of· PC 'and' LOC. W&,!! stu'dieQ as Ii fun.ction of pceP"
: Cbn,Ce';1tr~'tion '(F,i9: J'Oa). l( Th~ 'b~':;ding ~f ~~P. to .1-~~o8o~es·
: ....;" ..... ". ,
composed 0"£ PC alone WAS poor.· The IllAximum b.1nding of PCBP
'-tbhe liPosome: w~s 'ob~erved'w~en the .l~posome~:c~~.ta~nE!d·
·25' LPC (.Fig, JOa). The .recovery '.of phoapl'iol1pid. from the
, p~llets- was quant~tati.~e ,in, Upo&om~~ compOS'ed ~f lOOt 'PC'
. and .75\ 'PC, 25~ LPC ~Fig. JOb). .H~ever f,urther ill~~ease in'
. L~ (ie, iri, liposomes con;pqsed ~f. 50.' ~, 50' L~ an'll 100'
,LPC) _re.duced -;.~s ph06Pholipid~'recovery - iri .~he lipo80m's
.pel~,etB (Fig. ?Ob) ". 'n1.e a~OI..int of PeBP bound, to ea<:h of
Uposomes when 25,':> \oIg of.PCBP w!ls 'a~~ed is 8h~.':l in'Fig, jOb.
,
,
Effect of' LPC on the binding of 'PCBP to liposomes.Fig. 30 •
12.
.' .
25." ~C" f~', "Lpc; (" ~ ) and i'oo,-:pc (D.'). The amount of PCSP
bo.und ~~s ,calculated as described in legend: to "Fig.· 29a.
,b). Th~, li~,os6nie 'pellets o?~ained"from,eXlJerime·nt
described in .£19 .. ..:308. we~_e alialy.zed:for !'hosphoppid ¥,i,
fol.io....ing t.he method, of Fi~ke an~ SUbba'Row (150);' 'I'he Pi
.r'eC(;lVered'has been expressed ,as, the P!!!rcent~ge of P recovered
inth~ :~eliet.. ~ax~~um '~unt .of' !J>ip, ~~d. (60119) has, 'b~e,:, "
',' , " ," ",': ~
,100% and ~he PCBP .b~un~ .~o liposo~es' of differe?~.
bee~expre9B~~d as the .percen"tage of
. .l,a)., a~d' r~c:ov~ry.: 6ttOEiPlt~liPi~ ~.n.d ~~p fro~ ",the .lieOSGme
pellet as a function f!.PC concentration (b)· .. · ." >
a) Binding, as,says ,we~e cAr~ied 'Gut':":i'~ ~reBence 'of 10 mM :
ca2+,-. 0;'1, (';.,jv) BSA,.: '0..9 IJ g' ~t" I,2SI_peDe, incl:"e'as~ri9':amo~nts
of PCBP·.a~d ;~~S~eG (600 .mool :phoSPholipid) of t~e ~Oll~~ing
cqmpOsitio'n: 75\ ~;"'25% ~PC ·,'6.)~ so~- pc, 50~ LP~ "(-0-);
/
.'
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studied as a function of liposome concentration and the
binding increased up to 1000 rimol of phospholipid after
.....hic~ it ,remained unch~nged ~ higher concentrations of
ilposomec (Fig. 31).,' Maximum binding (about 70~9) was
obtaine'd with liposomes containing 1000-1200 omol' of,
· ·~hOSPhOlipid. ,'In routine - ~\~ays liposonfes c:;..ntain\ng "600
nmol :0£ p~o8~hOl}p(ci"'were ud'ed. as" this valueOwas on the
l.i~·ear part ~f·th~ co~c.entr~n-c~rv~ (Fig.: 31):
6'£ PCBp\t.O fip08omes.
T~~~ ·b~·n·~i'~.9 of'- PC~; to' l~po:>omes remai~'ed 'un.Chang.ed
};letween 20 an"d 120 mi n of incubation a t 3.7~C (F).g. _·.3~) '.
TherE!forc, an incubati6n- time of ~o ~in ......as I.Ised in the
.
binding :as,says.
~'e effect of incuba~ion temperat~re .....at.o studi!'1'd on'f.h~
;.; bindi.·ng ~f pcsp to l.iP9some~.·. The bi~ding \'faa ~light.:lY
decr~ased upbn incub~tion'of the ~~'say mix't~re at 4\?c compa)~d
, " 'l"" .. /' .
to incubati"on at' 37oC~
G. Effect 'of di£ferent'molecular species .of phospholipids
· and polar .~ead 9~o"UP'substit':"ti?ns'on the'binding of PeBp to
li.po80meB.~
~The binding of PcBI? to liposomes'was unaffected.. wh..n
• ' ." - • • 0
· li~someB c-omposed 'of different Ph~SPh91ij)id acyl.gro.ups 0










r. ·eoic ·i~o· 12~' ~OO· nmd P
Fig. ~ 31.. Effect of increasing of- Ilposomes on thtl
binding of P,CBP to liposomes. ASS~Y inixt\Jr~~ontalned 0.9
9 of 1~5I_PC~P. 10 ~··ca2+. ~.l' (~/v) ~SA. 108 ... g PCB~ and"
in"creasing. amounts of lipqsomes composed of 7.5% PC, ~5 LPC.
Ot?e~ ?etailS of ~he assay ae described "in le9_~~d'to Fig. ~9a.
The recovery of ph06ph:~lipid ~n che tip080me p~llets was
quantj..-t:.at*ve. Th~ ma~imum amoun~ of pCBP bound (7~ Ilg) ~as
. be~n. as'si~ned as: 100%. and ,PCBP bou.l)d at '.,differe~t li'Po80me'




Fig. 32. binding of peep eo 11poe6me"s 4S a function 'of time ..
~s~ay.s" consiBt~ng of 0'.9 llg of 125I_PC~P-, 10 roM ca:+",
9.~' ("'Iv) BSA, 12~ 119 PCBP and lipo some s composed of 75%
PC, 2~% LPC- -(600, n~ol phospholipid) were incubated' for
v~riou~' timsil./ at. 37°C. The t,!.bes were centrifuged f.~r 30
"min "and pellets were 'counted 'fot' 12~-:i activity. The maximUm
'. '. . \ ....a~.~.t:--o: PeBP bo~nd '(44 Il~l has :.~een. assigned ,as lOO~ and
PeBP bound' at varioua times has ~een expressed a~ pe"rcentage















r:.ig. 33. Effect on the binding of 125I_PCBP to liposomes
composed of different acyl ,9r~ups of. :he phospholipids tA)
and of phospholipids having different polar heAd group (bj.
a) Assays consisted of 0.9'\lg 125I_PCBP, 10 mM' Ca2+,
'I .. .
0:.1 \ (w/v! BSA, increasing arn~unt's of ,;CBP an~ 1 iposomes
(600 ronol' fthosphclip~d) containing 2'5\ LPC.• 75% 1-01eoyl-2-
'pa1mitciy1phosphatidylcholine ("'0 ) 25\ LPC, 75\ DipalmitoXl-
P\oSPhatid~lcholin~~~LPC.75 \ diolepYlPhOspha_tid~~Choline'
(. ). . D'ther conditions of the a;$S~;'a~e as, described' in
,
.. legend to Fig, 2~,
l?") . Assays w&~e' carried o~t in pql;sence of 0.9 \lg
l25I_PCBP, 10 mM ca2+. ~. U (w/v) BSA I iO'crealij;iog amount.s of
PCBP and liPosome.8 containing 75% PC, 25% LPC' ( 0 ), 75%
phosphatid"ylse;rine, 25\ LPC ( A ) ~nd 75\ phosphatidyl-
ethanCl"lamln~, 25% LPC ( 6 ). AmOU~BP bound to the.
, . l1posomes was c"lc~lateci as describ~d in legend to ·Fig. 29a:
c) s~r.uctures of rhoepholip~d.8 used ,to study the
binding of PCBP to \ liposqmes. Liposomes compoeed ot:
phospholiJ:.lids having different 'polar head groups were used
to .st."udy the binding of PcB~ to liposomes as dell'Zcibed in
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PeBP bound to liposomes composed of three different mOl"cul,u:
species of 'ph06pho11p1d5 ·vi-:z.. dioleoyi-. dipalmit~Yl-. and
1-oleoyl-2-palmitoyi- was simi(ar. ~ In contrast. the bin('-in'l
of PeBP to liposomes was significantly af'fected' when p01<"1r
head groups' other than PC were uscu (Fig. 33bl. Substitution
of phoaphory lchollne h,ead 9rou~B of PC by pnosphory lethanolami.1l1l
and ph"'ilphorylserine 'in t..he '11p08omes reduced the l:;indinq
substa,ntially.
Inhibition 6f binding 0'£' PCBP_ to'lipoBomes by P:"'ch011"no •
• ,The . lJiridin~ of PcBf' to lipoBolnes was' s,tudied in '~h8:'
- '.
!::'resence of P-cho110e. The.binding was progressively :n~ibi1;.ed
by 'increasing concenbrations (O .. 400l!M) of -P--choline" (Fig.", 34).,
4,3.~
.The data obt<line~ in thLa 9tudy. suggests that ~BP can
bind to Illultilamel,.lar liPo;omes. composed of f~ and L~c,..
\,lJespite the' binding specificj.tl( .~fPt:BP fot" 'Pho~phoryl­
choline, it ~u~d pOQrly to ~ipolilom;&".~ontaining.phosp'hatidyl-
". choline .a16ne (Fig. 31a), A delinit.~ amount of LPC (25i~ was
requirfitd' t.0' be incorporat.ed 1:n the liposoln.es for maximal
binding of R:;~P, Th:~ ~reqUirement of LPC may be att.r.ibuted
to constJ;afnts on the orientat.ion and ac;cessibility of the
polar hfitad groups of PC impoBe~ by intermolecular Lnteractions
in PC coritai.ning liposome.s (165), Incllis~--on of LPC' at lot'
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Fig'. 34. E·ffeC~·Of'Ph6·8';Or:1Cha~in:on·the binding· of l:a5~_PCBP
to_ ...HPo~omee:. The' incu"b~tio;';-·mixtuFG ~o~e.ined ,0.9·\1 9
~125I_P·CB;' ·10 ~ Ca 2 +, O.ll (wJv) BSA, J:1posomes comp,osed .pr···
.. 7S1~ .PC. 251 .LPC. (600 nrito.l· of phospholipid). 126 \I 9 peBP and
increasing amoUnts. of P-cholfne. The maximum amoun't of pCEn'
bound. [4"8 II 9')·' in th~ e:~sence ot;" !?'-ChOl..i~e .;.." . been aSsig~ed
, '
'as 1001 a~~ the ~iip bo~-nd'at different ~-cho'line cpncentration









such that th~ polar hea~ groups 'becom~ '"accessible for
bind~ng of ,PeBP•. H~w~:er. th~. pon:lbilit~ that ~ .bindiny
of Peep is mediated, directly, through th~ polar hea,groups
of LPC cannot 'be excluded. 'Att.empts to examine this poss,ibi'lity
were unsuccessful due to, the poor recovery of' phoSPh~id
'r . I
from the liposome pellet, at higher c:onc:entrations qf loPC
(Fig, JOb). Consequently th., PeU! bound' either to ~ or Ll?C, ..
would ~e lost".!n th~....sll·pernatant I f'ter sedimentation. It~
likely -the.t LP<; c:aused solubilization of the 'liposom~ pellet
a'ndt~us ';eduoed the,~.pho~Ph~OliPid recoveries' in the peil,et.
Direct eViden~e for t~e i;'po~t~nce' of ph,osphoryl'choline
~ head, ~r.oups 'i,n the bind~_n9 ,o'f .~c~p to Hp~soine8 co~es from ..the
,studles' .kl'tli._ liposomes c~mposed tlf different he1\ld 9rO~PS an4
L!?C (Fi,g. 33bl,,' Liposome,s' ccint~-l!lin~.phoSPh?rYI~Oline:a,s
the head gfo~p bound thr'e,e to ~our' tlmes, more Pciep, than
those contat:;;'ing p~osph?rYl8er,ine or PhosP,hO~Ylethe..uiola~ine
h:ad ,~;OUP8' ~ep:~_ace,ment ,0'£ ?,ho'line ~~~h' eth~nolami~~ _~r
se-r+.n~ greatly reduc,es. t!J.ili! bif\e;ting (Fi,g. 'J3b). The' enhanced
binding 9f PeBP to'~osphorylcholi~epolar,head',group containing
li:V19sonu~,a 'compar~d 't,~ thos~·,~ont~inlng,P~,od:.Ph<?rYlethanolamlne
'.or- Phoep'~or~lsel:'iiie' ,su?:geste a, 8P;c:,~f~l'C in~ot,(fement Of~·,
P,hosp,rYlcholine ~e,~d groupe ,in the. bindin'i;l of PCBP;. '. I.t
~s ,of ,course poesible ,that p~oBphorylcholine ~ead group may
be" more' ~ccessible' for bi-~dlng' of PCBP ,than
-, : ~" , , .











. The '~indi~~ 81t".e, for 'Ph08hOrY~ChOl.ine'(in~hu~a~ and
rabbit CRP haB De en shown to consist df a Fri'ary locus. for
b~nding t.he: ~hOSPhOrYlester··gro~p~f Ph'::lsPhor lOh~l~n.e and .:, .
secondary \ locue. fCr binding the quaternar,Y,~ monium group.
(91) • _ Th~ binding of .tl1e ~hOSPhOrYl group 'Of! ph sphorylcholine
. t.o CRp requires the pre~eJ.1ce of Ca2+~a) . I PCBP ~.inds to .
plio8ph,;a::YIC:ho;ine head group by ~ 8.~milar tw I lde! me~hani~m
as proposed for CRP,' it may GJtplaln tjle enha,nced binding 'of
~CBP ·~o 'lip~H~ome8 in the ~["e~~~ce ,of 'ca2+ <fig. 294 a~d bJ./
A.lterrtat'iyo+y ca2+ ',may <le't al~o5teri.ca.llY. an~ n~t participat~~
in the bindLng site- of PCBP. With t~e. pres,ent dat;~" it::
. ca.rnol:. be est~.b~,ished:....he'th~r .calcium is, act.lrng allosterica ~.lY
or 'ie ~ comp:~~nt l!J'f .:Uie bi~di.ng ei~~ '\f P~BP, " . '. -\ ,
I~. contr.a&:t to, the .importan.ce of ty,~e ,pd,ar 11.ead gro?"p, ,,:•
. ~a~1at.i~~ O.f ~attr ·a.cY~ '~~.~ins ~. Ph~SPhOli~~~S .di~'.'not;'
affect the bi~in~ ~f PCBP t'O liposome (Fig, 33a), Similarly,
binding· of P,CBP 'was' not signiflca;""tly affected by v~riation
of incubation temperature (370 and, 4 0cl,
, 'One of~ reCJ,uir~m~t.s pr~posed.for J::'CBP to expr~e.B the
'inhU;litory e.ffec't, ~n, hepa4n-li~oprotein.pr~ciP~a~ion wa'a
itli ability t'o bind to PhospnOl,ipids ..<on 'the lipoprotein
'(Dia'~ua'B'io"n, ~aPter.·l l.. The ~pec,ifiC' .binqi~q" of ~CBP 'to
',. P,C:LPC "c~ntaini,.T19.-,iiP..~some.a .. "';i1<~ relat:(V~I\ ,~~ aff~'nit~ ,
(Ka .- 1,8xl"()6M-.l, FJ.g. '29CO) together WJ.t ~e other ·data •
. ~~e~~n.t:d".h4r~~ a~99es~,. ~he . po.S'8i.b:llit:/ Of. an inter,act·i'on'·'·
hetwe~n 'peBP and, lipo~~oteins., '. .. I .
I . 1.)1
Althoug!' phosphatidylchol.i:-ne is an important constituent
, '.
of all plasma lipoproteins. the present data suggest that
. . ,
surface orientation 01 the polJar pho:sphorylcholine' head
H~u'man ~.RP has 'been eh~n t~nd t'O lipoaomea;l varic:ua
c'olllpos?-t~on.s'(i07, iOtl,l,09, 169). ~!!!.! (l09') Have reported
~ro\,l.e; mat ~ a detlolrlll.ining factor for t~e interaction of
l,\poproteins with 1'CBP. A dlffere·n.ce in the surface 6rientation
or accessibili~y'of phosphorylcholine h~a~. group .in va-rioue
1ipoprot~ip8 may atise due tt? differe~ce'8 in the phpsphol~~id
. and apopJ;"otein com~osition of. the li~oproteins. .It, ma~ be
relevan,t ·to addt here that in LDL abQu·t 20% of the
. .
phosphorylchol1ne groups are immobilized· by interaction ....ith
apo B, '....hereas in· HDL there ,appear t.o.. be no ~mmo~i'liZi~9'
inte~aCti~ns betlof'een PhOSPhOli.~~d heaG ~r~d apoproteina .
(l66.16.7.• l6,il). . ... ' . .
(
the binding of CRP to. positively ~harged l'i~.omea"'~'cmpoae~
. , .. . .' .',
of s t'ea--ry 1 ald.ne, dimyr i s t;oy iphospha tidy lcho 1 i nSJ
ga1actosYlceramide .and ~h~lester~ll' The bindi"'ng' of CRP to
such liposomes Iofas Ca 2+ itide~enden~, occurring in ·,the. presence. '
of EDTA and in fac~ inhihitea ,-b.y .'h'i9h conce~trat·i9n8. of; ;
Ca 2+ •• -In ·ad~ition -bi'n'ding w~s no~' i·'lhibi.t·ed. b~
P~08phOrYlc;ho,lin,e,j Dimyrist0,Yl Phosp~,a;ld;le'~~_Olamin,!
could. b~ ·subst!t"uted ,for di!'l\yr1stoyl ..pho.sPhatidhcholine
. '. . / . . - . . . .
....ithout. aff"cting the binding o~ ,CRP to lipo80mes: On the,







polyc:ation binding site of the protein.{Reviewed in Chapter
". 1) the po;ycationic ligand 'being provid\!d ~y ~earYlami"nc••
. -_ "t .
Similarly: Teujimoto !.!::. !l (169) have demons rated the
binding of CRp to liposomes composed of stearylarnin'e,
dipa1llJitoyl- or dimyriatoyl phosphatidylc:holine and cho~esterol.
On the o'thar hand-, Volanaki, and Wirt~ (170) have shown
the binding of _CR.P to unilamellar liposome.s composed' of PC
and LPC. In theac ,studies, ·CRP failed to bind to liposomes
containing PC alone and incorpor",tion of LPC.ln 't~e liposomes
was necessary to demo!1etr;ate' b.1,nding_ The binding "-of ~RP
,w.a\~· ca2+ aepende.n: and-could be inhi.bi~ed'by. pl'lI';Phor;lChoiine.
'J-In th'le re"spect, the binding, of ,"CBP t;.o"lipoil'omes appears to
be. similar-.t.o ·CRP.




STUDIES ON THE BINDING OF HUMAN PLASM" LIPOPRO'l'EINS
• iMMOBILISED pcap ~ .
5.1. Intl';"oduc::t.ion
The resultlil obtained from the studies lipoprotein
precipitation react.ion and its ~nhibitlon by PCBI' indicat.ed
t.hat tJ:le inhibition inay be mediated by the Phosphorylcholine
bindIng property 'and t.he pres~n~e of si.alle acid ,residues of




binding of PCBI' "t. Q the phospholipids on the surface of
lipoprot.eins 1,8 r'!qulred for _tlla !-nhlbition proceso (Chaptet:
3). A· pivotal questial'\:" r~i,sed by thos." st.ud"les is, ....het.her :/~
,PCBI' can l'l)deed i~t~;act.w;~th· p·la.~a ~liP~p~.otein8:: The "::.::~
pr~~ent. study ....."08 deslgt:1ed to :-Characteri.ze. the interact.ion ":;_c1~.'.J
of peBP inunobili~edon Sepharoso wit.h human piasma HpOp.rot.eins. . . :3
The 'mel';"cula'r lllechanislns' involved -tn these l"nteracti'on~ bave :-~
'~"-t;e~n exp~or'~d. '''l'h~U ~'tudielJ ~; shed 11.9fi~~n~·th·e 'baoi~




• A. .Binding of V.LDL to sep~arose-PCBP
\ Appl.ication of. purified human VLOL.. to 'seph~rolle-PC9P
·co.lulllfl in preeence 'of -10 mM ca2+ showed that about 3,e\ of
. '. . .
t.he VLDL . (in terml of prot.ein applied) did -not.: bind t.o the.
• Dietrib on of li id and a 0 rotein nents of VLDl -in
,
unbound and bound' fractions obtaine9. from a Se harose-peRP c lumn
I
Appli"ed (mg) ~ Distribution .'
I - .• in unbound • in bound
Total p~otein (0."7-2.6; 39:t.4.1 *48!:5.6 '
Apo B (0.16-1.10) 46:t.5.6 ~69:t.10.20
Apo E (0:6~.-~~) S0.;t3.4 *57?4. 20'.
Cholss.teto! '(0.15"1.08) 6~:t.?1 58:t.8.60·
, Cho1este'r~'l esters ('O~21:"2·.O) 5"0:t.~., fi 0 :t.l1,.9
Phospholipids, (0.64-3'-75) 55:t.6'.10 64+'10.10
,-
Tri.g -!-ycer ides (2.13-7.55) 66:t.6 . eO **36:t.5.20
The range of V~OL apPl~e.d· to. the column ar;:e 'o8ll.0W~ -.~n
p~rent-he81e •
,-Re~u~tll spow average values (n-5) \.,;ith':t. S.E. Qf means.
*' 'p .<0.0'5 compar:6d t6 the unbound fract:i0n. . , .
' ..p ':(, o-~ 0'0.5. '·c~mp.ared .tb:' t~e ,unbOund frac~on. ~ta~i9~icai.·
algnif.ican<;e W~8 ca,~~~1at.·ea ue~n9: E!tu~ent's unpaired ~-test:._
A'poprotei n ·and., .1i.pid ~omponents::were' e8,tim~te~ l;Jy
sle'c·t.roinununoa8say, and gas. liquid. chromatograpy. tech"l':i-1ques





a 'l'-choline gradient (eluted ~t 68 mM P-choline) •. " typical
elution prClfile of VLDL from" the Sepharose-PCBP column le to
sh.ovn in 11'9' 3S. .Th~ profile sh<?ying absorbance at 280 n., .
1.s not' represe"ntative o:f protein milt:s for -lipoproteins
because of li<;iht scattering due to turbidity 'Of .vLO~. Table
7 shows the actual protein mass distrl.bution in the unbound
and: bound fr~cH(;>n8~ A possibility ..exist;e~ that aame VLDL'
may not bind to Sepharose-PCBP due to. Itp exclusion. from the
column. ,However, the e~ution vol\lme ot'the unbound "VLDL Willi
gre.ater than the e~clusion VOl.ume' Of sePl'lfrose-PCD'p c::0.+umn,.
indica"tinq that· t~e .unbound. VLl?L ",was not:, ~ItClUded fro~ :the
. " r. ..' ".
.Sephar.o~e-:PCBP column:_ ~he poulbil1ty ~lthat the un~ound
fra,c_tl?n result.ed: due }O_ ~aturat.i~n of ~he l;:C?"lumn ",a~
". investigate¢!_ 'by 'applying di~feief!t:,allll)~'nts of VLOL to t.h'(
~ (Tabl.e ;l. When "'2.s"mg ~f~LOL'~rote~n was"app1.ied" ,:
" ', .,,",.,.' .. '
l.? m9" protein was r!tained on. the col~llIn: "A..aumin~ "this .to
',be th~ capac"ity of the colu~...a'sub-saturating al80unt to.l'
mg protei~i: of "YLDL vas applied whi';h a~ain: resuit.ed ~n an
"u~1;l~~~~ '(0'.27 mq) and a 'bou"nd (0. 35 ~g) f;~ct.ion. The,e
results', "ugge~,t. th~t the un,bound" 'f,ra~tion is not due~to .
sat.uration of the column.
The di,st.ribution of the 1. i-pid and apoprotein components,
of bOund" and unbound -fra'ction '.are al~o pr~sented i'n Ta~l~' 7. ';










·Fig. 35. Elutio'! profile of VLDL ,'fr~m sepha~ose-PCBPcolumn •
.After the application o£VtDL. the column ~as .,.,ashed.exhaustively
~ith ·O-.OlM Tris';HCl ~uffer' .(pH 7.4) containing :0. iSM. NaCl·
lind 10 ~ Ca'2+., The· b~und fraction. was el~ted-at>68 roM
P-cholin,e onappl1ca·tion .of· a p-ch~l1ne ·grad:ient (0 ~t:o 250












There wa~ 'n'o binding of the· VLDL to the col-umn in
absence of ca2,+ ,(Table 9).. A. control e-xperiment with a blank
Sepharose column show~d no retention of VLDL. Elution with
.P~cfloline grad.lent d19 not e,lut'e any ':1e~ectable pro;:.e.ln fro{l1
compared to the ·.ll\bound feactio'n {Table ih The compo,aition
of the bound and unbound fraction is present.ad in Table 8 .
.The bound fraction contained' more pro(e1n but le,ss triglyceride.
comp?-red to the VLDL applied (Table B). 'The. calcu lated diameters
showed that the bound fraCtion contained VLOL of a smalle,r
si~e than the unbound f~action. The decreased triglyceride
·c'6Fil.-eiil-- and -tne-- -s-mal-~er' arze-OI the'bOu~VLj)Lindica-te that---
~he bo~nd "Era"ction may represent a partially catabolieed
VLD,L. Since it lias. been pr.opos9d that apo C levels. l'n VLOL
decrease. pro_9r~ssive'lr 'during catabo1.ism (19). "the. bound- and
the unb~una.fractio~s were. analys"ed; .for apo C I~ ~onte~t- by.
electroimmun9assa.y. Resul ts. showed that" the 'Qoun'd fr~citi~n
c~ntainea less (371: o~ ap~li~d) apo C II ,comPdred':to, the
unDollnd. fraction (50',,). T'hese res"ults do SUf?foct·'tf.e·po88ib~1i·ty·
that the bound' fraction may .represent. p~rtially' ~atabol1sed
.. \-- ..
B. Binding of uDL to sepharose-PCDP.
Three: differ~ni:. amounts, O~' purIfied LOL (660'lJg, 750 lJg









the VLOL fractions (% by weight) obtained
from Sepharose-PCBP column ..
The percen,t lipid of th,~< fracti'ons was calculated from t;·otaJ.
tip:id pro~iles. Results are the 'means ~ S.E. value~ (,n ".
6) •
• p ( 0.05 compared to VLOL applied.
+.p y'a~ues be'~ween the- c9mponents Of, the unbound and applied
wer~ l\ot signifi:,cant. 'Statistical signifi"cance was calc~lated
u8ing' ·~tude~t.'8 unpaired. t~-test., . ' .
-The"diameter of',each fraction w~~ estimated from ,th~ lipoid
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Lac:~ of binding of lipoproteins to sepharo"se-PCBP in the absence
. ofCa~+. '








98HDL (3 mg" protein,)
VLDL Jl. 4 mg protei.n)
LflL (0.8 mg fJrotein)
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of C&2+ and in all resulted in quantatfitive bindihg of
/
the lipoprotein (Table IO). The LOL bound "",as typically
eluted at 68 111M P-choline when a P-choline gradient was
applied (Fig: 3(d. The recoveries of ape 8 (94\) and lipid
COlllponents in the bound fraction were 'quantitatiYe~'This
. binding of LOL to Sepharose-PCBP required C<f1 2 +, since ~-: •
ab.!lence of Ca 2+ no binding wu ob.!lerved (Table 9).
:,.,.:.
C. Binding of HOt. to. Sepharose-PCBP
Bi~din9, studiep of HD.L to Sep~arose-PCBP ~howed that in.
the 'presence~ 'of Ca 2+, a~out' 80% HOL applied (in terms of
protein) ~as recovered in the~ .unbound fracti;n' (Tab!e 11') •.
" About' 1 i \ ,was bound to the c;pfumn and we~ ,luted by. a.P-choline
gradient (at ,68 ~ ·p-.ch.bli,n~•. Fig. 3J.). f'urth~r elution Wl.th
1'.4 M N~Cl did not elute any _addiUonal lipoprotein•. The
apopr?te"i.n char4~ter~zationof'the bou~ unbound f~actions -
included th.e, analysis for Lp'",) since Lp(a) 'lipoprotein is
k':lO'<m to occur in t~e .HOL densi:t.y range (1111. The results
~howed t;wo important featur,es. 1'he'boundo fr.acti~n pontained
. 'Sa\ of apo E and 97~ ~f Lp(a) .from the HOL applied. " In contrast
oniy 7.2%' of Apo' A:"l 'was recovered in thE" bound fraction.
'{'he analysis 9f .pr.otein and lipid composit:ion of the bound
. ..
-?:nd unbo~nd~ £ra~Hons of HQL .~howed that the bound. fract'J.Ol1
'conu;ined less .protein .but more c'holesterol, ~ cholesterol.
, " ' "
es ters .and phospholipid.s compare~ to the unbound haction







Binding of LDL to Sepharose-PCBP and percent recovery of
lipids and protein in the bound fraction
Applied (""OJ , hqund
Total protein (0:66-0.. 96) 94.1:!:.4.2
Apo B . (0.61+0'.89) ~ a8.6:!:.l ...
. C~olesterol (0~23-0.3·4) 91.0:!:.8'.6 .
Cholesterol esters (0.89-1.3) 1?0.J:t.8'.6
Phospholipids (0.59-0.81:.) 86.9:!:.5.6' ./\
Triglycerides ( 0.12-0.17)
The range of LDL applied to the column are shown in the
parenthese!l' ,
Results presented .a:re average values (n"3) with :!:. ·~.E •.of.
meanll. Lipids· were "'determined from total .J..ipid profiles and


































f.;',',,"~ . F~g.· 3"(if: The cOl!Jm~ a~d' .,elut.i~n.'condit'iQns· we>r~ the 8.~mii .011.8~,:;~. d.~CriJ:l·.d· ;1n, Fig. ;?:~.. The .bound, LDL wa.~ 'Q~U~ed ;t 68 'mM~ P:-.
~ :., '" ··~hO~·i~. ~




'.:' I Dist.ributi·on .of 'iPopr~tei'O .-and. lipld' components of HDL 'in
.unbou~d and boun'd fractions obt~ined·from·sepharose.-PCBPcoiumn.
"\.
')\--.---~-~'-ap-p""l-i'-ed-' -'----.-Di-a..,'·r-·i:.:b-~'-.i'-o-n ._..c.:._., _
(""l
The range at 'HOL ,APPlied to, the column, is ahal,m. in the
p.a.renthe8i~•
Resulta ~hOwn' are .average ·value. tn-3} with:" S.E; of me.ne.
,~~~~~a~~~:~h:r~~~i':.l~~~~~i~~~~~~:8e:;.~:~:~~~t~e~~?i:ol:~~~~
, det..ctable J .' ..
. ;*. P<Q..-OOli 'co~pared to ',unbound f~actJ.on. Sta't.i_t.ical
, significance wae calculated using Student.' _, ullpaired t-t._t:
" . " .' , ~ " .
, boundl\Wbound '
-.
Total prOtein (1:5-6.0) 80:t.3.46 -:1,O,9,:t.0 • S7
Lp(a) (0.02-0.08) NO 97.S:!:.2;48
\
-
'po E (0.005-0.013) NO 86.8:!:.6.17
AJilO A-I (0'.62-2.23) 85.8:t.4 • 9 ··7 • 26~.1 ~ ~~ .
Chp1ea~erol (0.056-0.116 ) . S7:t.2,.4 ·17.6:!:.O.7?
l::sterified (0.190-0.76'0) 65£2.6 ·9. 59iO. 54.
choles'tarol
..
. Phospholipids (0 ...260-1.006 ) 63±'2; l' ~~,.4:!:.0•.6?
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ElUTION VOLUME (inl)
.\
?i9. 37. Elut~·on. profile 'of HD.L. f;om se,?~a:role-PCBP colum'n.
eO,lumn and elution condi'tions' we're . t~e. same .as




~ C'£mpositlon ,of HDI. ~raCt10n~ ('I by':~ei~~t) ot.ained" 'from
S'epharose-pcBP column
-- app"l~ed unbou'nd bound"
•Protein 62.3't6 • 3 '65. 9!.'} 6 54.!.4· 9
C)lolesterol 1. S0:t.0.2O o..S8tO. 13 J. 30:t1. 9
Cholesterol esters 10,0:.2.42 fl. 7±..O.96' 16.1!.2.0
Phospholipids 19-.1:.3'.0 18.5!.~.6 24.0!.2.;S
Triglyc'i!r-ides 1. O:!:.O. 86· 1.8:!:.O.O6 a.a:fD.l?
The per,~eri~ 'lipid of, th~ fract ions was' calc'ulated f~om t.o·~il .
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related to the presence of..Lp(a) in the bound fr.actio'n.
C, ·ba'••d' on their retention timee which
''-0". Binding of lipoproteins. from whole,plasma t.o seph.aroas-peBP:
The re!J·uit.s pr,e~erited above. ·.....ith purified .liPoprbt~ins
'8ho~ed 't.h~t. t.he, 'frac;,ions bound t.o imrnobiti.eed ~BP. by the
application '.ct' VLDL. and HDL had highe);" concent.ratiol\8 of. apo
\'B ~n~ 'APO E.' The p~eBibi1it~ that ~e~h~rOSe-pq3P8~led,ivelY
I intenc.te with these :twO, apoproteins wa!!J lurthe'!:', investigated
by the applicati~n of whole 'norn.'al h'uman plasm~ '{.2~ ~.~ 130.
mg protetn) to the column. A p-!=holine gradient' ,~~11 t~e.n,
~pplied an"d.;::;-!.I~ulte~ in ~lution of a bound fr~~tion~:' ',Further -- .-......:
elution w~th l.4M -N'aCl dip..·not elute anY' ,additional- prot.ein
.. (Fig'.38). The r,esults -in'Table 13 .show the recovery of
~~pid and ..apoprots·ins in the bound fraction.' :APo B (111~ 'of
appUed)an.d aFo.E (8\ of .applied) w~r,e prAsent in the, OO:~nd
'dfraction. In addition, t.his fra.ctl.on contained 6' of
, cho~esterol, 16' of ChOleB.t~r01.e~ters;..... PhOSPh~1i~ide a.nd
, IS' ot triglyceri,dee. ,
. !rhe' 'percent.:comp,oeit.-ion· of the boun'd fncHon is presented
.. " . ~. ':', " . , . . .. " .
. in. Table ,14. Tps .ch~mic&.l composition of t,his fr.act:-iC?n
dif,f~rB" 'f'~~~' '~~~t., o'f. :t'ypi~al'\;LOL OJ:: LDL.,' a~4 ~y' repre8.E!n~
~h., pr'~8Eln·c., of·~. mfx,tJre ~f lipoprote~n.a•
.' '. 'rh;' tr'act:io~: elu't.ed by P-chol~ne'gradl~'ntW48 d~li~idated
and rea~.lyed' int'o'. three"'~~~B by ~el flit;ation.Ju~~ng HPU:
. "., .' . ", ", ," " .




Fig. 38. Elution Profile of Phsma on Seph~rose-PCBP
th-e HPLC resolilt.ion of apo 8, "E,and'C from plA~ma f'racU;'n bound
to "Sepharose-PCBP.· . .. , ' .
aL. Elution profile ·of plasma (2 ml~., 1,30 m9 protein}) on
_S~pharose-PCB~. Th~ bound fraction ....as eluted. by:'!! P~chol'ine
9.radlent (0-::2,50 mt:',i. . ,,"
'b) El'lt~on ~rofile of VLDL..~polipoprot~i~8 ,(a.bou,t. ~o
9 proteinl'_~ojection volume SO ~l). ,Eluting buf~er'wa8 O.SH
:'sodium sult;.ate, O.2··,M s0d:ium phosphate (pH .6.8) containl1;l.g:
• O~U· 50S. Th~ retenU'cti' times as indicated' on -each peak',
for "'Apo B, Apo E- and Apo C .... ere .5;08,' 6.8 and 8 ..2,'m1n
respe·ctive~y. The 'arrows indicate the elut~on poa!.tion of
molecular weight startd"atds run sep~~ately under' identical
colullUl conditions. 'Th~· follo;"~ng· standards ....ere used. l)
thyroglobul~n (670,.000 HW) 2) ovalbumin -(44,000·HWl. 3)
myoglobin (17,000, MW) and 4.) cvnocobalamin (1350 HW).
,c) Eluti.o'n profile Of' ap~protei~.~ in fr~ction· bO!1nd· toO
Sepha.rose-PCBP (50 iJg protein, injection vol~me, SO lJ.ll. ·The
elution c,onditions were e~actly:a8' in Fig .. ·Jab. ·The retention
t,lmes of .the . three peaks we're' 5·,1, 6, 9 a~d ·8·.4 ·mi'n· which
·b'orres~onded to_ the retention ti,mes optai'ned for A.po _B, ~po..
~ andApo--C .~espectJ.v-elY as. shown in Fig.· Jab. The rete~t~on
'2: of 2-mercapt,oljlthanol in Fig: 3ab and c was 13' 'min.
·Ot ,e~-detal1~~f ths,HPL~ run ~re as described under expe~i~e:rytal
~_p ocedure. ,Identification" of the ap<?protli'ins .wall based on
their de9i9nated.~rnolecul~rweights. A.'baorbance unit full··









ELUTION VOLUME (m1) .
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hUlllan' plasma









the' mean ±. s.>!:. val.use (n·.' 3)·.
Tab~. '~3
~pplied
















", A90 B: "'and E ",,~rl!i qu.antit:ated by .... l.ftroilll·munoa.~y and










Co~pari80n-pi .the coinpoaition (% brio/eight) of- the 'f.ractiOn








Cholest.erol esters 33: 5:!:.8. 6 12 42,3
Ph~8PhOlipid..- 20.~:t2.3 18 23.6.
Tri91y~er~de 18.2!-8.9- 55 5.1
Thl' percent', COhlposition· 'of the fractions' bound f.rom plC!.sma
WAs CA!cql.&:ted"lrOl!!, 'total l~pid praHl.es. Results "are the'
'means ±. S~~. Vlll.ue8>(n~3~.
aActaPte~ from DolPhin {:-I >.'
, - ..... .
-.
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of apo '8, E .an'cfC~\ purified '~LDL (Fig. 3~b). These
results demO,ns\.~ate a bi~ai.n9 specificitY',_bY' SePhll.rOSe-pc~p
for &f1o.B and_E',containi~9 lipopx::ot,eins even from whole,plasma.
. . .
E. 'Role' oi phosphorylcholine binding site of peBP a;"d .the .
'. . ,-'.
sia'lic'~acid r'lli:idues tin PeRP in the bindiug of LOL•.
T~ invest:iga.t,e the role' of PhOSphOrYIChOline binding.
~ite on PC~P in .the pinding. of- LDL the f~llOwing ex'~eriment
was pe~ formed." The Sepharose-PCBP.( 5 mt bed .volume) column
was pre-equilibrat,ed with. exceS.9 (35 mil P-choline (250 mI;l)'
sUbseq!J~n~lY .the ~olumn:'~as equilibra:t~d with 50 .mi, of a.DIM
Tria-Hel buffer (pH 7.4) containing O.15~: NaCl and 10 mM ca·2+.
. ......
Purified LDL (960 M-if -frote~.n) 'was then appU.ec;1 to' this
column. 'Ninety percent of apo 8 applied was,· recovered in
the unbound 'fraction and there was no detectable protein
eluted by the "'-choline gradient 9r 1. SM NaCl.
In a~other experi~e~t the role of siali"G I~Cid residues
of "PCBP' In the binding of L.OL. wa~ oxa'mined. To"a'
\.. '.Sepharose-desialylated PCBP column, LOL . (SOOJl9 . l'rotell1 I was
app1{ed in the preeet~e 'of Ca2•• T~e applied LOL bo.'nd






F. Effect ~f chemic~l modification of apo 8 on the'binding'
.of LOi. to s~pharose'':PC8P,
.' . - . - ' . ' .-
The role of lYI!iI~ne and arginine .residues p£"ape ,9 in
the bindipg of LDL to SepharoBe-PCBP ....as investigated. The
lY~i~e c:eSid~~~ .;,e~~ rnod~fi~'d ....ith· d.\.ltete.ne: and"the ar~i~irie­
residues ....ith 1.2-cyclohe.xan'edione respec:tively, It l'!as
'been previously shown' that thes'e' r~a~ent~ ar~ select~ve" for
,lysine:and arginine residues of apo:8.iri·LDL (26,27) .•
"F~rthermore the m6~Ufication proced~res are mild an.d do nat
affect :the'. P~.08PhOl.iPid co~ten.t of LDL (26":"27!.
The ~odiHe'd ,LOL (500 IJ 9 protein) .."was applied
Sepharose PCAp in the pres'ence ef' 'c.a 2+. and' the 'bound f;action
el~ted .";it:h a ~-choline q~adie.nt. O.... ta pres~n~~_~ ~n Table
15· shows tha't the modificatio~ af either 311 or 46\ of the
. : ,...' ..
t'ot~l' lysi'ne res'i~ues resulted in qUantitatiye binding' of
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Control None 0 100
L 29umol Lysine 31 100





2h Arginine '37 32
3h Arginine 40 30
~---'-------'--------'-----c----',
a), .~u~ntitati9nOf ~~ extent of lysine or ar'ginirie'~Odf~iCa,tiOn
was based on tp.~ .difference between lysine or at."ginine"
'content' in the modified' versus· the control LDL determined,
by amino acid !1nalysis.
'~.l.. LDL ~(50'O \.I 9 p;otein)' wal! applied. to S"pharoas-PCBP in
. 'e-a:ch' exper iment and 'the protein- 'estimated i~ U~bound~bound




Second, even t:he passage of whole plasma. through tne column
re:S'ulted in the retention of ~po B ~nd-'''ll:PO E (Table"'li3),
Third. 1'n ~~e s~udy with VLDL. there,was considerable enrichment·
of apo Band apo E in the bound fraction (Table 7). Fina:lly ,
all the a.po B in the LDL walil' .bound. to ~epharo5e.-PC(UL.c.ol.ullUl.-~
_These .findings clearly 5'uygest that peBP has a special
~
af~inity for apo Bo a,nd apo .E containln~ lipoproteins.
The fact that '~ertain apoproteins interact pr.e,f~re·ntially
with pclBP woUld suggest that the specif~c ~mino acid re.sidu.es
or the amino acid- sequenct:!, of_the apoproteins are .irnvolved.
in,the binding. Chemioal ~difi~ation·~tudieS'~nds,r~ai<.en,to-~
d.atarmine the ['ala of arginine, raaidu8s of' apo a in ttle.
bindi·P9. of LDL tG ,SePh~)oee-pcsP''dO in,deed ~uPlJort th'i"a
suggestion'.' 'MOdification of arginine residues' in apo B
. .
ma~kedly' ,reduced 'tha binding of LOL' to FCBP-Sephar~5e
~ ... ,... '; . , '
i
Th.e' da"t:a . presented in thip. c~apter demonstrate
~8P Immobill~ed on Sepharose binds human plasma lipoproteins
. in._ the prescn.ee af.'Ca 2 +. : 'On the bas;s of _cUFc.e.nt dat;a, . +t
appea:rs ,that Sepha.rose-PCBP can selective~y .bind lipoproteins
containing .apo Band apa E. This conclusion is suppor·t(!d by
several lf~ne:.- ,of E1videno,e. ~'irst. ·in the HDL binding st.uq,y.
t~e bulk of Apo A-I (the pr~domj,.nant apoproteln of }lOL) was
not bound to the coJ.6mn. in contrast almost all of the ape
~~_~___ ._.' _J...."---..........._~. .
E: and Lpt a). lipoprotein (an a,pa B containirig liJiloproteinl
pees-snt in ~I)L weje retain~d by the' coluln~ (Table 11).
160
, ;;,
lS}. The,se resulta not only estabJ..ish the 'importance of apo
B but. als? aemonstrl!-te the. signific~nce ~f 1l.t',9in~ne re.siducll'
in. the. bindin~'of LDt. 't,o Sepharose-PCUP ,column:, .'l'li~ ;i)npleat.
eXplan~tion for the invoJ,vement, of arginine f,esidues',may, :b~ .'
. tha:t basi~ ~r~up of arginin~'in't~rac:ts with the bindi'ng si~e
fo~ a cationic quantern~ry· ~mmohiu-m group on PC;D"P,
In ,contra:st. to the imp0.rtar'l'ce· of arginine reaidues., at"!
absence of a role of l~sine .residues tin 11.1'0 Bin, 'the bindi'ng
is appare~t from ,the studies with lysine modified LDL, (Table
15), The binding of LDL to Sepharose-PC8l> w4s una'ffected by'
lysine ·modification.' It may b~ psrtine~t to ~dd ~e' that
D1camelli ~'~,(96) have S~Ud,i-ed the interactions of pOlycatiorts'
~eg,"poly L:'~~ginine andpoly•.:.'L-lyslne) .....i·t~ human' C'RP,
(.raviewed in c~apter 1),:.1 The~e '~t~~~es p;ovi~ed evidence L' '
for a poly'cation bd..nding ,site on the CRP molecule and' suggested.
tha;, this site, has a greater af#inity for ~OiY-L":argini~e
than fot p01ymer~ Of".L-iYIl~
Investig,at'ions o~ t~~ \ttvolVellJent of' the ,ca2+-depe~~ent­
.PhosPhorylcholine binding slte and. ;the sialic ac~d re8i~ues
on PCBP .in th~ bindin? of lipoproteins have' yielde'd intereeting
,results. The results show that the birllUng of lipoprot:e'ino
to, sePh~roae-Pc'BP.J:lada strict require~ent for Ca 2+' (Table 9)".··
l' In '~~diticini' t.hs ~xpe:riments wi~h equilibration ot' 's~phar~se­
PCB.P by p,,:,cholin~',suggos,t. that ,th'e ~inding~ ,of lipopr.9teins
p~obat;lly' occurs 't~rdug" th'O" ph08phOrYlCh0l1.~e bindi~g slte
!'.' . , .. ,;







.indicat~'a~bS~nCEi .of a direct rate for t~e siali.c acid.
residues in the ~indi"n9' of liposoraes. Desialylate.d pesp
i~bilized on Sephllcose mai-ntlline~1its o.bi tHy -t.o bi~d I.DL.
~bi.s re~Ul( thcO'lots tu:the.r.-U:ght :0' the crltlca.i·-r~ie that ('
the 5ialic 1I.9io1 re!,idues, on peop p~y in the inllibi_tiO." of-
heparin-lipoprotei? prec,ipitatlon. reactiQn. (Chapter 3). l.t
. is now apparent' that the nature ~f the' t ....o interactions. viz.
. .
t.he inhibition of heparin-.lipoproteLn precipt'ta-tion an~ the
oinding" '~f li:p6pt'oteinll' ~o ;~~., is different. .
. ",;.
, . - - - ,
res~ect ~o both size and compos_ition (.L72,173 ). +put:t~ermor-o
it h-as been demonstrate·d tha,t the .various Bub-classes of
~+ -' \ "
VLOL diff~n t.~el£" ability to\interact ""L~h· the LDL receptors
It is of interest to note that:- PC-BP s~~:f.ical.i.~in~:
to apo B -'lIn~, ape E ~o~taiiiin.p~p~:'teln~ •. and' th';se are . :.•. '
·th~. t ....o apoproteIns recoc;Jnized .by, LOL ,reoeptC!.t- on liver lind
extr~':'_h~,Pat~C. oi9~n~ .( reV,i"ew~d :.n. c~apter. 1:).:.·, However'
wherei!:s chemical,.modification of. bo.th +lys.!n·o· and· argj.nine
res"Ld~es ~n...!"po a~r·o~ult.S in--the ,.toss ·of receptor bindi~g
ab,ility, the plosent stUdies; have shOl,m t,hat onJ.y the -.
modifi~~t10nof argin·ine ·residu~s afro~ts the bi~ding·to PCBP,
+ • ,.- .' • •
It is well re~09ni%ed that VLO~ are fleter0geneoua with.
'-
on oormal human fibrobla.sts-, 1114.175)., ·For· ample normall:y ,
. ex : . :.'---2
·the large-sized VLOL though they cOE~aLn apo a,and ~po. E,do
not bind ·to LOL t~cept6rs pr~sent :on nor~al· ~uman. cin"l{ the








both' ape Band apa E· in the l~rger VLDL do not posses,s' the
a~propr~'~e'CO~form~'tL::>n for ~.C'eptQ.r rece'goitien (~4.176)•
.Upon· lipolysis', ':'po B acquire~ the- ability to interact with
, "
the LOL' receptor. In the pres-ent. study applicati0rt Of' VLDL
~8e-PCBP resulted in an unbound aog bound fraction
. .,
(Fi~5) •.The unbound fr~cti.on also C~f1.ta·ined '\~.e apo ,8
and apo E, albeit less than the bound fraction (T.,able 7-).
rhe~unbound f7~ction' was not t~~. result of sat~~~'tiOtl. of t~~
cO,luron (T~bl: 7)., It is possible. that tp.e bound fraction;-...
rei,resents ;i~iipolysed VLDL. ~n l::upport" of-this; is the data~
th~:~ t~e :td9.~yoeride.,and apO.. C ~I' ~p~~~~.t of t~e bo~n~ .
",ftactiCln .~.: 5'L'OLwa.'s .io~.er ~h~r. t~e ti~d VLOL bu.t ap,oB
and E 'conte~t:"''';'e~e increased :(Tabl·e'·.7) ~ Trezzi -.~ ~''''''('172)
. h~ve "·fracticiriate"d··'no-r.mal hum.an .vLUL using heparin-Seph~ro~e'
chromat.o9raphy i'nto four 9ubc.~as8es, each increasing in apo
B and ape E «ontent' with decrease in triglyceride. and apo Q
cont~nt, It "is 'therefore a.ely tha~ iri-tb:i pres~nt studies •
• Sepharoiui-PCBP bin'd8 to ';some of the sUb-"blll.~~es.of VLDL.
. .
There are severll.l-..reports in older a terature of association'
betwe~ human ~RP and p;asma lipids. \. .
As far. back' as 1941, MacLeod and Avery (177) r~!?orted
, - '.
that ,CRP...p!esent in human serum' and in pa~hOlogic. .fluiiis w~s
aspociated with' phosphorous-containi'ng :s.~bstances, of lipId
hurna,n CRP .~.e.mons.tFat~d '~he. '~~~~l for",d~'l1pi_~a;tiPI), Of-eP





assocl.cit-ion ~ith lipids. Later, Wood (179) UB~d antilferunl
direct;ed·.a·gainst. n~~~ li.um~n· beta 'lipoprotein to r~mo~c
. '---/ .. .
-,ass.ociated'lipid ,:ontaining material .in CRP prepara_tions~
,.'sa.to an~,Hara-. (180) .characterized t.he lipids associated with' rIO.~ and showed .·thE; presence of "ChOl~;-st"erol; ch.o1esterol"
es~~'s_ an~ ~iglycerid~\..
t"lore r~c::.ently, several :.abor,atories haye been able to,
de}llOnst~ate intera.etions 'between human and -rabbit CRP with
~erum l-ipoprot~i~s but var'iable ~esu;ts ',hA-ve been obta"ined·.
'!?y di fferent 'laboratories.
po:nt~~ !i ~~ .(18:1) h~.ve rep~~ted t'hat\isolate~~bbit
_c~.;o~ms !!!. vitro coniI:'~e.xes~ Furthermore. it was- sU'99~~t'ed "
that. rabbit- CRP in acute :.Phal;ie a'erum exists' iii. a.coml>lex '<
with·I.DL.
On -the oth~r hand the res,-,lts of Cabana' !!,-~, '(J,82).'
sugge:s~ th.at the i.nteracti'on of rabbit CRP is, primarily "at?
rabbit. V.LDL. but· not with.. L,OL or HDL, • CRp·· i~ acute Ilhase
. serum was shown to'be assod6ted with- VLDL. 1'his_ !!!. illE9:
interact10.J;l. pemonstr~tc;.d usin';l iIJ1lllUnOelectr~phoresis. did
'nOt occu'r in the pr'es.enee· of EDTA .or P-choline, Th,dse-
:r:!,!~u'lts suggested that. the..int'era"ct,ion of' rabbit 'C~P ~ith
VLDL. was· C·a 2.+ ·d'ep.e,n?ent and probably in,volv'ed ,the
phospJ:!or;lchor'ine binC!ing ~·ite.
Rowe '!.!=.-~, (ls'3) have howev"er, shown that .rAbbit CRP,
·immobi l1ze~ on'" Sepha,rose bi.hd"S v~~~ ··as .....ell as- L!?,~. from
~J:101e norma16 ser~m 'iri~ t.he presence of ca·2'+." In addition,
~..
.~ .
. ,,_'-,:., .'.~ ";''J:,~.. -,
'coupled per ml of sepharos~.
,
did not bind to" CRP7sepharose ~oT~mns.: Although 'fhe .ba~i:s
for~'8pecificitY .for LDL -and "l/LO£; was nct' investiga~ed. it
, • t '-
.....as. speculat'e~ that -apo 'B' may play part. in the interaction
o~ lipoproteins' W.{th:.CRP.-,s~pharose. In,~contrast· to ~he
lmmoblillzer.l, 'form; free h~ni~h C~P fail$d ,td inter,a~'t- with 'any
164 .
, _the!r studi,as ~hO'Jed tJ)at.:p~rifi.ed l"abbit 'CRP, torm~ co~p{~xe~
with" pu;;fied 'VLDL, _LDL as 'well ali a-VLDL, an <1bhormal
. . ..
lip@proteip ~ie8'mt in hypercholes£erole;mic 'se.rum. However,
,ie. ,was 9h~wn that in acu,te phase s:rum•. rabbit CRP was not"
asa-oc.iat.~d· w!--th an;y ~e.r-um lipO'prot~ins but in
.hY"PerC;hoi.e~tl~diGm·~~ ser~m p~rt. or all' O,f' the ~~p ~~s. f<illln~
to be complexed with a-V.LDL as when analyz~d ~Y gel;fil:t~ation
o~ lm.mun·6elect~o-Ph~i;Si'5.:~chniques (183) .
•Human· C.RP ha!!l also been" s~own to bind huma'n .~.oL. and
~race' ~r?un.ts of Y00L -from human P'l~_~~ ·in. th~.I. .t5're_sen.~e ",of
. Ca 2+jU~4 l.;. ~C1W'ev.:r•..th:fs 'b~ndiri9 was d~-"nst.r~t·~'d only. when •
•" CRp'was im:n~bili~ed 0." s~p)1~ros~." tn __fact."exp~eS.SiO?:Q~::O·~~d·in9 .?;:
.. depend~.d~~n.the'CQ~ce:nt~~t:ion.~CRP. ill\.ilobilfllted o~,'SePltarose.'~~:
_ o't:cucrin~, _app~ecia.blY ·......~en .gt;eatec" th~n 1 mg' df ,CRP ...... as
Eve~ under ~u:h' conditions" ffDL
.-:.'.
varia,ble' resu·lta ob~.ain~d:b·~. different ~a'borato~i~~;:-lt is
difficult :t.o ident.ify a specificity of .CRP towards. par.tlcula~


























c;bapter 6 ' .•' ,'.
ST~OlES ON THE INTERACTioN~ BE,TWEEN pe8p, LOL AND LOr..-RECEpTORS.
6.1 Iiltroduction
The studies' de~crib~d 50- far in this the~is demona,trated ,
the abili ty o'f P~'8~ to bind to plasm~ li,?op~o~eins~Fut,therlllor~l
the j binding appears to be selective towapds apo 8 and apo E .~
:contain!~g' lipoproteins." pbip, i~obi~ise'ci on Sepharolile c~~
reCpgn,iB~ .apo ,B 'or ap~,~:,'in VLDL, LDL or HOL. It may' be' "
r~cal.ied (Chapter 1) that these aPoproteins' Capo 8-100 and E'
----- -_.------.-..Adllifnist.rati~~'·o'f pharmac.ologic.alt dos,es c)f 17 a.-ebhi.nyl
e~tradiol to rat.e, ha,s been repo~t,~d.to -induce .~ LOL receptors
" ,". '", I .in~~h~e +~~er~.. (13'.-),. :ThE1,se LOL r..ceptors ·h~V.~ b.ee/ri c~,acter.~zed "
usi!!-9 liv~r membrane px:e~arat,io~,s, Th,~ receptors sho:-,~d a
mark.ed "preference' for' 'bindi~g: a.po 8 and "apo E:" d~n~al~i.ng
" ' I'", ,.' ': ,:"
!ip9'ptoteins!' retj,uired c"alcium,. and were sensitive to pronase'
('~37):o', 'These propert,.i,;;;' ,o~ .the ;ril.em~~ane receptors are'
c.haracteris~·ic 0,£ ~he' .LOL r~'ceptors present "0"' ~ormal !luman
fibrobl~sts 121). ~'e' ..LOL· rec';ptor -~n" liver membranes' from







A, Binding. of 1251":'LOL to liver
sug'gested that this recepto'r may funct_ion to b'ind ap? S' and'
apo ~ conta'ining' lipopro~eins (137:,
In this chapter iE. vitro. intoerac.tions between estradiol
trea,ti~ rat liver -membrary~,LOL receptors, pur~fied huma.n LOt..
and PdBP are described, p,~ understanding 'Of these interactions
with model sYSotems. is 'expec.ted,:to ~aid' in"the eVilluation"of "
the ~Ol~gical function of pce~.
. \',
, , Besides th~ LDL r:ceptors" ~t. ~eaat:-t....."o o\~ei- li~opr~~ip
re.ceptors 1. e: an a~o-E, spe.c.~Ei!= ch?Le>.micro~ I;efanen\receptpr
(187') and, an a.~ A.-I o.~ H'[)L'receptoln88l .have' ~een d.,~8c;'.i'Pe:!3
'01'1 r'a,t L·ive~. ,The forme.r r.ecogni'ses· 'O?lY liP,OP'f~t~'i~9'~'
conhinin"g a,po' .E_a'nd', the' l,a1=:ter bind-e lip'op~oteins. co~t:ain.ing
, , '." . .r '. ", .
Apo AI; ~.ince .the s.eec~fic objective, of the pt:esent ·s.~ud'y·
was to dete~niLne~he~EEec:t Of'~t:~P (,)0 l14.POP;~~'~in-Ll?Lresceptor~~
..c-----",..."hunio,; 'tBLlpgO:,La~hl!!9'excnrs~'velY' apo B. has 'been uti~ieed.
The use of human LOL' should ~inimise 'the p~:t~'cipation of th~
apo E and apo A-I specific recepto,r:s'and a,imp'lifY interp reta:"loTl
of the resl,llt,s.
m,e~bra,ne. ~s 5~own i~' :19 .· 3"9a. ·11'1. the:~~a.enc~ oE" ECTA. ",the "
~.r.¢ssiD~_ ,?f bi.Tlding was non:-linear :uggesting" the presenc~'
. . .











Fir!.'••39, Binding 'of -125I_L'DL t"o liver membranes (A)' and
effect Of PCBP. on the blndu19 (a); . . .
A) :LIver· membranes (.loa~ oooxg peliet) were prepared \
. frOf!!..rats trea:ted- )-litb 17 CI~ethinyl es~radiol for 7
days. The binding a.ssays contaiping 100llq membrane
protein .arid· indicated cOncentr.at.ion of "12SI_LDL
(124_ dpm/~. pr,?tein) . were ,incubated .at age t:or 90
.min ei.ther in absence ( 0 ) or ,presen~e_·( .• ) at
20 .roM EDTA. .The :l-25I._LDL . bound to the membrane'
sediments was determi'ned •• High affJ.nity binding.
was ca-lculated- 'by sul>tractirig 'the 1251-oouod in the
. presence of. E01'A ..from th~t ~und·.in. the ·:absepC!.' of'
'. B)' ~~~~"membr'anes"(.lOOlig 'P~ot~in)' w~re .inculfat"ed'·
;~~~~it~I:L~~ 4~ '::~7 n:,~~tre;:~~~) 'an~' in ~~~:~~f~:
'. conc;::entr'atiol'le, oJ;-':PCBP and th'e -'e:mounts of 125r_LD.L
bound to the 'membranes determined, The 100% valuefo~. 12.S,.t-LlL ',bound, i~ the .absence ot. ~BP ,wa~' 0,85:'
Ug/l'fl9 membr ~e protein.. ~ch. data po1.nt r~p~e8entB

















of EDToAo. the .o~erall•.bindin9 -of 12SI_LOL .....~5 r~duced ~~
"1!:Xpected (137), ·a~.thou9h the f~~9reSSion of binding .....tu
·l~Jar. The difference between bindinq. of 1251_LDL in the
aotsenc~ and" presence of ~DT1 9iV;S a '!R.eaau,te Of' the specific
~9h affinity' binding ll.S sho..,n in Fig. 39a. The effect of
~ '. .
addi.tion of incr.aai~9 concentrations of peBP "?n theoinding
of 125I_L~L to estradiol tr~~ted r'~'t ~iver mem,branes ....a:~ st-udLed
{FL'g.•, 39b):-- In a,bsence of E~A,' the binding 'of 125I_LOL to ••
l~vet=. m~'mbralles Jecjeasedl in 'the, pre8enc~ of" Ln9reasl!l9
, .->' '\ • •.concen:r~tion's. ot' P~'~P" in ~ concen~r;tion i1e;~endent manner:.
. . ,. I .' ...
B. ct"fe·ct_.Of. ~reinc~tultioh;'0£ 1i"v~ ~ l~embraf.105 with PC'BP on
LhO' 'bindin,q ~f' 12.SI_L~i... / . ..
. In. an attenipt. to det~;mine ....hetb.er 'PCBP bi-nds to liver"
l:Iemb~ane and thus ainhibJrtlie bind'lng o~ 125I_LD~. liver
membr::an~s "'ere' pr~inCUbat~d ~./.v~~ous c.o~ceotrations of'
PCBP. Aftdr preincubtltiorl. unbound 'PCBP W~5 removed. 125 1_
LOL adde;d and the binding! of me~branes measured. ·Results
L' ' .-'
pre6ente'~ in F~9' .4Da show that preincu~tio~ did not ~ffec~
the b~Jring of L2SI":~~L: ellen though. Bome.,·PCB; «LO\) lOla!
f>o~nd to tVe l!Iembr~ne8 (Fi~._ 40b) as determini!d. from ~arallel
. :i"~~bation,.U'f:". i25i-PCBi' ." \ .
IC. Binding of .;t'2SI '-PCBP to LDL., .•. Chro~ato.graPhY· o~ ~'j'mixture of L!,L and' 12S I _ PCBP'
·J ....s~Phacr.;l S-~OO column in' the presence 0.£ c~~+ ·(~i~. 41b): .
" . . ". . I








- - .Fig. '40. Effect of preincubation with peBP on the binding of
125 1_£01 to hv,er Rlembranes (A) and ~he b1.ndU'lg of .
.125I_PCBP to l1vE!r ·membrahes (8). .
A,~"'-' L1.ve:c. m~brane8 (120 ~9 protel..n);'were preiricub~ted
\ ' ~ :bB~OaC~ ~~~i~~t:~~ :o\t~O;:dC~;~:hien~d~~~~~~t:lH~~~L~~
(4811g:" protein/ml, 172' dpm/ng protein) jfhd furthe"r
~ , inC?ub~ted for ,90 min at., aOc. ~e, "amount 0.£ 12,5r_LDL
. bound to the m~mbr,an"!'l_ sedifllents was determined
af!:ter" cent.ri:.l;ugati6n at 92,OOOxg for 30 min.
B) Incubatipn mixture in buffer A cantil-tned -liver
,membranes (120\19 protein), '!'25I_PCBP (1l1.g) diluted
with unla,belled PC~p. to give concentrations ~s
indicated. After iu.cubation at OOC for 90 min. the
. tu'b"es ;;;ere~-·centrlfugea ,ana l251_pCBICbound-to
~::~~i~~:dW::~hd~~~r~~~~an~:Os':di::ntsa.dioEaa~~i~~~~















resulted in co-elution of 125I_PCBP with LDL. Similar
• • . I •
experimet;ts loIere perfotmed, in tne absence of ca2 + to ascertain
whe-ther the co elution of 1251_PCBP with LOI. i.5 Cll.2+ dependent.
As shown in Fig. 4~a' in the absence of Ca 2+ the two peak.s
t!luted separately. These finding;;; support the possibility
of binding of LDL and' PCBP in fluid phase in the presence of
Ca 2+ .,"
The possibili:ty that the inh'ibition 0"£ the b~ndin9 of
1:o! 5 r-ipL to ~~e liver membranes by PCBP. may ~e . due. tp the
'formation of an l.Dl:,"":'"I?CBP ~om~lex was exar,;ined by analysing
aliquot's-·of the 'supernatant from the binding assays by,
.' " . .
gel-fiitrat~on Qn sephacryl-400. l~cupat!,on of irftreasin',j
c~n~entrations o! 125I_.PCBP with LDL and liver me~r':lnes,.
. .
r"esulted in i~crea$ing amounts of 125 I _PCBP 'being comphixed
in'the supernatant with LDL (Fig 42').
l)ur'ing ;h'e course of these exper~ents it was found
th~t the elution volume of free l25I_~.BP, i~ the presence of
ca2 + was larger than in the absence' of Ca 2 +. This slightly
• retarded' :~ution position of 1"2'?-I-PCBP' ~n the' presence of :...
ca2+\}._\)~ be due to a 'weak affinity of PCBP for sep~ac~y.l.'
sephadry:l. is prepa..;ed by covalen.tly ct'oss-li?k.~,ng alkyl
dextra~ with ~,N'-me'thY1ene bisacrYlamide •.. t small,number
• of carbcrxyl gro~ps may also" b~ present-, peal' may interact
w1,1;.h alkyl dextran in the presence. of Ca?+, In :this 'respect
it is 'relevan,t 'to notE! ~hat..in the preseO!=E! of Ca2+, 'hu~an








' .. ~ .
c~ r '~':;
(
". \.' . .'
~h:eb~~OfnqO~a;~;P~;Pq~~~fli:raitlo~U~~~i~~:~~.from
BJ.nd.lilg assays COntill,nl.ng ll.ver lll'emlJrancs ( 100 vg
prote1n), LDL (33.9~g pro~ein/ml), 12SI-PCBP ()Ilg)
diluted with unlabelled PCB[1' to give .final
concentration's as indicated" were, incubatt:ed' ·in
buffe.r A (containing 2".5 mglml eSA j,nstee.d ·Qf 20
'mg/ml eSA) for 90 min at OoC.· The a"saay mixtures
!Nare cent.rifuged at 12~800xt;j'. for 36 min and the
Bupernat;.ants rlOQul) applied on a Scpba1::cyl' 5400
~~i)m~d~i~t~1~;a~~~~fhNa~'lOl:ndT\i B;~C~a~~~f~~i~i~
. PCBI? complex~ with 'LDL .:i,.n the supernatant'S WliS
determ.ined \~rom the- radioact.ivity p0;o-elut,in'g .with
LDL. Column size and ,flOW rat? were. as described



























g!lacJ,:.OSY' residues 1n agarose and t.hil binding was pr~.,t.d
by P-c~o1t.ne (L89).
6·.-~. Di8cu'a.ion
- The.demp!'~tri!ltlon· of selective binding of a'po B ;!u~apo
~. . . - .
I:: containing lipoprotelns to SepharOle-PC8P in th~ lalt.
-. chapter prompted t.}\e current i":velt.lgatlOn on .the inter,action
bet.ween peBP, LI1L and LO~ receptors. I'.n "assay system with
tiver....memb·ranef fro~ .;stz;ad.l.ol-treated rats a.s described by'-
·\o....ll.;ten ~.~. ~(lJ·7J. 'ha~ be"in utilised t.e:" study the ef~ect '.J
of .PC8~ on "125I-LOL ~_Ij:si-..~Dlt ~.e·c·ePto~\nteractions. Th~ dat;'
delllOn:,tl:'"ted tt}at PCBP i.nhibit.s. ?he. binding of 125I-,LDL. to
,.':~nn::;~~Ei::~~,:E::~:::~:n~;~::~:~~~~:;;:~~;;~;;:~'.'
SU9gesting tha~ the LOL-receptor .~lte.:,/, membra.n~s weC(,~~:.....~ "!:
blOCk~d "b\c peep, although some PCI\P wall bound to the Illembrh.s~
(Fig·. 40a and b). Using' Sephac'ryl S-;4,aO gel fi1~~tion
., C:h%:~lDlI.tograPhY~ H, ,wa'~. ~emons~~~ert ,~hat' 12S~'-~CBP~'CO-~lut~d.
with'LOL ·1n the pre88nc~ of ca. 2 + (Fig. 41b). A Ca2 + 'dependent-
". "bind'in9 o~ ~O~ t~ pe8P im~obn1s8d sep~a~o~e' was alll~
• de~nlltra~'ed i~ CJ:lllP~~r 5, F.ur~her-:C-r:this '.>ind"i~gof 12.SI~PC8P ,
,. . . . '.-
:,to' LDL was also demons'trable in the LD.L-I:'eceptor assay
:: I P.ig::-4'2 ) , '1 ~.C:Ubat:i~n ~f in~rea'~ing' amount's, Qf l'25I_~C8,P
with '~OL. p~ogressi~e~y. in~reased .~DL-PC8P complex formation
in the ClilIup~l:'nal:ant f~om the assays' (Fig. 42 )', Fro;'! '~ese
','~ ;--:'
" .........:,'. "',~', . '. "'•.•.. 'd ••
... -'
. 'glycoprotein.
results it is reasonable t'O· corl<:lude that the inhibit.i'on of
the binding ~f LDL to the' receptors on i~ver membranes by'
. ~BP ~;sulted frQlll a 'fluid phas~ interacqon between LUL 'and
PCBP and not due to any bindi~g to receptor sites by veep.
P,re,,:ious WO'rk 'by Goldste,in ~~: (69,190) ~as shown that
'heparin and other, sUlilfate~ ~1~c,9s'amin"91¥ca~that 'bind to
LDL i'nhibit ':r-e 'binding- ,Q:.f. ;~5I':LDL to its rEi'ceptore' on
no~mal f.i,brob1Ilpts. In addition, Bro....n ~ g. '(L91~ have
shown that certai:~ 1l0s·1ttvel.Y .cha~r"9¥ proteins .",~e da1Jllble
',. 'of [nhibiti~!- L~~"re~ep~~; .int~t:aCti~_. . It was suggested
. ,,':' , ' ..... . ' '
th~t t.he~e p"i-otsins· inhibi:t the binding by binding ·either to
the-rec~tt.~'.o~,.tt:>:'an' aCljaccnt ~ite. This. is· in cont~ast
.. ," " .,. . "
'. " 'to the' mechanism of.iJ:jhieltion by pcep ....hich probably invo1 ... tI,8
• -,--, "<;-.' .
the binding of LDL to-~pCBP. '!'he ~same a.u-t:hors al-so found
<To"" . '.,' .'. I '
. ~;~:~.. , t.hiL<t. '~eVtral glycoprgtelns, did not in1ii~i"t, t.h'e· bindir1~ Which
gives further ,credence to ,the in,,:!ibitlon by PeBP ....h~ch ia a
,
In conclus'ion, 't~e pre;ent ublile"vat',~:ons support 1:I
notion that an int~raction of peBP with lipoproteins!.!2
" ,





.7: 1 .. Iftt.t'odu~tion
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P1a8~a·LDL· has been .t'ecogtliz~s II. primary risk 'factor
in th~ ~eve;opment. ·of atherosclercDsis. Familial liyp~r-.
'~t:olemiais an inherited meta!X>lic disorder. characterized
by a genet,io deficiency of functional LDL receptors. BeCaU!ie·.
of 'thi~ de-ficiency, pat.ients-.....i~this disea~e !l,re 'unable' to •
clear LDL.-DY LDL-rt;Ceptor me~iat,Qd endocytosiB_ (reviewed in
Chapter"l f and ,gC;; ha;"~ sev~ral-fold higher plasma LDL levels
compared to normai. These high ).evels of circUlating LDL
lesu~~' in pre~at.ure.on.seL?f atherO~cler.()ti"c ~rteriai l~Si:onB
often leading to de~th (22), .'
. sever:l sttidie~ have be~n re~~te.d (l9~. \93, 194) that .....ere .
designed. too reduce ·plasma LDL. cholesterol, concentJ:latiGrJ,s' in
·experimental animals and pa{ient8 ~rth 'familiar hype~chol-
> . .
esterolemia. These studies ''involved plasmapheresis .-a.ri~
extracorporeal removal techniques. Plasmap~eresisis tYPi~a.lly
, performed by shUntin~ thi blood frOltl arterial bran?h ~ b~~ween
the common carotid artery and inte~nal jugular vein, aepar-at-ing-.
,the 'blood into a ~ell concentrate' and a plaljlma fraction by
,". . ... ' ...,
means 9f.·a select.ve plas!TI&.. set:lara,tor m~m'bra.ne" The plasma
. ft~ction is 'passed over an affinity-adsorbent colUmn. s~cific
for ~L, and _t,he LDL-d~~leted'plaRma. recycled into. tl'!e cell''''!'





.vein. The a'ff~nity- adsorbents that have been
~eparin-sephar.ose co/lumn (192). anti.-LIlL sepha;oae
immunoadsorbent column (193) and .~ext.ran sul.fate-ce11ulose
beads (194).
On the basis of the. ability of sepha~ose-PCBP column to
~cifically bin"d apo' B epn.t.l'i,!ing lipoproteins (VLOL "and
LDt;1 ~Ch~p~er 5) "':'hic~ carry 'the 'bulk of Plasm; chOlesterol'.
in. huma,ns· and rabbits the ,prese-nt study _was undertll.k,en to
evalu'ate' the s.xtent ~Q Wh~\ch pla.sma IlLDL .an~Di.. ca.n be
bound bi a Sepharose-:-PCBP column in "a p.t,asmapheretic~ syatem.'-
!E. .vivo. 'B~-'fore proc~e~~n9 to studies ~ 'vivo,exP~J;"iment.s
'~ were .perform7d !.!! vitrq ·to. t.e~t Whe:ther' plasma VLOL ·a.n;cl'.LD~ .
,.ca,n. be.relT!oved by a Sepharose.,.PCBP co.lumn. For t~ee~,perimente'
.4~ '~ltro.' pl.aama "from d'i'/;!'~-induced hy!-'erch'Ol~atero\emic'
rabbits was used a~d the e;'.per.i~entl';, !!!. Yl.'!2 'were per'~ormed'
in. normal and diet-induced hype;~"01esterolel.lic rabb.i.ts,
Diet-induced. hypercl)oleE'te];o~8JIlic rabbit.s were, ..used. in
thi·s s~udy because of the extr","e sens~tiv..tty of ~his animal.-
species to die~ary c~~lesterol. After the initiation of a
, high cholesterol diet; the- pt"aama chole·~tel"ol lev.sl 'riees'
m!3re than IO-'fold ac<:ompanied by marked changes 1h plasma
'liPoproti;!i-;;; 69. ],,95). . The Pla.~~a concentrati~n8 0; V~Dr.•.
IDL and LDL rapidly incre~se (195).fr'- In compa·~~.~ori. wi~h .n9rm.al-,
~~L, • in which triglyceride - are the ~r~dominan·~n~j.d and .
apo B is the majo: protein, 'the VLDL particles of ~hole'sterol­






are naarkedly enriched.~napo E (3;9)" .The hype.rcholeeterolcmic
. .
V40L are also larger in size than normal V'LDL, Becau$e
th~se VLDL show a~. abnormal B mobility on el.ectrcphoresis,
they. are 'Called S-VLDL. '.,;
. In adtHtion to the occurr:ence of &-VLUL. anotln!r alt,eratiC;;n
in the lipoprotein pattern induced' by choleateroi· feeding ·is
, . . ':' '/' .
, the appearanc~ of ':IDLc' a cholesteryl ester ri;t:h lipoprotein
that coD.tdns ",pO J:: as the }najor apo~ro~ein (39), .'
Since in ~abbits'plasma cholestercw.. levels inc~~ase' in
I-,a' very short time ·af~er th~ ·in\tiatiOQ.·of ,high c,,~ole~t~t'ol '
. diet.' th.i~_ aE:1imal mOde,l: has been. used',¥,' determine ·trye, .
.' ef.f~.~~veneiui of se.Ph~~oS~-""'pcBP 'ioiumns to-bi~d \fLO.r. an~, LOL .




!".. Experiments In vitro
. .
~. Binding of plasma lipoprot.eins to Sepharose-PCBP 'as r
func·tion of Ca 2+ concent.ration. :, .
Studies presente.d in Chap'ter 5 had ~hown- a requireme':,lt
, ., ~.
of. Ca 2+ in th.~ bindin'g of lipoprot&ine to Sel?harose-VC1JP
',columns. 'In,ord.er to deter!!dne 'tlle op~imai a}"ount of Ca2+
.' .
required to 'bind lipo.prote·ins. fr,om hy'p~rchaFe~te~olem~c
pr'aema. 'the bi,\ding .was perfo~me~ as a f'untlon...of Ca 2+
.concentratiori. H,.perch~lestro.lemic plasma (2 ·nU,. 29~5 m9.,·
..i~~._-, ::.;~.~,.~JE
:hOllilllterol j waa ",-pplied: to Sepharo~'o-'pcBP columns '"("2 ml bod "
volume) in the' pr~8,~n~~ of i~crea8ing concentrat·ions -of
, ...,.
Ca 2 +,. '.The bound fraction was eluted by EOTA and analysell
for tot-al chol~sterol. VLOl" + LLlL cholest.erol, HOL cholesterol,
.~riglyceride and total plotein content, AS,sho!"'n in Table 16,
the' amounts - of .choleste·rd"l. ,triglyceride and protein 'boun9-
increased upto a Ca 2 + concentrapon of 2,51 roM, (T~bl.e i6)
~fter which' the' binding remain!!d unchanged. Th& diB~'ribution
of cholestel:"Ol in', VLOL t LOL and HOL ~Jbfraci:.ions .is bhown
in Table"16.' The res~lts s~ow that >90' o'f chOle8te.r~l(
bound td Sepharo,e-PCBP ~a.· pre,ent a. VeOL + L.DL cb01eet'.rol. . f .
Th'ese experiments show~ that the pres!,!nce. of i, 5 mM' Ca,2+
. . .
~is sU~ficient, f~r, .opt.imai binding ,'o'f pias~a Hpo,proteins. by
. '. l3epharo"~e' PCBP.olumn~ ,and that most, of th,e ,bound choie.et.ero~
was rec'overed in- VL~i..·+ LDL. sU.bfJ;'action~.
T.rial experill.lents had shown ~ha~ th.~lut.ionof liPop'rPtei~"
bound .to S~Pharo~e-PCBP ~it.h 'either 20 mM ED.TA or 100 mM P:-
choline resulted in identical' recoveries. Thera.fora 20 mM EOTA
was rout.inely 'used to elute-· the bound fraction~ -in, all
experiment~.
ii: Bindin of· 18sma Ii 0 rote ins to Se haro e-PCBP
~uncHon of th. am6u"nt Of
The ·bin.ding ?f' lipoprote'iQ..s frpm "hyperch
plasma was studied- a.s a fU'.1ction of ~hOle8;,ro~.
applied, to· det,el;mine' ~he capacity of' seph~ ose.-PCBP _ for
binding lfpopr~tein Ch,ol:sterol.
( ~ncrQasi.ITg volumes of hyperchoieetrolem ~ pl~:s"!.a
\.
V Ca2 +a·. Totalb , of 'bobndc '-' % of .bound Tri9~yceride Protein
concentra'tion ..chplesterol cholesterol· cholesterol in bound inoound(mil) "bound (mg) recovered in' recove.red' i~ fraftion fracticn
VLOL +. LOi.
~
'. 'HDL (rng) {mg}-
,
0 O~ 14 98 . 2 0.06 0.03
0.30 3.53 97 3 0.50 1..53
0):60 4'.40 '9. 4 0.6X 1.61
1. 25 5.98
'.'
6~ ',0. 7~ . .i, 1. 9• ~2.50 >. 6.10 96 4 0.68 2.435.00 6.08 r. . 90 10 0.76 ·2.32
10 •. 0 6. 00' ~ '2 .8 0.61 2'.41
sepharbse-PCBP
Hypercholesterolemi.-c piasma (2 rn1.·. mg chol.:est'ero1) was' appli'~ to sepharose-pcBP
column, (2 inl,bed vOl,ume) 'previously equi.librated·with 10 mM Tri~Cl buffer (pH .J
7.5) containing 150 roM, NaCl and t.h"e indicat'ed COrlc.entrations.of ~a2+. Prior to
~~~~~~~~~oo.~h:~~o~o~;::n~q~:~:b;::~O~s~~f~,:~e.d~et~:p~~~:~~o~~~~~:t~~~:
oP7ra~ed at 2'Soc at a f.low rate of'20'ml!11'and 0.5 ml fractions were collected.
Lipoprote~ns ~und from the plasma to :Sepha,rose-'PCBP w~e eluted by 20 mM EDTA.
Estimations' 0:1; tot-a.l chol~sterol and triglyceride 1n the bound fracti.on were
performed enzymatica:U.y on a Hitachi ,705 "Ran"dom.aJtis anal.yser using the Boet,lringer-
::~::t~md ~~i~::;:gdaa:~r:~:d .l~:~:i·Of ~~~;;i~'~~t~~~lt~ bound fraction was
The amount of VLDL + LDL chol.estero,l. present in the bound fract.ion were ca1CUl.a~ed
~~~.ma~~~~:.i::e~;~c;hOblee~wteeernolt1~a~h~h~t;:~~~~~~~r=;::~~;:2'+t~eep':~:d.p~:~~~~~~t:~
,of VL.O~ + LDL (152) ius deGc'ribed in ..Chapter 2.
Tab~e ~6




applie~14.15 lng/mf>concentration,('chal-esterol( seph4rose-~BP columns (:2 ~l bed volume) .'in the presence of
.........: 8' 2.5 mM Ca'2+. The. lipoprotein bouna to the columns W~8
eluted by EDTA and t~e bound fr.ac~ions. from each experiment
analysEtd for ··total cho.1:esterol •. VL~L + LDL 'C!,,~l~aterOl! HDL
cholesterol,_ triglycerid"e and protein. The amount of lipoprotein,-
bound to Sepharose-PCBP increased up to the appl.icfltion of
29.~ plasma chola,sterol, af1:-er which binding remained un"changed
9u9gesti~9 saturation of the column (Table 17). "Most (>90%)
'. Q. •• .',
of'the cholesterol· bound 70 Sep1)arose,.,PCBP columns :--,a8
recov~rec,l in VL.!J' ~ LDL. fracti.ons, thus .suggesting 'that:-' the
column mainly ·binds VLDL + LDL and son.e «10%) HOL'. The'
• . • . r
m~ximlJm capa-city" o.f Sephar0;i:e-PCBP columJ;l.s es~at"ed from
the'se"QXperi'ments wa5',1.·6 mg i::hoI~stero1./ml of sephilrOSe-I>CBP •. ,
,
iii" Reusability. of sepharose-PCBP column
In order to .de.~ermine the r~u9ability of s~Pharose-PCBP
columns, the following experiment,.. w.as performed":
To'.a Sep"harose-PCBP column. ,(2 ml be4 volume) '.
hy~e~Cholest'erOleniic plasma !2 ml.~ '~9,,5 .mg choleste.rol) 'was
'~JiI~:ied in the ptesenc·e of 2.5 mM c,a2+., Th.e"bound ·iipop.ro~ein
was elut..ed with E?~A. After elution with Ecn:A, .th~ C;olumn
was equilibrated with seyeral bed volumes of O.O~M 'I'ris-Hel
buffer (pH 7:4): containing O~i5M NaCl·and 2.5 mM ca"2+ and
hype~ChOle1Jt.erole~~c plasma applie·~ B;~ain-. ': This expe"riment '.
Seph~rose-PCBPrepeated, a times using. !=-he
I
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"
Effect of -plasma cholesterol on 'the in vitro binding of pluriwa lipoproteins to
'-.·rl-,·
Amount of • TOtat" , 'of bO~~d'
,plasma· cholesterol , chol~6teroJ.."
cholesterol 'bound (1119') 'recovered' in




7.5 . 1.60 92
29 '6.20 90
•• 1 5.8. 9.
73 5'.96 9.
._. "In order to dete:t"mine the carty-ot 'se~har:o~e-PCBP. ~olumn '"to bind lipopr~~ein
cholesterol, increasing volume ot. 'lyperc~9l.estrolemic plasma was ,applied, to sepha.rose-
PCBP col.umns (2- ml ,bed volume) in the presence .ot. 2.5 It'IoI Ca 2 +. The other column
con~itions were as .{!!c!="ibed· in th, lfge'n~ to Table 16. The bound lipoprotein fractior1
was eiuted by 20 roM EDTA •. Total cholesterol. VLOL :.. LOL and HOi. cholesterol. triglyceride'
and. pz:ot.ein .preae·nt in 'the bound Era'ction w.r·~· ellt.1mattfd a .. described in legend








and under th.ese ~ondition8., no appreciable 10s.~ of lipo~roteln }
binding caPacity of the c;olumn was- observed, - as judged by
~ . "
the b.~nding'Of eillilar aw:>unts of protein ",nd total cholesterol
in each experiment.' The restllts suggest t~at sepharose-pc'BP
.""
· can. be reqenerated and Ilsed fOr at'least eight ~lperiments..
..
,






plasmapheresis in normal and hypercholesterolemic rabbits as'
~ ',r .
d,., sed,bed iri Chapte,r 2. T!'lble\ 18 ,lUmmariieS the .r,e9u~t8 ~~
fo.ur exp!!rimenta perIormed/, 1A.ftet; e.ach experiment the
Sephar9s~-PCBP. cO,tumn ~el~~-fd.....ith EC1!',('. 1~ eaCh: CIl.S~, •
~the 6ou·nd fraction. showed thF \pres'~nCl! of,.-<ChOl.e8t~rol,.
triqlyceride and protein. ~ FurtherlllOre .. al shown in Table' 18,
I - '
most of. the chollllterol ( ) 95 \) bound to the .sepharose-PCBP
columns wa's recovered in the VLDL + LDL fraction and the rest
· ,in ~~~ HDL f~CtiOn. The alllOunt df' cl\oles·t..er~l bOIl.n.d to
Sepharose-PCBP .ranged from 0,22', to 7.7' of the total plasma




· bound was propor\:icnal to the bed volume of !the Sepharole-P.CBP
by' comparing t.he pre- and post-plasmaphereeis' plasma
concen-.rations·.of albumin .and t~tal protein. Thl! post-
columns used.
In ~l1e experiment '(animal nu.mber 4), the specificity of
the cofum~ w~'s evaluated by estimatinq the r'ec~verl~,s of
alburrin and total protltir1:. The recoveries were calculat.ed
.:' '.~ . -':. ...... .:.'.... " ~ I " ··1.' .t.,. ·.d.: .: .
Table 1,8 rI;
." .
%~ twrrl '"Triglyt:eride Protein lcftd3l.·
d1olesterol 'liurd ~tnrn_
""""""".' (ag) (ng) d-oleitBt:i
in~ '- b:u'rl
ue;ed.(ml.).
'I'yp! of Tctal plasm Be1 \Olme Total %of lx:lriI
~t cb:>l.esterol ~ Of~. d-olesterol dloiesterCJ..
. (ng/dl) l::o.:n:1 (rrg) ~
oolmn in VIlL +
UL




rornal. 13.8 10 3.86 97 0.68 0.99 7.7






11.62 <iI. ..,1.42 4.2 0.22
Hyper
ctol.estro1.eTlic 2B2 40 'Z1.62 98 2:4 14.56 3.27
.' I . .. ....
Rr~is~. an .extrattlr(xreal c:irn.rl.t....t\i¢ ircl.uded a Sq::harose-fCEP colum an:l a pl.a>:rn:1 sepa.ratol:"
was' a:nstrv<:±ed. Bla::d 'o..es wi~, fran the -c.arotid artery of the ral:bi.ts ard~~ted frcm the b.l.o:rl
cel.J.s i¥~ t:hrtu:jl the. plasrra ~tor. The p1.aslR was then f8SSe:3. t:hrw;t\~lum (bOO \OllFe
'~~~t,~~~:eWm~~'~~~~~~~~
the p1asrlBp1ere$is systEm. After l..i.p::px.t.ei tx:un:1.to:~....ereelute:.'iw:i.th 20 IlMEDI'A.. -Total dDle3terOl,
VlfL t La..~ ffL dxllester¢. triglyceri.de arrl prot:.eiri "in.the txiJrrl fta::titn \\ere e;tirratl'rl as d:!scri.brl in J.e:;1erd








va-lues were corrected for the (rfTIn:~ dU~in'':l t.he
experiment. ~esu1ts' showed that ,94 and 92l ':of albumin 3n,1
total protein, respect iv'tY , '...ere recovere,l, thus suggesting.
tl:ti'lt: the p,,t::;2,l;cdure docs not cause i'I significant degree of
... ..,..., .
nor-speCifi.~~oval of plasma proteins. The 5m.,11 l..?ss ,rn~y
be due to the non-specific binding of fibrin or gammaglpbulins
to the surface' of the eQUipment...o,l9'ed. Such non-spce-ific .
binding o.~-: thes,? plasma proteins to plasmaPher~5iVdevices ~
has been rep~'rte~ bi!fot>c (,194'), ,although aosarption of "smari
dlllOunts of other comp!?!\ents o.f plasma to Sepharo;le-PCBP




!E. vitro and iI! Jivo, demonstrate. that
SQpharose-PCRP columns can retain plasma linop'rot9ins, Of
~bte~tial irn~~tance i~ the ob~ati~n t~,at the sepharOS~~PC13P
columns bi,nd mainly VLDL + LDL_ and Qn ly some YOL (Table
16,17,lfl). The vLIL + LOL and HOt. fraction's in the material
bound to Sepharose-PCBP 'were 'scpara~e.-l u"';ing the
heparin/rnangane-se pree ipitation pro:cedl1're (,1'52),
Heparin/m~ngane5e reagent specifically prec.!pitates VLOL +
LOL leavi~g HDL in t.he supernatant, A possibility cKists
that the HDL e (,containing apo E as m~jor apoprotein) present
in hypert:h~lestrolemlc 'llas-ma, may bihd.. to sepharose-PCBP',
r ~Dr:.c' if. pres'ent' in the Era'ction bound to 5ephl\rOS;-PC13P may
be preci'pitated by heparin/manganes'e reagent. However,




st.udy have been shown not to !Jreciplta'te HOL cont<'lin.i.ng apo
J:; (152) .. HDL is thought to play an im.,p0rtant Yole in plasma
'cholesterol transport\ and, in contrast. t.o LOL•.it seem.,; to
'protec·t 'again~t the pr·ogression of atheroscler~l5is (J4).
-- ~ .Therefore, t.he .miryll)al .binding of HDL t.o Sepharose-PC~P
"columns'observed in exp'e'I"iments !!!. vitro and !.!! vivo; is ~
desirable _property for the potential use of such columns ·to·
seleo;::t·i.¥ely . red~ce plasma ~DL levels. ~t., may be relevant to
add th~t periodic remov~l of a.. small fra,ctiO:Of HD,L.dU~ing
p~asmaphet'esia tr.eatrnents has .~ctually been sugg~sted to
induce <'In &l:-ev~tion of 'plasma HDL c0'l.centration.s (197).
',l'he Sepharose-PCBP' columns do not ·appear 1;0 significantly
remove any ?ther plasma proteins as sl:lggested by tbe allnQst
quapt.itative (>92%) re'coveTles of albumin and total' protein.
Ho....ev:er. t.he ·column capacity 'for bindi"rlg cJ'~o~·e~'te;ol in vivo
. '. -..
does not appear to be similar to that .expl'!'cwa fjOrn st,udies
!!! vitro. From the studies ~ vitro, the maximum column
capacity ....as estimated to be 1.6 n:g cholesterol per ml of
gel bU~ the maximum capaci~y estimated ~~om the e~periments
!E. viv~. is onlY'lo.69 mg cholesterol per ~ of yel. In
comparison· with the other ·affitH,ty adsorbents used in the
plal:!.maphcretic lowering of plasma cholesterol. i. e., anti"'-LDL .
. ' ) Sepharqse. h;"parin-agaroseanddextran cellulo.pe.(l92.l9J.l94), .•~\"
the l.ow capacity·of Sepharose-PCBP columns in. a plasm~phei:etic




One reason for this r.ed.uced, column .;apacity llll.ler·in vivo
conditions..may be t:te h~emody~amic an,'i hat!lUo<li lIlt i ..m f,,,::t0rs
involved in plasmapheres/s. For proper. ffi.'\inten<'H1Cf! or the
blooj pressure and healtn of the animal throu'Jh the experiment.
th£· .arterial. .... i.tndrawal rilte anCl the venous ~nfliSiOTl rate nf
6,e b~')odweremaintained at approXi~ate~l'r:22 ml/min withdrawaL
al:ld 5 ml,/min infusion. '1'hese rates tr3nsl.'I.te into xcry hr~Th
flo..... rates. at whieli the .plasma .i_s ,chro,natog·rap.hC~d on
~ , ~.,
. // Sepha;ose-PCI3P column;.' It is' possible that at such hl(]h
flow ~ates, the Scpharos~-PCBP may not function tq ita
. capacity. tn 'the' eKPerim~~ts ~~. the Scphilro5c-rCj1P
columns were ~per~ted. at only 20 "mC per hour. -./:
Prior to' each experiment. ~ tlle circuitory of tl1t.~
".-', ...
'plasmapheresis .system -:a.s p'r:ime~ ~.ith lactated Ringers
solution .....hich caus~'" as ~i.Jch 'as ~'n"~~-'fOld di lutlon ;)f the
tot
f
blood volume. 'Th·ts' haemodilutioo "",ill lower the
pl.as,a. con~e.nt-ration.of all the compooeots... "n:l.rn"y r~slllt in
the t. ed;uced biod~~q capacity ·of Sepharose-I'COP Cl)~UrnnS Eo"-
ltpo roteins. Furtller experiments are required tfJ invasti'J"te
the influence 0f thesE\.....(aictors 00 t~e pt!rformnr'lce of
Sep'harose-PCBP col~mns in vi"vo.
'.' . . ~
A possible approach that may circum....ctlt the .influenco of
haemodynamic a'nd haernodi lution factors is to u,s~ Septru~o.Be-l'CBP
.it"!.a batchwise fas~i~I}.' Such an apprb<'tC~ hilS been a~loPt(!d ,.
l~ the use of' heparln-agarose for' the r~movaL of plasma




withdrawn into 1)100(1 tcana£uaion bags conti:l!ning heparin-ll.g<:lrose
ana ca2 +.· During j;,h~ withdrawal of blaod, the blood bag was
'. mixed by qent1e a9it~tion and ubder these, conditions both
yLDL anc:!·LPL.. were ,complexed with ~eparin-a9aroae.
blood. defic;:lent of sOIl\e VLDL and LDL was reinfused 10t9. the
patients. The simplicity,of. thi~ procedure makes it possib-le'
to at~empt. similar studi'es with sePhirose-POBf'
In the ,preaant experimalJts PCS'P ~~ immobllieed on
. .
Se~haro6e at a conoentration of 1'mg/ml. The pOBBibilit::(,
'e~i~ts that. incrtea?,.ip9 the'co;.centratipn ~~ immobi~ise;d PCBP
Inay increase l.ts~ipoprotein.bi.ndinl'capacity.
~ . I~ ~h; prese'n:,' exper1ment it.. is.~ lilt-~lY that ~O~DL
(also' ll-VLDL·-in case 'of' hyperchoiestrolem1.c rabbits) and
"'.. ..... '. ." .-"
LDL are bound by Sepharoae-PCBP columns ". 'Although the_ " .
,'. . .
'binding of VLDL' is' 'not--undesirable; this binding may be at
the ".expense ot;' LD~ a~.~ ther.eiore 'reduced amoun~s of 'LOL mar
- .". ~ . , (
be removed.. In a.ddi~t.~n. i.n the. experiments with
hypercholesterolemic rabbits the presence of large··quantities
of apo E ri,ch . B -VLDL nla~ reduc~ the' amount' of ~.rJL bound to
SepharoBe-PCBP.
In their 'studIes w,ith anti, .LDL-S~Pha:os·e. St-offel. and
l!emant, (193) .h~ve ·u.sed -pl..asma separator filters. to remove
excluBiv.ely LOL from the 'plasma· and not ·vr;DL. These plasma:', ",
separater filters 'retain the large. sized plasma components.
(MW ),2:. QOO,,'~OO) in<:l~dit:tgvi-n,L, 'bU\ ~~'~h 'LDL an:d BDL coin~letel~
pase, t!'trough ·these membran.es, e,y' U1ling ~a ·combinatiOn of th,eae
",,'
lB.
plasma sepat"ator filt'et:s and the 8nti-LOL-Sepharose columns
in the plalll.aph.retic system, exclusive c.maval of LOL trom
the plasma was achieved. The use ot such plasma separat.or
. filters may imprO'"ve t.he LDL' .bindlng capacit.y· of t.he
sepharos~-:CBP columns.
The main aim of this study was to test the ablllty ot
se~harose-pcop eOlUlTl'ns to:' bind VLDL .. Ll,L in a' p'tasmapherety:
system.' In this respect the pilot study has been successful
and generated new ideas to ir~p:ove the per~..orman·cf'! ..Of the~!,
cQlumns. However. t:he selectlvity of this .column must be
rigpurously teetod and- its capacity improved before the
, ,
feasabilitY~Of use In clinica.l ~~~(l.ls·is;,..considered •. It.may
.be relevant 4:.0 aCld here t'hat t·he dth~~'affinity a¢lsorbents'
used for' lowering . p.~a.sm~ LDi.~ lev.e,l.s. - h.'lve some dem~ri.ts.
For instance. the prOcedure Which utillz;es tho anti-LDL-Sephacos.
. .
co~'Umns involv~s. t"aiuing monospec~tlcantiDo$1i~s against. LOL.
isolation of 'the antibodielll using an app'r'opt"late' aff~-n1.t.y
column and. .then coupling the antibody to II Sephllit"o.!'e. These
lire t'illte consuming and ex~ensive. proce.dur~s•. r,equJ t"~n9 !
great deal. o~ exp~rtise 'and manipu.li!'tlons. Potent.ial pt"Qblems
·also exist. with the ol1'e of hepoat"i,n-Sephat"Olle· slnca .numerous
impot"tant plasma proteins 'an! 'knOwn'to have high .. fflnlty to'
'iT1Ull9billzed h~parin. 8-.9.-, se;"er8~ i'PDa:-tant ~ompo'n8nt's o'f
f the. ~oag.uration ca.cade, iipo~,ot.'n 11pa.o, and :componen", .
.of c'omplement syrtt1em (~9a). Similarly the use of delttt'an.
su.l._f<tte cellulose haG. a potential pro~lem ~onsiderlng the
. . ~,~ .




known effects of high molecul~r weight dex~rans" to increase
~:eciPit~!.c:.n O"~~ibrin09:n o.s well as cause aggregatibn of
platelets. It is possible th'at Sepharose-PCBP .may have y"e~' ."
unidentified advantages over the above mentione.d affinity
",dsorbents. The results obtai~'ed from t'hcse pilot studies
should ,provide the (impetus for further work in this direction.
Chapter 8.
PERSPECTIVE AND FU'1'URE DIRECTIONS
The. major purpose of this thesis ....as to· understand the
m';lecul'ar basis of lrit..eractlons bet....een peBP and phospholipids
. .
and ~ipoproteins. It ....as reasonable- to expect. that l.nsights
into the mechan,isms qf interaction may provide clues as to
the function of this protein. Efforts in" thi·s direction'
....ere made by utilizing condit~ons of limit-ed complexity. It
. i~ likely that under isolated co·nditions it may be eas~ei: to I
defir.~ the pro~~rt.ies-of·PCB!?, becaua~ of ma:xedly de·creased
c;omplexity~ Once a .link .... itJl functional capabili,ty is
i,?entitied it ....ould :pr·ob~b~:r. be easi.er, to' deal wi.th the
additional comP.14e~ities of sy~tems !:.!! v1vo. This. ~pproac~
necessitated the use of moael systems ·and studies '!!!. _vitro.
H0"gever, sliCh- a-n approach ,does permit. discuss-iona and
- .,' ~
speculatio~s on the potentia,l implications that. mi't;y ar:iae
'from the new information. unravelled. '--.-.
.\.\., .
,8.1. Possi?le. ,implications of PCBP-liroprcte·in intera~tion8
Tl'!e results· pre'sented :l.'n Ch'-!pter 3 ahow a strixing
/difference in the 'reacti';ities ~f glycoeylated PGElP and 1-"P'
. .
and the two non-g'lycosylat'ed CRP (human and rabbit) towards
hep~rin-lipoprotein i-nteractions. The preservation. of
phosphorylcholilie-binding property .in all' these' proteins
SU9gest that it. may .be 8,~n9lY important in their ~i010gical --...,
£unctio"o'i s) of·th·e.s\ proteins.
iOn Chaptel:" 3 show that the presence of sialic acid resi'dues
............... 'c,jnfer an aaditional ability ie.· to inhibi~ the hepa'r1n-
iipop,rotein intera!=tions. It is temptin.9 ~o speculate. that
this inhibftory prpp.eyty' of .PCBP. and FP may have a' functio,n~l .
• rol~ in the rat and Syrian golden hamster species.
It lias been proposed that an inj~ry to the,outer endotheli'al'
cell lining of the arteries may expolJe the'underlying glycosyl-
aminoglycans (p~esent as pr?teoglycans), and lead to complexing
of piasma VLD~'aQJi'L~L with the c;llycosarrJinoglycans (~3). As
reviewed in Ch~Pt~r 1 of this thesis,- ionic binding' is' the
. . \
mos.t. .J.ik~lY mechani9~ _by which !las~a li~oprote~ns~n.Qe
s"elective l:r' retainli!d by the 8u.bendothe.lial glycosam!noglycans ..
This\~~titial entrapmeJ\t o~~·VLDL.and ~DL w~th~.:· the vascular
endothelium is postulated to' be one of the mechanisms a;ssOci.ated
with,the 'proces~'of l~pld 'ac~umulation'in the arteries.
It is' concel-vable.,; , therefore,', that the presence of j?CBP
,?r FP may' lead to 'inhibition of:intera"ctiC¥! between plasma
. l.i;poprot·elns· ~n'¢\ arterial ylycosaminoglycans. Th,Us the·
'pr:esence of glycosylated phosphorylchol"ine bincj.i.ng proteins
in th'e circuliltion ~ay have a"' 'protective t:01e'tn the deposition
. - . . .,' .
'Of 11Pc:'proteins i.n the artery, ......
If' ,this l.in·e of r.~ason1Jng !.!' e'xtended further;-, jl'\S
failure of nOn~glYC~SYlat~d ~uman or rabbit CRP to inpi~.it
heparin-l.ipoprotein ,iJlteraction~ r~i.ses the ques,tion .. o'f
wheiher thi.s {nabilf~y. rna}' 'have any 'p~thdgenetic signffic~n~e.




SU9,9ast,th"at:-the presen'c~ of' CR~ at a si"fe of arterial
endothelial .damag~, ~i9ht facilitate the 'irnmobiliza,tion of
VLDL/LDL by glycosamin01;llycans. ..
. .
In this regard it iS,af intere!!t that recent "results of
/'(
I
Reynolds anrvanC7.(199) have shown .the Presence of CRP in
human atherosclerotic 8<?rta by immunohj.stochemical techniques.
The patl"ern of. CRP localization was found. t\) be similar ~o
. , '"
tha.t of app B." T.hese findings were .in~erpret'l!d to euggol!fst.
an aggravating role of CRP· in the depositi<J,n of lipids in
·the artery.
Thus _t'~e co.n;:rast..i:ng behaviol.lr o~ .PCB( {and FP)._and c~p
-towards heparin-lipoprot,ein' inter<i'ctiooa ffi.dY bear "some
• r,elationship t~ the obserV""~bn !,hat tlie rat and -'~---'---',<,
(200,201); whereas,. humans and rabbits are stls'ceptible to·,.
such deposition {22,2Ql}. In cas~ .0,£ syrian h~mster specfes.
given the" lOO-fold' sex difference -in serum FP "levels, one
may e~pect a corr~spondiry9 se,,' difference in l-i"pid deposition.
This' question remaips p.nan~were~ at 'p~,e~ent and co~plicate,d
by exte'neive amyloidosis and .earlY-ejlemi~e 'Qf temal,e ham8te.r~.:
. \ bottt8'ex l_i~h~d phenomen~, ;.-'hich ar~'poseibty ~~lftted to ~i9h
FP serum levels (202).' .
... However the: SU99~of a role for the's¢ proteins i~
arterial- -l-i.pid ?epositiori .)us~. be supported by further'
investigation. rids 'becomes esr-eoiaily important. in view of
194
,
the fa"ct that ,l:teparin-lipopr'!tein interactions were not
p~rfo.rmed\ ..... ith physiological ionic st.t:ength and ca2 +.
concentrations. although it i~ generally .recognized that
. .
.atherosclerosis is associated ....ith increased dep~ition of
calcium,~ th? arterial wall (203). Further un~rstandin9 of
the moleqular mechanism of li~oprotein-g~ycosaminoglycana~d
a role of phosphory~oholine binding proteins in this p~ocess
may re"'al BO/Il~ insightlil i~to the mechani;m of .lip~d d~p08ition
. .
in the arteries: The syria: hamster mOQel c'ould be exploited
to study· the mech~nhm ·of lipid .de~Bition aft.er mod~iatin9
it eeirns .rea8on~b·le to .specul~~e·,that peBP' and FP. may affect
)
. . .
th~ levels of FP by appropriate hormona"l treatments:.,
.Another potential consequ-en·ce of the inhibi~io~.
..'----'__hepa'r-i~n-~~ritirn-p~iPit-~~i-~~~;',·~~~'~-:-~-~·~-;-·:~~~l~~s -. :.:.,
the ~nzyme ,ii~prot.ein.'li~ase.· .·This enzym~ whi ch hydrolyses
tri~lY~~rid'ei ri.Ch: liPo~r.~teins oC,curs· on, t~e surf,ace q.f
ondothel.iai cells lin·in.~ .ca~illary ·beds and is known to be
associated. "'i~t~ ~h~~ar{~f~~tr~t;ure~ that a:r;,e pre~.en o~
,<he surface of these ~,ls (.~04).. It has been sug'gest.e tha......
the interactit>n Of :triglyceride-rich lipoproteins w h t~e
hep~rin structuf~S migh.t serve .to~ anch~r the lipoprotein
part~c·les to the .d:pilla.ry wall. thus allowing .the· enzyme
accesd 'to hydrolyse· t~e triglyceride core (104)._ .Both aPo .0
,. , .
~nd·apo E.pres~nt ,in tri~lycerid..El-ric~ lipoproteins could ,~e
.invOl'{ed ·in ·~he ~I!-choring proce~s_ In light· of the abil.ity
. , . .






the lipolytic action.of lipoprotein ligase,
The most interesting revelation that' emerg.ed from t~is ,._\
thesis was the selective interaction of lipoprot:.eins containing
apo Band apo E' with peBP imiobiiized on Sepharose as
,/mcinst.rated lIT'" Cha~ter ~5"; Jhe'~iewed in the overall
conteft ~,lipoprotei_n met~isml several~nctio~al roles
may rnlerge from th&> selective interaction of P,CBP with
lipoproteips cont,aining {:ope: B and ape Eo' Theoretica·lly; the
binding o,f P~BP ,to the surface of 1!.r9protei~s may lead to
an a,~terati~:Hl in -th~ accesBiQili~y of ~he lipoproteins t.C! _ ,
various enzymes 'and trans'fer proteins tha't' particip'lt:ta il'l
l~pop,:otein me.taboli~m.~ S~Ch:an alterart'ion ~~ul"te expected'
t? hCive a' profound ~ffect on the structural remo~ell-ing·that
. .' ..
resu1.ts. f;com t.he action of the enzymes and t.ransfer prote.ins ," '
Since t~e stru;,\:u'ra.l rem<;>delling 01: lipoproteins 1"s an
integral component of thei~ meta~lism, peBP could .indirectly
ha~e an cf~.ect o~ the met.abOlfs,m of liP<;>protei~. ,
In addition, the' binding of P.CBP to lipoproteins.!I!
vi~o may inflluence the .rece~to~-mediateduptake of lipopro,teins. ./,.
The results prl'!'sented i~ Olapter 7 support the conteil'tion 'that
-' . .
flu...id-phase interactions between l'DL and peBP may inhibit, the
binding' of LDL to LOr, receptors. In, order t::o postula,te a
role for peBP in the pro~ess of "receptor-mediated uptake o~
. 1.i"poprbte.4ns ~ viv-;' certain un~~ue ~e~t1ires o'f 1/.Pid tranljport
in: rat should be 'borne in mrn~. For inata"ce'; relatively
..~







~hile m~st piasma cho~sterol is carried in flOL (J9, 471.
Furthe.rl'llore, in'. contrast to hUnlllnt.HDL, ra't. HO~ contains
8ignifi~ant a.mo.unt."S of apo E: (3;). 1n vie", of .th~ low
--- "
concentration of LOL in rat plasma, it has been proposed
that HOL t.hat contain apo,E,i may be a major vehicle. for
transport ot chole~t~r'ol to cells conta·ining f:oDL receptors
(205,206r. This role is normally fulfilled by LOL!n humans.
::'.-,
,',
'it .is believed that the presence of high amounts' 0: Ilpe E-
'rich HD~ in rllt pla'tma makes it a~ effective 'substitute for
LOL ,in this 8lJe·c.les (~05):
con8i~e;ing. these observat:ions ir\' prope~ pe.rspec'tiv~,
i't:: ~Uld'.ppear th~t 'ape E-'rich" .HOL" is an at.tra~tive cand.id;ee·
'_ .fOJ; intera~;lon wi.th,' PCB~ in rata-. ,"'I~ J.~ likely ~ha,~. PCBP- 'II
apO Erich HOL £nter~ction! would be fa.,:,or·ed by ~he 'preserace'
... of large amounts of 'apo E-rich HDL. The possibility of
, ,
interact.J:,on bet....een PCBP al}d ~po J:::-containing HOL is in
.accord· ....ith the re!'ulta p~es.ented·on ,?,apter- 5 Which shows





to PCBP immobilized 'on Sepharo~e. In ad ition, preliminary
re;'ults 'in~icat" significant ~inding of. fa HO.L to Sephar~8e­
PCBP (211).
and cUatrlbution of cholesterol to various tissues.
, , '
What are the'c0r:teequences of accepting that an interaction.
between PCBP' and. lipoprotein l!!~ does lead to inhibition
~f the' LOL,receptor",:mediated uptake? 1t wciuld suggest tha,t . ,.: .






However in view of the total :dCk of knowledge :reCJ~rdin9
interactiDns btl tween PCBP an~ lipoproteins ~ vivo these
propos! tions can only be regarded as speculative. The potential
implications of interactions between PeBP and lipoproteins
do warrant further inqu--rrr-es along \he~e l\.-n~s. ~ 90~U
,starting point in pure;ui-ng ·t.his proposal would be to isolate
PC~p-lipop'rotein 'complexes '(if an>}) circut'ating in the
I _. •
pJ.asma and perform physi,;o-chemical chara~terization at
these comPlexet' ' ,
-\ 'llhe pr,ese t" studies have a~so brought to light certain
," .~bindin9 propert s of SePhar~se-PC8~-which rna; ~ro~e to be
'useful in further unlierstanding the metabolism 0.£ VLDL a"no'HDL;
The .r~sults pr~sell~ed -i'n Chapt;er 5, show th~' separat.i,on
of VLDL into,' two fractions (unbound and bo~nd) by means of
chromatography on S,epharose-PCBP column. The bound fraction
.,. ,. .
was enriched in ~po. Band. apo E compared to the unbound
fra·..:tion., Similarly, application of tlDL, ~ sePha~oBe-pc,BP,"
also"' resul t.ed in t'10 f;a~tions, where the b~und RractiQn of
HDL contained' all the a~ E and Lp(a) a,pplied" ').
A nu-mber, of earlier stu4ies have utili,sed various
techniques to isolate VLDL and HDL sUbfractions with varying
ap~p?b.terl1content (~8, 59, 172.'.207, ,20ij),. These tl;~iqueB:in~olve
ultracentrifug'atioll. f.ollowed 'by Geon-PE!vikon block
electrophoresis. 11) .applyi:ng these techniques ,investigators
have used the p}'lyeical propertie.s of the. lipoproteins.
\ additi·o". ~e,p'ea~d ul1;;racent:.:ifUgatio.n ca~seB .Big~fica.nt· ,',
.<
19.
Iassell 'of ,?poproteins, e~peC(1allY_PO E. from lipcpEoteins
(3Q.209). Ape E"-enriched .s;tlbfractions of HDL have also be~e'n
obtained by heparin/manganese precip~tation (70). t!0wever,
this p;G1cedure involves preclpitatioQ., washing, resolubili~ation.
and dl<:lysis o~ the lipoproteins' and may. result in the
dis.soc.iation of apoprotei,ns (210). Heparin-se'pharose affinity
chromatogt'<tphy has beel) used to separate VLDL and HDL,
liiUbfractions that di.ffer in t~eir 'a~ilitY'to bind in vitro
with LDL "receptors (172,207). ~e basis for the separa"tion
. ~ . ..
. on heparin-Sephar~e is the affi?ity ~or h'ep<?-rin t9war'!.:>. "ape
Band apo E ,.(56). In this %'egard,one importalTt'di"fferenc'e
bet.weebpeBP ,binding and .heparin ·-b!ndi~9 rn-ee'"ds to be. POin~ed.
~t i.,e:, .where~s the n~utrrli'zation of p~sithe char9~s on
.ti'Qth the lysine or the a"rg·ini"ne ,residues ab~lishes..,~e
ability of lipopr~teins to int!'!ra'ct with 'hepar(n (56), on~y
.r~OJific~t~on of ~r9~~ine.'residueS aff~cts~~ binding of LDL
to S~p)\arose-PCBP.. Therefore, the nature of interaction
between lipoproteins and heparin appears differ~nt from that
of, PCBP-lipopl;"o.tein· ~n.teraptions, On the basis of the
results obtail\ed -In Chapter 5, it seems po~sible tha.t
sUbfra.ct.ionltion of VLDL and HD_L by Sepharose-PCBP chromat'Qg~aphy
may provide ~n altQl"nate ,ap~roach to the abov,.-mentioned
methods. Further. stu~Hes may be. perf~~med ~o test the
ability of ·t~'e sUbfra~tions to inte'r~c't with LDL recep\ors
on cUlt~red 'cells. Basfld 9n th~ increased content'~o.f ap~. B




may bind bet.ter to th.e .LDL (rE!\~tor§ cOlllp·are.d t~ the unbound
fractions. If indeed thlS hypo.t.hesis is true, sUbtract.lona.tion
by Sepharose-PCBP chrolllatography may prove to be' a useful'
method to separate and_ quantitate receptor active and inactivoJ
Eractiort's of VL~L al1d HlJL.
8.2. Relatio.nship of 'pcap wit.h CRP
While it was not the puq.>ose of t~s study to ~6tabi.ish
t.he relationship ,~f PCBP with CRP, "evaluation'vE its posS:ible
r.elationship may help identify the ftlnction of these pt"oteins.
The f.':!nctions· .:If. ,Pentraxins are ,Poorly unders~OQd.
Several biological activities .!:.!l vitro. (reviewed in- ~hapter
. '. .
1) have1been described that are consistent with a role.in host
d.efence during injury and inflammation. The indu~tion of
CRP •.bY iQflammation and injury .fl.lrtner supports the concelJt
• of a rOI~ in ho~t ~defence ,eluting tissue dama?e 'and repair .•
By the same token, the presence of CRP in .the normal sta.te may
!Je a di!la<¥tantage and-therefore the protein is not produced.
Failure of CRP to inhibit gly'cO$4minoglycan-lipo,protein
interactions in the arteries could·be one s~Ch d.isad'1antage.
On the 'ot~r hand, PeBP is .pre!:ient ',in l.~rge amounts in
normal state and the curre"nt studies sho..... only moderate
. . '-
induction by'1nflalJlll\ation (Chapter 3). Tnese observations
may be interpreted to 8~9gest .that unlike CR'P, PeBP may have
a 'definite "role ,in normal daiiy physiolo"Jica~ proces8es . in





of. their met:abolism ,may be one-1uch role.
The results pre""tented io' this thesis also show that.
PCBP exhibits similarities with human CRP in its ability "to
, -
bind .to ·'phosphatidylchol.tne containing liposomes ,,"9 well as
plasma l'iPoproteins. tlpwever &..a"":discussed ab~e a major
di,.fEerence exists between PCBP and CRP with respect to their
eff~~S on heparin~l.,iP01=orotein pre~ip'itation reaction. -
~ased on these considerati'ons it appear.9~asonable to
specula'te .tl~at. evel1l ;'~OU9h bot,h the ,proteins m~, belong to
the same family, the~~ ~~ functional differences and
di\ie~tie9 between PCBP and CRP;
A s~milar a.rgument.·may be put fDew,aed bas'ed on the
evolution ~f PCBP apd CRP. ~n terms of"evoluti~m it is
possible that both PCBP and CRP Illay have desce~dea from a
.
common ancestral gene .. During the course of_ ~olution there
t:ould have been some divergence in the original gene giving
.....
rise to d'ivergencl'! in the protein products. Conservation of
~ the phosphoryl choline' binding doma~n may permit the .,ret~ntion •
of phosphory~ctloline binding .¢roperty, .....hile a divergence in
.• othe~ domains ff the protein may res'\.Ilt in glycosylation ~nd
differen~.i"al patte'rns of·express.ton during normal ,and acute ··r
phase states.
, ,
The glycbsylaticn and exp:':"ess,ion du'ring the normal
... ,'
state o~ the .animal may confer additional diverse functions
upon pcep, in comparilKm to CRP. ,Fur,ther accumulation of




functions of t.hese proteins will permit, a mor~ comprehensi.ve
ana1:ysis· of t.he rela tionship bet.....eel;l PCBf> "and ""CRP.
- /
In summary t~e ?SUltS presented in this th~SiS reveal
the ability of, PCEP to interact ..... ith phosphati.dylcholine
cont.aining liposomes and human plasma 'lipoproteins containing
apo B and ape E. Th~se interactions reqllj.re t.-h1i presence of
Ca 2 + and ar~ proba,ply mediated ~y a phosph~iylcholine binding
site on PCBP. The sialic~aCid r;-esidl;lesJori: peBP ~ppear not €~
be directly involved in the,binding of plasma lipoproteins.
Ho.....ever the sialic acid residues on PCBP are necea;sary to
. (
express its inhibitory eff.ect on hepar-in:"lipowotein
precipitation "reaction. The arginine resl<iu,,:s on apo ~ are
. .
directly involved ,in the interaction of LDL .....ith PCBI1. ..pf
particular interest is the demonstration in vitro that the
. . - --..
binding" of PCBF,.-to L,DL inhi~bits' the LDL-LDL-receptor
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